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Im Feld der Biologie, und speziell in der Synthetischen Biologie, ist die Verwendung von so-
genannten Design-Build-Test-Learn (DBTL)-Zyklen eine generelle Methodik um z. B. diverse
genetische Konstrukte zu generieren und zu optimieren. Die Geschwindigkeit für solch einen
DBTL-Zyklus ist hauptsächlich dadurch limitiert, inwiefern DNA Fragmente erfolgreich zu
komplexeren Produkten assembliert werden können. Eine Möglichkeit dies zu gewährleisten
ist die Automatisierung der DNA Assemblierung mit Hilfe von Robotik-Plattformen und wird
zunehmend verwendet. Unglücklicherweise werden dafür weitestgehend Assemblierungsmeth-
oden verwendet, die einen aufwändigen Planungsprozess benötigen, die Wiederverwendung
der genutzten DNA Fragmente erschweren oder sogar genetische Narben in den Produkten
hinterlassen. Eine Assemblierungsmethode, die alle drei genannten Limitationen umgeht, ist
die Ligase Cycling Reaction (LCR) und wird daher in dieser Arbeit verwendet.
Im Kontrast zu gängigen Assemblierungsmethoden müssen keine Konstrukt-spezifischen DNA
Fragmente entwickelt werden. Zudem bleiben keine genetischen Narben in der finalen Sequenz
zurück. Zur Festlegung der Assemblierungsreihenfolge werden einzelsträngige DNA Brücken,
sogenannte Bridging Oligos (BOs), genutzt um bis zu 20 DNA Fragmente in einer Reaktion
zu ligieren. Dazu wird der Mix aus Fragmenten, BOs und einer Ligase unter spezifischen
Salzbedingungen zyklisiert erhitzt und abgekühlt um das Denaturieren der DNA Fragmente,
das Hybridisieren der BOs mit den Fragment-Einzelsträngen sowie die Ligationsreaktion zu
ermöglichen. Letztendlich wird das Produkt nach der Transformation von Escherichia coli (E. coli)
mit der LCR erhalten. Somit ist die LCR eine Verkettung einer in vitro sowie in vivo Prozedur.
DieseMethodik wurde bereits 2018 von Robinson et al. mit einer Robotik-Plattform automatisiert.
Jedoch wurden teilweise niedrige Assemblierungseffizienzen erreicht was mit einem hohen
zeitlichen und finanziellen Aufwand für das Identifizieren von korrekt assemblierten Konstrukten
verbunden ist. Die Optimierung der LCR Reaktion und die darauffolgende Automatisierung
mit Hilfe der Robotik-Plattform des CompuGene-Projektes ist der Fokus dieser Arbeit und soll
die Reproduzierbarkeit, Robustheit und den Durchsatz von DNA-Assemblierungen verbessern.
Zusätzlich wird eine in vitro LCR Methode entwickelt, um den in vivo Einfluss von E. coli
auszuschließend und das limitierende Transformieren und Ausplattieren der in vivo LCR zum
umgehen.
Durch die Verwendung des publizierten LCR Protokolls von de Kok et al. (2014) konnten bis zu
zehn DNA Fragmente in einer Reaktion erfolgreich assembliert werden. Jedoch waren manche
V
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Assemblierungen nicht erfolgreich oder die Effizienz der Reaktion war gering. Daher wurde ein
verbessertes LCR Protokoll entwickelt: im Gegensatz zum ursprünglichen Protokoll erhöhte das
Weglassen der Detergenzien Dimethylsulfoxid (DMSO) und Betain die Effizienz und die Anzahl
der Transformanten. Dieser Einfluss konnte bei Assemblierungen verschiedener Plasmide gezeigt
werden. Weiterhin führte eine Erhöhung der Annealing Temperatur zu verbesserten Ergebnissen
bezüglich der Transformantenmenge. Das neue LCR Protokoll wurde anschließend verwendet
um ein Protokoll für ein automatisiertes Assemblieren und Ausplattieren von 96 Konstrukten
innerhalb von 19h mit Hilfe der Robotik-Plattform zu ermöglichen. Dieser Prozess wurde
im Trockenmodus entwickelt und erfordert noch eine Validierung. Um die Automatisierung
weiterhin zu unterstützen, wurde zudem eine Software zur automatischen Erzeugung von
BOs und von voll-kombinatorischen in silico LCRs entwickelt. Diese Software und der Robotik-
Prozess der in vivo LCR bildet mitunter auch die Grundlage für die entwickelte in vitro LCR:
basierend auf diesem zell-freien System könnten innerhalb von 19h ca. 5×mehr LCR Reaktionen
durchgeführt und analysiert werden als mit dem in vivo Ansatz. In Zukunft stellt die in vitro LCR
die Methode der Wahl dar um automatisiert im Hochdurchsatz DBTL-Zyklen von genetischen
Schaltern und Schaltkreisen durchzuführen.
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Summary
Modern approaches in the field of biology, especially the field of synthetic biology, are based on
design-build-test-learn (DBTL)-cycles to, e.g., generate optimized genetic constructs for various
applications. The overall speed of one cycle mainly depends on the ability to physically assemble
DNA with a high efficiency in a short time period. This is achievable by automation approaches.
Several automated DNA assemblies are described in the literature but are related to laborious
in silico planning, are usually limiting the reusage of the DNA parts or are introducing scars
into the final sequence. To overcome those restrictions and to enable a rapid automation, an
easy-to-plan and scar-less assembly method has to be utilized. The ligase cycling reaction (LCR)
is the most promising candidate and is the scope of this thesis.
For the LCR, no construct specific DNA parts have to be designed and no scars are incorporated
into the desired construct. Single-stranded bridges made of DNA (bridging oligos (BOs)) are
utilized to specify the order of up to 20 parts in a one-pot reaction. A thermal cycling protocol
enables the strand separation of the DNA parts, the annealing of the BOs and the in vitro ligation.
The desired product is finally derived by transforming the LCR mixture into Escherichia coli
(E. coli). Due to the benefits of this assembly technique, the LCR was already implemented
from Robinson et al. on a robotic platform in 2018. According to the authors and the results
presented in this thesis, the assembly efficiency for some LCR reactions is low. This issue is
associated with a tremendously increased effort to obtain the desired sequence. The reasons
for low efficiencies are determined within this thesis to optimize the LCR. Furthermore, an
alternative in vitro method for the cumbersome in vivo approach is developed and is based on
a cell-free system to screen for correctly assembled constructs. In the end, a workflow for an
automated LCR is designed and initially validated on a robotic platform.
Overall, up to ten DNA parts were assembled in a one-pot reaction by applying the LCR protocol
described in the literature by de Kok et al. (2014). Nevertheless, some assemblies were not
successful and an improved LCR assembly protocol was developed. In contrast to the literature,
to omit the secondary structures inhibitors dimethyl sulfoxide (DMSO) and betaine had tremen-
dously increased the efficiency and the total number of colonies for the assembly of various
plasmid designs. Furthermore, to shift the annealing temperature to the activity optimum of
the utilized ligase was beneficial. The new LCR protocol was implemented in an automated
assembly and plating workflow for a robotic platform to theoretically build 96 DNA constructs
within 19 h and needs to be further validated. To support the automation process, a software
VII
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for the BO design of combinatorial LCR assemblies was build. As an additional scope, an in vitro
LCR method was designed and validated by using a cell-free system for the test-learn steps of
the DBTL-cycles. In comparison to the automated in vivo workflow, ca. 5× more LCR assemblies
are screenable within the same time frame of 19 h and the same hardware setup. In future,
the optimized LCR protocol and the robotic workflow for the in vivo LCR can be adapted for
the in vitro LCR approach and represents the method of choice for automated high-throughput
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1 Introduction
One of the goals of synthetic biology is to specify, design, build and test genetic circuits and
to optimize the microbial production of, e.g., biofuels [53], therapeutics [77,110], to support
the development of new microbial or plant production strains [113, 124] or to promote a
cell free protein synthesis (CFPS) with cell extracts derived from various hosts [42]. Genetic
circuits consist of DNA parts which are assembled to functional genes, pathways with regulatory
elements and complete genomes [23,115]. The circuits are build with the help of computational
methods [51, 69, 116, 123] to predict constructs with a low susceptibility regarding, e.g.,
context dependent perturbations [7]. All these computer-aided approaches are based on the
design-build-test-learn (DBTL) cycle to support a robust in vivo functionality of the circuit and
accelerates synthetic biology approaches like an increased yield of a product of interest (POI).
As a prerequisite for a computational design, the lowest level building bricks, the DNA parts,
need to be characterized precisely according to their switching behavior [6], retro-activity [18],
host-dependency [7] and environmental context [28,35,58]. The DNA parts are derived by
chemical synthesis [43] or in vitro amplification from an existing template via polymerase chain
reaction (PCR). For the utilization of de novo DNA parts, synthesis is mandatory.
The DNA synthesis utilizes oligonucleotides derived by the phosphoramidite method [84] and
is applicable for a total size of 2000 bp [43] and they are commercially provided as ’synthetic
genes’, ’gene fragments’ or ’GeneStrands’. Larger genes, circuits or even complete genomes
can be ordered and are obtained by joining several synthetic genes by ligations and PCR
amplifications. Until today, this step-by-step synthesis approach is still laborious and expensive
[43, 57]. Furthermore, to receive large synthetic constructs can take weeks or even months
(personal experience). To rapidly build the designed circuits, an automated and robust DNA
assembly method is needed to join synthetic genes and PCR products [23,43,115]. For this thesis,
a robust DNA assembly is defined as a high efficient method with a low rate of misassemblies,




1.1 DNA assembly in synthetic biology
1.1.1 Status quo and limitations for rapid prototyping approaches
The synthesis of DNA,and especially the robust assembly of DNA parts, are the scaffold of all
synthetic biology approaches [43, 63, 114] and ’[...] the limit of what synthetic biology can
achieve is becoming determined by our ability to physically assemble DNA.’ [23]. By DNA
assembly methods already designed in silico constructs are physically build to test their in vivo
or in vitro behavior and are mainly representing the ’build’ process of a DBTL cycle [29].
Nowadays, several assembly methods are used for the build process, e.g., BioPart assembly
standard for idempotent cloning (BASIC) [102], Golden Gate assembly [24,25], Gibson assembly
[34] or circular polymerase extension cloning (CPEC) [80], and are based on specific DNA part
modifications like overhangs [34] or restriction sites [80,102] (Table 1.1). Usually, the DNA
parts for the mentioned assembly methods have to be redesigned for each desired construct
(Figure 1.1). For restriction-ligation-based methods, the utilized sequences have to be analyzed
and modified to remove unwanted restriction sites [37]. Altogether, the introduced assembly
methods are disadvantageous for the reusability and automation. Furthermore, scars can remain
after the assembly. This results in unpredictable behavior of the translation if the scar is located
nearby a sensitive functional sequence like an ribosome binding site (RBS) or for the design of
fusion-proteins due to introduced shifts of an open reading frame (ORF) [23,88].
In contrast, the ligase cycling reaction (LCR) [11,16,74,83] fits the prerequisites for robust
and automated assemblies [81]. For this DNA assembly method, no specific modifications of the
DNA parts are necessary and no scars are introduced. In total, the LCR fits for the automated
assembly of genetic constructs.
Table 1.1: Most common DNA assembly methods, their mechanisms and drawbacks. BASIC: BioPart
assembly standard for idempotent cloning, CPEC: circular polymerase extension cloning, LCR: ligase
cycling reaction, SLiCE: seamless ligation cloning extract, TAR: transformation associated recombination.
Assembly method Mechanism Drawbacks
Golden Gate [24,25] type IIs restriction scars, limited reusability of parts
BASIC [102] type IIs restriction scars, limited reusability of parts
CPEC [80] overhangs, PCR amplification scars, limited reusability of parts
Gibson [34] overhangs, ligation limited reusability of parts
SLiCE [126] homologous recombination ≤5 parts in one reaction, limited reusability of parts
TAR [55] homologous recombination mutation prone, 2-3 days, limited reusability of parts
LCR [11,16,74,83] ligation no automated design tool available
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Figure 1.1: Commonly utilized assembly methods like GoldenGate, Gibson assembly® etc. are hamper-
ing the usage of a DNA library due to specific modifications of the DNA parts. The LCR allows a DNA
library based on unmodified DNA parts. By using the DNA library and specific BOs several constructs
can be build with the same parts. The parts are illustrated by letters of the alphabet. Furthermore, no
remnant scars are introduced in the final construct. BO: bridging oligo, LCR: ligase cycling reaction, TAR:
transformation associated recombination.
1.1.2 Automation in synthetic biology
The automation in the field of biology is one way to ensure fast and robust methodical approaches.
It is considered as a mandatory tool to meet the modern demands of high throughput methods in




















































































Figure 1.2: Plasmid deposits and orders of the Addgene repository [50]. A. Plasmid deposits from
2006 to 2015 [57]. B. Amount of orders from 2006 to 2019. The raw data from 2006 to 2015 is derived
from [49,57]. Data points from 2016 to 2019 are estimated with a growth rate of 9%. They are based
on the announced and predicted growth from Addgene in 2018 (https://blog.addgene.org/celebrating-
15-years-of-scientific-sharing). For all other data points, the raw data of [49,57] was plotted.
the implementation of automation technologies is well established in the industry but is limited
in the field of academia due to a high financial effort for highly specialized devices. This is
usually undesirable for the research of public facilities like universities because it hampers
the flexibility in use. Especially, the lack of a universal, scar-less and easy-to-design assembly
method to build constructs in a high throughput scale is still an urgent bottleneck [114]. For the
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design of circuits, various software tools were developed, provided and utilized which allow a
full combinatorial design with and without a rational strategy [26,69,100,109]. The utilization
of these tools result in a vast workload for classical wet-lab cloning and can be estimated by the
dynamics of the plasmid repository of Addgene [50]. A tremendous increase of the total amount
of build, deposited and ordered plasmids is observed (Figure 1.2, data from [49, 57]). This
highlights the need for automated DNA assemblies and probably even represents the impact
of the increasing utilization of automation approaches. On the other hand, computer-aided
tools have to be optimized to lower the amount of assemblies by omitting irrational designs. A
promising DNA assembly method for the automation is the LCR. Unfortunately, low effort was
spent so far to strengthen this method and to automatically design and build genetic constructs.
1.2 Ligase cycling reaction
1.2.1 Ligase cycling reaction and ligase chain reaction
The LCR fulfills relevant criteria like a fast and robust DNA assembly and fits the automation
approach to enable a rapid build process for synthetic DNA circuits. A similar method is utilized
in the field of molecular biology and is also named LCR. This LCR, the ligase chain reaction, also
applies oligonucleotides and a ligase but with the purpose to synthesize DNA fragments [121],
to sequence DNA [13] or to detect DNA mutations [33]. For these methods, the ligation is
coupled with an amplification step by a PCR. Unfortunately, the same abbreviation ’LCR’ is
utilized. Nevertheless, the method of interest of this thesis is the ligase cycling reaction (LCR).
It is closely related to the ligase chain reaction whereby E. coli is utilized to amplify the product.
In the following, the abbreviation ’LCR’ is consistently utilized for the DNA assembly reaction
method ’ligase cycling reaction’.
According to the mechanistic principle of the LCR (Figure 1.3A), no construct-specific modifi-
cations of the DNA parts are necessary besides that all DNA parts have to be phosphorylated
on the 5’-end to enable the enzymatic ligation [20, 98]. No scars are incorporated and the
utilization of DNA part libraries is possible (Figure 1.1). The order of assembly is determined by
the addition of single stranded DNA (ssDNA) oligonucleotides which are spanning a bridge from
one part to the next and are called bridging oligos (BOs) (Figure 1.3A). Based on the BOs, the
LCR offers a DNA assembly with a full modularity. To shuffle the order of already existing DNA
parts, new BOs have to be ordered only. This reduces the experimental workload by omitting
an additional DNA part synthesis or PCR amplification. Further, 12 kbp constructs consisting of
up to 20 fragments can be assembled in a one-pot reaction. For the ligation of the DNA parts, a
thermostable prokaryotic ligase is utilized in combination with repetitive thermal cycling and
the transformation of E. coli (Figure 1.3) [11,16]. In 2014, de Kok et al. [16] published this
LCR method and is the baseline condition for the following sections.
4
1.2 Ligase cycling reaction
1.2.2 Ligation of DNA fragments
First, the dsDNA is heated up to separate the strands and to allow the hybridizations of the
forwarded BOs with the ssDNAs of two DNA parts in the annealing step. The ligase recognizes
the 5’-phosphorylated end at the single nick on the opposite strand of the bound BO followed by a
binding [19,71] (Figure 1.3B) and a conformational change of the DNA by bending [68]. To bind
to the DNA, the ligase recognizes two recognition sites which are asymmetrically placed around
the nick. On the 5’-end, 7-12 bp and on the 3’-end 3-8 bp are mandatory for the binding event of
helix-hairpin-helix motifs [20]. The ligase is sensitive to a missing 5’-phosphorylation [20,71]
or a gap ≥ 1nt [97]. Both tremendously decrease the ligation efficiency. On the other hand, this
increases the fidelity of this ligation method due to a high sensitivity to mismatches, unspecific
hybridizations and overlapping bases at the ligation site. After the ligation of the nicked strands
of two DNA parts, the forwarded BO is separated from the template by a denaturation step at
94 ◦C. In the next cycles, the ligated strands serve as template for joining the forward strands. By
25 denaturation-annealing-ligation cycles most DNA parts are ligated to a double stranded (ds)
construct. Afterwards, the assembled sequence is obtained by transforming the LCR mixture
into E. coli and by screening the obtained colonies via PCR or by sequencing.
1.2.3 Melting temperature of the bridging oligos
In the LCR, a stable hybridization of the BOs with the ssDNA parts is mainly influenced by the
annealing temperature, the melting temperature (Tm) of the BOs and the salt concentrations.
At a given BO-Tm, the BOs are in a folded state if the annealing temperature is too low. No
hybridization with the DNA part is achieved and no ligation will appear. By increasing the
annealing temperature equal to the Tm of the BOs, 50% of them are unfolded [90] and can
participate in the annealing process. A further increase of the annealing temperature results in
less hybridizations and less efficient assemblies in the annealing time of 30 s. Concluding this,
the interdependence of a precisely calculated Tm for the BOs and the utilized temperatures
have to be considered carefully. Besides the adjustment of the BO length or the annealing
temperature, Tm altering supplements can be utilized to influence this dynamic homeostasis.
In the LCR, 8%v/v and 0.45M betaine are added to accelerate the strand separation time
during cycling [11,16]. Although this is regarded as beneficial for the ligase due to a shorter
exposition to high temperatures, both additives are also lowering the Tm of the BOs [65,112]. No
investigation on the synergistic effects of utilizing both additives, the BO-Tm and the annealing
temperature was performed. Furthermore, the Tm calculations of a BO tremendously differ if
another algorithm is applied for the design of BOs with the target Tm of 70 ◦C [90]. This is related
to the simplified calculation models, estimations in the utilized formulas and the complexity
of the multi-state melting behavior of oligonucleotides [90]. Those inaccuracies in the design
process of the BOs are assumed to have an impact on the LCR assembly. Additionally, the Gibbs
free energy∆G is considered as the more significant design parameter for oligonucleotide-based
5
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Figure 1.3: Principle of the ligase cycling reaction. A. DNA parts are denaturated by heating up the
LCR mixture to 94 ◦C for 2min and to obtain ssDNA. In the annealing step, the forwarded BOs are able
to bind to the free ends of the two ssDNA parts and to form a single-nicked template for the DNA ligase.
After the ligation with the help of the BO, the ligated reverse strands are serving as a template for the
forward strands. Finally, the DNA parts are assembled to the desired construct. [16] B. To accomplish a
stable complex of BO and ssDNA at the thermal conditions shown in A., each BO-half have a target Tm
of 70 ◦C [16]. The BO binds at the ends of the single stranded DNA parts to form a dsDNA with a single
nick. The thermostable ligase recognizes the nick and binds asymmetrically [20]. By utilizing NAD+
or ATP, the ligase joins the DNA parts by utilizing the phosphorylated 5’-end (’P’) of part A [98]. ATP:
adenosine triphosphate, BO: bridging oligo, bp: basepairs, NAD+: nicotinamide adenine dinucleotide,
nt: nucleotide, Tm: melting temperature.
molecular reactions [40, 90], respectively the BOs. Altogether, investigations on the BO-Tm
and ∆G, the utilized calculation rules and experimental temperatures are so far neglected
for LCR assemblies. To determine the effects of varying these parameters is one scope of this
thesis. Based on this, optimized LCR conditions can be postulated and validated to increase the
robustness of this assembly method.
1.3 Automated LCR assembly
To address the automated assembly of genetic constructs, several computer-aided approaches
are dealing with specifying, designing and building constructs but are mainly utilizing the
aforementioned undesired restriction-ligation or homology based methods [41,45,69,76,103,
114,122] (Figure 1.1). To address the assembly automation with the help of the LCR, several
design tools for oligonucleotides or in silico assemblies are mentioned: Nowak et al. [70] offer
a software for the assembly of sequence-optimized DNA parts to reduce secondary structures
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without altering the coding usage. This tool is supposed to optimize the negative effects for
synthetic gene synthesis and was not applied for LCR assemblies. Bode et al. [3] describe a
tool with an analogous functionality. Another web-tool was provided by Hendling et al. [40]:
it is applicable for the design of oligonucleotides and checks the Tm and ∆G crosstalk against
all participating sequences and chosen genomes but is not suited for LCR designs. Besides
the design of optimized BOs, studies were already applied to observe the influence of a wide
range of LCR-parameters by using a design-of-experiment approach [16]. Within this study,
the ∆G crosstalk is tackled by the secondary structure inhibitors dimethyl sulfoxide (DMSO)
and betaine but was not considered as a limitation for BOs [65,112]. So far, no comprehensive
design tools are provided for the automated LCR assembly.
According to the build process, the LCR was already utilized for automation in 2018 [81] and
is a promising DNA assembly method (Figure 1.1). Robinson et al. [81] offered a workflow
for their utilized robotic platform, the management of DNA part libraries [107] and a design
tool for BOs. This tool is available but it is not published so far. It is an easy-to-use web-based
software which allows the user to adjust the Tm for each BO-half 1 by utilizing the design rules
of de Kok et al. [16]. Interestingly, the assembly efficiencies in Robinson et al. are significantly
lower than the proposed results of de Kok et al. (40% vs. 95%). This supports the mentioned
discrepancy of published results and their reproducibility [47]. Obviously, more insights into
the design of BOs and their impact on the robustness of the LCR are mandatory to validate or
redefine the design and experimental parameters. Further, the utilized detergents DMSO and
betaine are not regarded as automation-friendly for liquid-handling robotics [1,10] due to the
extreme viscosity or hygroscopic character. The omission of both additives without affecting the
LCR efficiency would be beneficial and has to be investigated. For this, a screening system has
to be utilized to detect the impact on the LCR.
E. coli
transformation















Figure 1.4: Investigation principle for assembly efficiencies. A. The classical in vivo approach utilizes
a bacterial host to uptake the assembled circular construct with a reporter gene and to amplify it by
plasmid propagation. Genes of fluorescent proteins are normally utilized as reporter molecules. After the
transformation, colonies with a specific fluorescent phenotype are counted to determine the assembly
efficiency and the total amount of colonies. This workflow usually takes 24 h. B. In contrast, to substitute
the transformation of E. coli by a cell free protein synthesis (CFPS) step enables an in vitro readout
within one day and a higher throughput. Circular and linear constructs are detectable and no origin of





1.3.1 Screening system to detect LCR efficiencies
By considering the kinetic parameters of the BOs and the thermal cycling of de Kok et al. [16],
the positive effects of DMSO and betaine has to be validated. Otherwise, new criterion have
to be defined. Furthermore, the influence of omitting DMSO and betaine while maintaining
the LCR efficiency is of special interest. To enable a screening of varying those parameters,
the classical approach is utilizing the transformation of a bacterial host like E. coli with the
LCR mixture (Figure 1.4). This workflow results in an in vivo amplification system of circular
constructs if an origin of replication (ORI) and selection marker are incorporated into the final
sequence. Afterwards, the plasmid of several colonies is isolated and verified by PCR, restriction
digestion or sequencing. The amount of colonies with the correct plasmid is divided by the
sum of all analyzed colony forming units (CFUs) to obtain the assembly efficiency. This value is
the main criterion to evaluate the relative success of a DNA assembly. A second criterion is the
total amount of colonies after the transformation. Together, both criteria are utilized to analyze
one assembly reaction and were already applied for various methods [16,25,102]. In case of
similar efficiencies, the total amount of CFUs is utilized for a discrimination. By applying this
verification workflow, no high throughput screening is possible or it is associated with high costs
for sequencing. Additionally, the detection of linear constructs or constructs without an ORI
or selection marker gene is limited. In summary, a detection system which facilitates a rapid
prototyping of linear and circular assemblies without the time-consuming colony screening,
plasmid isolation and sequencing is preferred.
For this, the utilization of a fluorescent reporter gene is useful and was already implemented for
the development of DNA assemblies [41,102]. Correct assembled plasmids are detectable by
screening colonies or populations via fluorescence microscopy or fluorescence-based cytometry
(Figure 1.4). In addition, cell free systems represent a useful tool to obtain assembly efficiencies
by a CFPS. Cell free protein synthesis is increasingly utilized for the synthetic biology, rapid
prototyping and circuit characterizations [42, 61, 96]. In contrast to the classical approach
of transforming the LCR into a bacterial host, the assembled construct, including a gene of
interest (GOI) or reporter gene, is transcribed and translated in vitro by a cell extract and is
named cell-free transcription-translation (TXTL) [31,66,85]. By utilizing fluorescent reporter
genes like the green fluorescent protein (GFP), an in vitro LCR system can detect and quantify
correctly assembled constructs and overcome the limitations of the in vivo LCR (Figure 1.4).
Improved LCR conditions are detectable by an increased fluorescent signal due to a higher
quantity of assembled sequences. Currently, no CFPS approach for the LCR is described. The




To fulfill the rapid design and build of synthetic circuits in the field of biology, the automated,
robust and easy-to-design DNA assembly is a mandatory tool [47]. Unfortunately, the current
workflows for DNA assembly automation are error-prone due to the complex design, the intro-
duction of scars in the final sequence or are unreproducible [114]. Common assemblies like, i.e.,
Golden Gate assembly [24,25], Gibson assembly [34], CPEC [80] and SLiCE [126], are based
on construct specific DNA part modifications or require a massive in silico planning process.
In contrast, the ligase cycling reaction (LCR) [11,16,74,83] offers a promising opportunity
to tackle those drawbacks by assembling unmodified DNA parts in a desired order with the
help of single stranded oligonucleotides, the bridging oligos (BOs) (Figures 1.1 and 1.3). Up
to 20 DNA parts can be arranged in a one-pot in vitro reaction without restriction. Due to
those unique features, the LCR was already implemented for the design and build automation
of DNA constructs for metabolic engineering [81]. Unfortunately, low assembly efficiencies
of ≤40% were revealed which tremendously increase the overall screening effort to obtain
correctly assembled constructs. Investigations of the impact of the utilized LCR protocol are
necessary to address the low robustness.
To optimize the LCR assembly, the experimental parameters like the annealing and ligation
temperature, the amount of cycles, the effects and the stability of the supplements, and the
design rules of BOs are varied to determine their impact. For this, a reliable and rapid screening
system is obligatory and is achievable by the utilization of fluorescent reporter genes (Figure 1.4).
To determine the impact of altering the LCR parameters, the two evaluation criteria ’efficiency’
and ’the total amount of colonies’ are utilized. Both are obtained by observing the fluorescent
phenotype of colonies derived from the transformation of E. coli and plating the suspension on
agar plates with a selection marker.
Based on the LCR optimization results, new improved parameters are postulated and their appli-
cability is validated by the assembly of additional DNA constructs (section 3.1). Afterwards, the
validated protocol is the scaffold for the automated in silico design of BOs for combinatorial LCR
assemblies (subsection 3.4.1) and the development of an in vitro LCR to further accelerate the
design-build-test-learn cycle of synthetic circuits (section 3.3). The in vitro method substitutes
the cumbersome transformation step of the in vivo LCR by an rolling circle amplification (RCA)
and a cell free protein synthesis (CFPS). Finally, workflows for the developed in vitro and in
vivo LCR protocol are designed and implemented on the robotic platform of Prof. Dr. Kabisch
for an automated DNA assembly and also includes the computer-aided in silico design of DNA
constructs and BOs in a combinatorial approach (section 3.4).
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Autoclave Systec GmbH (Linden, Germany) VX-75
Camera Sony Cyber-Shot DSC-QX10
Shaking incubator VWR (Darmstadt, Germany)
New Brunswick™ (Upland, California, USA)
Incu-Line Tower
Innova© 44
Centrifuges VWR (Darmstadt, Germany)




Electroporation chamber Bio-Rad Laboratories, Inc. (Hercules, CA, USA) MicroPulser
Heat incubator Eppendorf AG (Hamburg, Germany) Thermomixer comfort




Magnetic stirrer (heatable) IKA-Werke GmbH & Co. KG (Staufen, Germany) IKAMAG RCT basic
pH-meter HANNA Instruments Germany GmbH (Kehl am Rhein,
Germany)
HI 2211 pH/ORP Meter
Thermal cycler Bio-Rad Laboratories, Inc. (Hercules, CA, USA) DNA Engine Tetrad2
Power supply for
electrophoresis
Amersham Biosciences Europe GmbH (Freiburg,
Germany)
EPS 301
Safety workbench Thermo Fisher Scientific™ (Dreieich, Germany) HeraSafe KS15
UV/-photometer Mettler-Toledo GmbH (Gießen, Germany) UV5 Nano
UV-table
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Table 2.1: Equipment (continued)
Equipment Fabricator Model
Vortex Heidolph Instruments GmbH & Co. KG (Schwabach,
Germany)
REAX top
Plate reader (for in vitro
LCR)
BMG LABTECH GmbH (Allmendgrün, Germany) CLARIOstar®
Robotic platform (Analytik Jena AG, Jena, Germany), also see Figure 2.3
Robotic arm Precise Automation (Fremont, CA, USA) PreciseFlex PF750
Nanoliterdispenser Dispendix GmbH (Cellink; Stuttgart, Germany) I-DOT One
Plate reader BMG LABTECH GmbH (Allmendgrün, Germany) PHERAstar® FSX
Cytometer Beckman Coulter® (Krefeld, Germany) CytoFLEX S®
Pipetting robot Analytik Jena AG (Jena, Germany) CyBio FeliX
Thermal cycler Analytik Jena AG (Jena, Germany) Biometra TRobot









SERVA DNA Stain G
Carl Roth GmbH & Co KG (Karlsruhe, Germany)
New England Biolabs (Ipswich, MA, USA)







Carl Roth GmbH & Co KG (Karlsruhe, Germany)
Alfa Aesar, Thermo Fisher Scientific™ (Dreieich, Germany)
Carl Roth GmbH & Co KG (Karlsruhe, Germany)
Carl Roth GmbH & Co KG (Karlsruhe, Germany)
Sigma-Aldrich Chemie GmbH (Taufkirchen, Germany)
Cell culture:
Glycerol (99.5%, water-free)
Lysogeny broth (LB) powder
(10 g L−1 NaCl)
Agar agar, Kobe I
Carl Roth GmbH & Co KG (Karlsruhe, Germany)
Sigma-Aldrich Chemie GmbH (Taufkirchen, Germany)







Sigma-Aldrich Chemie GmbH (Taufkirchen, Germany)
Sigma-Aldrich Chemie GmbH (Taufkirchen, Germany)
Sigma-Aldrich Chemie GmbH (Taufkirchen, Germany)
Sigma-Aldrich Chemie GmbH (Taufkirchen, Germany)
Carl Roth GmbH & Co KG (Karlsruhe, Germany)
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Table 2.2: Substances (continued)
Method Fabricator
Cell extract of E. coli (adapted from [106]):
2× YT
Potassium phosphate monobasic solution
(1M)
Potassium phosphate dibasic solution (1M)
TRIS base
1,4-Dithiothreitol (DTT)
L-Glutamic acid hemimagnesium salt
tetrahydrate (Mg-Glu)
L-Glutamic acid potassium salt monohydrate
(K-Glu)
Acetic acid 100%
ATP dipotassium salt dihydrate
GTP disodium salt hydrate
CTP disodium salt hydrate








Sigma-Aldrich Chemie GmbH (Taufkirchen, Germany)
Sigma-Aldrich Chemie GmbH (Taufkirchen, Germany)
Sigma-Aldrich Chemie GmbH (Taufkirchen, Germany)
Sigma-Aldrich Chemie GmbH (Taufkirchen, Germany)
Carl Roth GmbH & Co KG (Karlsruhe, Germany)
Carl Roth GmbH & Co KG (Karlsruhe, Germany)
Carl Roth GmbH & Co KG (Karlsruhe, Germany)
Carl Roth GmbH & Co KG (Karlsruhe, Germany)
Sigma-Aldrich Chemie GmbH (Taufkirchen, Germany)
Sigma-Aldrich Chemie GmbH (Taufkirchen, Germany)
Sigma-Aldrich Chemie GmbH (Taufkirchen, Germany)
Sigma-Aldrich Chemie GmbH (Taufkirchen, Germany)
Sigma-Aldrich Chemie GmbH (Taufkirchen, Germany)
Sigma-Aldrich Chemie GmbH (Taufkirchen, Germany)
Sigma-Aldrich Chemie GmbH (Taufkirchen, Germany)
Sigma-Aldrich Chemie GmbH (Taufkirchen, Germany)
Sigma-Aldrich Chemie GmbH (Taufkirchen, Germany)
Sigma-Aldrich Chemie GmbH (Taufkirchen, Germany)
Sigma-Aldrich Chemie GmbH (Taufkirchen, Germany)




New England Biolabs (Ipswich, MA, USA)
New England Biolabs (Ipswich, MA, USA)




Carl Roth GmbH & Co KG (Karlsruhe, Germany)
New England Biolabs (Ipswich, MA, USA)
New England Biolabs (Ipswich, MA, USA)
PCR-clean-up:
Monarch® PCR & DNA Cleanup Kit New England Biolabs (Ipswich, MA, USA)
Plasmid isolation:
innuPREP Plasmid Mini Kit 2.0 Analytik Jena AG (Jena, Germany)
Rolling circle amplification:
illustra GenomiPhi™ V2 DNA Amplification
Kit
GE Healthcare UK Limited, Buckinghamshire, UK
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10×-HiFi Taq ligase buffer
DMSO





New England Biolabs (Ipswich, MA, USA)
New England Biolabs (Ipswich, MA, USA)
Carl Roth GmbH & Co KG (Karlsruhe, Germany)
Sigma-Aldrich Chemie GmbH (Taufkirchen, Germany)
Carl Roth GmbH & Co KG (Karlsruhe, Germany)
Carl Roth GmbH & Co KG (Karlsruhe, Germany)
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2.1.3 Media and solutions
Table 2.3: Media and solutions
Medium Composition
Lysogeny broth (LB), liquid:
LB-powder (10 g L−1 NaCl)
ad 1 L A. dest.:
25 g








E. coli cell extract
2× YT + phosphate (2× YT+P):
2× YT (31 g L−1)
1M Potassium phosphate dibasic solution (40mM)
1M Potassium phosphate monobasic solution (22mM)







2M TRIS base pH 7.7 (50mM)
ad 1 L A. dest.; add 2mL DTT directly before




L-amino acid solution :
140mM leucine (5mM leucine)
168mM all other amino acids (6mM others)




ATP dipotassium salt dihydrate (156mM)
GTP disodium salt hydrate (156mM)
CTP disodium salt dihydrate (94mM)
UTP trisodium salt dihydrate (94mM)











ad 0.6mL A. dest.:
30mg
NAD+ solution, pH 7.5-8:
NAD+ (175mM)
2M TRIS base pH 7.7
ad 0.3mL A. dest.:
34.83mg
27µL
cAMP solution, pH 8 (650mM):
cAMP
2M TRIS base pH 7.7
ad 0.2mL A. dest.:
42.8mg
73µL
Folinic acid solution (33.9mM):
Folinic acid calcium salt








ad 155µL A. dest.:
23.55µL
3-Phosphoglyceric acid (3-PGA) solution, pH 7.5:
3-PGA (1.4M)
2M TRIS base
ad 3.2mL A. dest.:
1.03 g
1.73mL
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2.1.4 Used organisms and strains
Table 2.4: Used organisms and strains
Organism Genotype Origin
NEB® 10-β E. coli ∆(ara-leu) 7697 araD139 fhuA ∆lacX74
galK16 galE15 e14- φ80dlacZ∆M15 recA1
relA1 endA1 nupG rpsL (StrR) rph spoT1
∆(mrr-hsdRMS-mcrBC)
New England Biolabs (Ipswich, MA, USA)
E. coli TOP 10 F−mcrA ∆(mrr–hsdRMS–mcrBC)
φ80dlacZ ∆M15 ∆lacX74 nupG rexA1
araD139 ∆(ara-leu)7697 galK16
rpsL(strR) end A1 fhuA2λ−











Geneious (v. 11.0.5) [52] Biomatters, Ltd. In silico cloning
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2.2.1 Cultivation and conservation of cells
Escherichia coli cells were cultured in liquid LB medium (in culture tubes) with or without
antibiotics at 37 ◦C and 200 rpm. For solid media, 1.5%m/v of agarose was used. When neces-
sary, antibiotics were added (ampicillin: 100µgmL−1, kanamycin: 50µgmL−1, spectinomycin:
100µgmL−1). Overnight cultivations of all strains were inoculated with 1-2µL of a glycerol
stock or by pcking a colony with a sterile tooth pick followed by an incubation for 16 h. Bacteria
were stored on agar plates at 4 ◦C or in glycerol stocks at −80 ◦C. For glycerol stocks of E. coli,
800µL of an overnight culture were mixed with 200µL of 100% glycerol.
2.2.2 Competent E. coli
To get electrocompetent cells, E. coli TOP10 or NEB® 10-β E. coli cells from an overnight cultiva-
tion were used to inoculate liquid LB medium supplemented with streptomycin (100µgmL−1).
After reaching an OD600 of 0.5-0.7, the cell suspension was transferred into 50mL tubes and
stored for 30min on ice. Subsequently, the cells were sedimented by centfriguation (4 ◦C,
15min) and the supernatant was discarded. Afterwards, the cells were resuspended in 15%v/v
glycerol (4 ◦C) by using one volume of the main culture. Centrifugation and resuspension were
performed again for three times with stepwise reduced volume of 15%v/v glycerol (0.5 and
0.05 volume units of the main culture) ending in resuspending the cell pellet with the residual
glycerol after decantation. The cells were aliquoted in single aliquots of 30µL or masteraliquots
with a cell volume for 1 to 20 transformations with a volume of 30µL for one transformation.
Subsequently, the aliquots were stored at −80 ◦C.
For chemically competent E. coli cells, the protocol from OpenWetWare1 was adapted to prepare
the CCMB80 buffer for the washing procedure. For this buffer, 10mM of potassium chloride,
80mM of calcium chloride, 20mM manganese(II) chloride, 10mM magnesium choride and
10%v/v glycerol were mixed in A. dest. and the pH was adjusted to 6.4 with 0.1M HCl. The
buffer was sterilized by filtration (0.2µM filter) and stored at 4 ◦C. For harvesting, an OD600
of 0.5 was used. The centrifugation and aliquotation were performed as described for the
electrocompetent E. coli cells.
2.2.3 Electroporation of E. coli
30µL of electrocompetent E. coli cells were incubated with the plasmid DNA for 2min on ice.
Afterwards, a dry and ice-cold electroporation cuvette was filled with the cell/DNA suspension
followed by the electric pulse (2.5 kV, time: 5ms). Immediately, 470µL of LB medium (room
temperature) were added to the cells followed by an incubation step at 37 ◦C for 1 h and shaking.
1https://openwetware.org/mediawiki/index.php?title=TOP10_chemically_competent_cells&oldid=677117
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Finally, the suspension was plated on agar with selection markers. For a blue-white screening,
40µgmL−1 X-Gal and 200nM IPTG were added before the plating. The plates were incubated
for 16 h at 37 ◦C and stored at 4 ◦C afterwards.
2.2.4 Chemical transformation of E. coli
For a chemical transformation, 30µL of chemically competent E. coli cells were incubated with
the plasmid DNA in a 96-well PCR plate for 30min on ice. Subsequently, a heat shock was
applied for 30 s at 42 ◦C. After 10min on ice, 170µL of LB medium was added to each well with
transformed cells. The total volume per well was directly transferred to a 96-well flat-bottom
MTP with a plastic lid. Afterwards, the 96-well MTP was incubated for 1 h at 37 ◦C and 800 rpm
in a thermomix (Eppendorf) followed by spreading the cells on agar plates with a selection
marker. For a blue-white screening, 40µgmL−1 X-Gal and 200nM IPTG were added before the
plating. The plates were incubated for 16 h at 37 ◦C and stored at 4 ◦C afterwards
2.2.5 Plasmid isolation from E. coli
Plasmid isolation was performed by using the innuPREP Plasmid Mini Kit 2.0 (Analytik Jena).
4mL of an overnight culture were used for the isolation; for overday cultures, 2mL LB were
inoculated and used for the isolation. For the isolation, the cell pellets were resuspended
in 250µL resuspension buffer after the centrifugation step of 1min at 6000 g. The lysis was
achieved by adding 250µL of the lysis buffer followed by an incubation step of 4min at room
temperature. Afterwards, 350µL binding buffer were added and mixed with the lysed cells by
inverting. The suspension was centrifuged for 8min at 17 000 g to generate a cell pellet. The
supernatant was transferred to a purification column of the kit. Subsequently, the DNA was
bound to the column by spinning the tube for 1min at 11 000 g. The bound DNA was washed
by adding 500µL of the washing buffer A and a centrifugation step for 1min at 11 000 g. After
a second washing step with 700µL of washing buffer B and a centrifugation step for 1min at
11 000 g, residual buffer was removed by centrifuging for 2min at 17 000 g. The column was
transferred into a microcentrifuge tube and 50 to 100µL of the elution buffer was added to elute
the DNA by a centrifugation for 1min at 11 000 g. Finally, the plasmid was stored at −20 ◦C.
2.2.6 Quantity and purity of DNA
Concentrations and purities of DNA from isolations and PCR amplifications were obtained by
photometric measurements with the UV5 Nano (Analytik Jena AG). 2µL of DNA were used to
load the pedestal and to measure the DNA quantity. The 260/280nm and 260/230nm ratios
were utilized to determine the purity. Afterwards, the purified DNA was checked for the correct
size by gel electrophoresis.
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2.2.7 Agarose gel electrophoresis
For an electrophoresis, 1%m/v agarose in TRIS acetate EDTA (TAE) buffer was used for a gel
electrophoresis. To stain the DNA, 1.5µL SERVA Stain was added to 30µL to the liquid agarose
before pouring the gel. The electrophoresis was performed in TAE buffer for about 30min at
100V. A DNA ladder served as a reference for the determination of the DNA size. Afterwards,
gels were documented by using a UV-light table and a digital camera.
2.2.8 Polymerase chain reaction (PCR) and colony PCR
For a PCR, 0.1mM of dNTPs, 0.25mM of each primer, 2.5U Q5® High-Fidelity Polymerase,
5× Q5® buffer and 0.5µL DNA template were mixed. To get the total volume, A. dest. was
used to fill up the reaction mixture to 50µL. Initial denaturation was achieved after 3min at
95 ◦C for plasmid or chromosomal DNA as template. The following denaturation step at 95 ◦C
for 15 s, the attenuation and elongation at 95 ◦C were repeated for 35 cycles. The attenuation
temperature and the elongation time depended on the Tm of the primers and the amplicon size.
The PCR was ended by a final elongation for 2min at 72 ◦C.
In case of a colony PCR (cPCR), a part of a colony was transferred to a PCR tube with 5µL
A. dest.with a sterile tooth pick. The volume in one PCR tube was filled up to 25µL and the
PCR mix described above. The high-fidelity Q5® polymerase and buffer was substituted by the
Taq polymerase and its 10×C buffer. For the initial denaturation step of the thermal cycling, the
duration was prolonged to 5min followed by the protocol described for PCRs.
2.2.9 Clean-up of PCR products
The purification of a PCR amplified DNA fragment was realized by using a column-based
Monarch® PCR & DNA Cleanup Kit or the corresponding kit for gel extractions. Binding buffer
was mixed with the PCR reaction in a 2:1 ration for fragments with more than 2000 bp and in a
5:1 ratio for smaller fragments. The mixture was transferred to a column in a microcentrifuge
tube. The DNA was bound to the column by a centrifugation step for 1min at 13 000 g. Subse-
quently, 200µL washing buffer was added to the column followed by a centrifugation for 1min
at 13 000 g. This washing procedure was repeated. Afterwards, the column was transferred to a
microcentrifuge tube to elute the DNA with 20 to 60µL elution buffer. The column with the
elution buffer was incubated for 1min at room temperature followed by a centrifugation for
1min at 13 000 g. Finally, the DNA was stored at −20 ◦C.
In case of a gel extraction, the excised gel was solved by adding 400µL of the Gel Dissolving
Buffer to 100µg gel followed by an incubation at 50 ◦C for 5 to 10min. After loading the column
with the PCR or solved gel, the column was washed twice with 700µL washing buffer (30 s,
13 000 g) and residual buffer was removed afterwards by an additonal centrifugation for 1min
at 13 000 g. Elution was performed by using 30 to 60µL of elution buffer.
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2.2.10 Ligase cycling reaction
According to the literature [11,16], baseline conditions for the LCR were initially utilized and
optimized in section 3.1. The baseline protocol utilized 3 nM for each DNA part, 30 nM of
each BO, the Ampligase®, the Ampligase® buffer, 8%v/v DMSO and 0.45M betaine in a total
volume of 25µL. Betaine and DMSO were solved in A. dest. and stored in aliquots at −20 ◦C. A
thermal cycler (DNA Engine Tetrad®2), cycling block (96-well AlphaTM Unit) and low-profile
PCR stripes (all from Bio-Rad Laboratories GmbH, Muenchen, Germany) were utilized for
the cycling and to reduce evaporation effects. The LCR was cycled for 25 cycles as shown in
Figure 2.1. Afterwards, the LCR was utilized for the electroporation or chemical transformation
of E. coli, the in vitro LCR approach (section 3.3) or was frozen at −20 ◦C.
Initial denaturation : 94°C 2 min
Denaturation : 94°C 10 s
Annealing : 55°C 30 s
Ligation : 66°C 1 min
Hold : 10°C ∞
25x
Figure 2.1: Cycling parameters of the baseline LCR. This setup was used for the initial LCRs to optimize
the LCR. This is further descibed in subsection 2.2.15 and in section 3.1.
2.2.11 Cell extract generation from E. coli
For the in vitro LCRs, a cell-free system was utilized. For this, a cell extract was generated
from the strain BL-21 Rosetta™ E. coli cells. For this, a modified protocol of [106] was utilized.
An overnight culture of 50mL with 2×YT+P medium was inoculated by utilizing a cryostock.
As antibiotics, 34µgmL−1 of chloramphenicol and 50µgmL−1 kanamycin were added. After
the growth for 16 h at 37 ◦C and 200 rpm, 800mL of 2×YT+P medium was inoculated with
the preculture. Additionally, antibiotics were added to the main culture as mentioned for the
overnight culture. The cells were grown to OD600=3-3.5 in a 5 L flask at 37 ◦C and 200 rpm
(3.5 to 4 h). The following steps were performed at 4 ◦C. The main culture volume was split
into four centrifuge beakers with ca. 200mL each and were centrifuged at 5000 g for 12min.
After the subsequent decanting of the supernatant, each pellet was resuspended with 40mL
of S30A-buffer with 2mM DTT. The DTT has to be added right before the previous step. The
cell pellets were resuspended by rigorous shaking by hand. In between, the beakers were
cooled down on ice. Afterwards, the beakers with the suspended cells were centrifuged for
12min at 5000 g. The washing step with the same volume of S30A-buffer + 2mM DTT was
repeated. The pellets were then resuspended by shaking in 10mL S30A-buffer + 2mM DTT
and pooled in two 50mL centrifuge tubes. A centrifugation for 20min at 3499 g resulted in
cell pellets. The supernatant was decanted and the centrifugation tubes were centrifuged again
for 2min at 2000 g. Residual supernatant was removed with a pipette. Subsequently, the cells
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were resuspended by a volume of S30A-buffer + 2mM DTT equals to the mass of the pellet
(1 g of cells→ +1mL buffer). The cells were split and transferred à 1mL in pre-chilled 2mL
microcentrifuge tubes and lysed by sonification.
For the sonification of the cells, an amplitude of 50% with 10 s-pulse and 10 s-pause cycles were
applied. The total sum of energy for the sonification has to be around 700 J. A successful lysis is
achieved when the suspension is turning aqueous/transparent. After this, the microcentrifuge
tubes were centrifuged for 10min at 12 000 g at 4 ◦C. The supernatant was transferred with a
pipette to microcentrifuge tubes and the extract was incubated for 80min at 37 ◦C and 220 rpm
in a thermomixer. A final centrifugation step for 10min at 12 000 g and 4 ◦C resulted in the cell
extract. For this, the supernatant was removed with a pipette and pooled followed by aliquoting.
The 35µL aliquots were stored at −80 ◦C.
The cell extract buffer was mixed according to the literature [106] and is shown in Table 2.3. A
step-by-step protocol for the generation of the cell extract and the buffer and how to perform a
CFPS is described in subsection 6.1.4.
2.2.12 Rolling circle amplification
To amplify the fluroescence signal for the in vitro LCR read-out, the rolling circle amplification
(RCA) was applied. The RCA was performed prior to the CFPS. For the RCA, the illustra
GenomiPhi™ V2 DNA Amplification Kit (GE Healthcare UK Limited, Buckinghamshire, UK) was
utilized. The enzyme mix was aliquoted and stored at −80 ◦C and the buffers were stored as
aliquots at −20 ◦C. According to the instructions of this kit, 1µL of plasmid or LCR was mixed
with 9µL of the sample buffer. The mixture was heated up for 3min at 95 ◦C and subsequently
was cooled down on ice. After the addition of 9µL reaction buffer and 1µL enzyme mix, the
RCA was performed by incubating the suspension for 90min at 30 ◦C followed by a 10min
deactivation step at 65 ◦C. In case that an LCR was utilized as a template, the incubation step
was prolonged from 90 to 180min. After the RCA, the cell extract was added to perform a CFPS.
To enable an automation of the RCA and to lower the financial costs, the volumes of sample
buffer, reaction buffer and enzyme mix were reduced step-by-step and is described in more
details in section 3.3. A comparison of the protocol described above and the protocol with
reduced volumes is presented in Table 3.3.1. The low final reaction volume requires conic
reaction wells. For this, a 384-PCR-plate was utilized (384 Well Multiply® PCR-plate, Sarstedt
AG & Co. KG, Sarstedt, Germany) and optical sealing foils (#4360954; MicroAmp™ Optical
Adhesive Film; Thermo Fisher Scientific™, Dreieich, Germany) scale due to evaporation effects.
Furthermore, a protocol of RCA and CFPS is described in subsection 6.1.4.
2.2.13 Cell free protein synthesis
A CFPS with the E. coli cell extract was initially performed according to the literature [106].
Following steps were performed on ice: 0.7µL cell extract and 0.84µL cell extract buffer (recipe
23
2 Material and methods
for the buffer in Table 2.3) were mixed with 0.46µL of DNA or LCR product in a well of a
384-well PCR plate (384 Well Multiply® PCR-plate, Sarstedt AG & Co. KG, Sarstedt, Germany).
An optical sealing foil was utilized to seal the plate (#4360954; MicroAmp™ Optical Adhesive
Film; Thermo Fisher Scientific™, Dreieich, Germany).
The protein synthesis was performed by incubating the plate without shaking for at least 3 h at
29 ◦C in an incubator or in the plate reader. The DNA contained the fluorescent reporter gene
sfGFP to enable a signal detection by fluorescence measurements with the plate reader. Due to
the utilization of a non-optical plate, a top-measurement with an extinction at 470 nm and an
emission at 515nm was utilized.
The protocol for the CFPS is altered to reduce the required volume for the in vitro LCR approach
presented in section 3.3. This optimized protocol is shown in Table 3.2.
2.2.14 In silico experiments and DNA-sequencing
For the design of primers, BOs and in silico cloning, the software Geneious (v. 11.0.5, www.gen-
eious.com, [52]) was used. All oligonucleotides were ordered as salt-free custom DNA oligos
from Eurofins Genomics (Ebersberg, Germany). Sequencing was performed by utilizing Mix2Seq
tubes of Eurofins Genomics (Ebersberg, Germany).
2.2.15 Toy-model plasmid for the optimization of the LCR
The LCR optimization experiments shown in section 3.1 were performed by assembling a toy-
model plasmid consisting of seven DNA parts (Figure 3.1B) with a total length of 4918 bp. As a
plasmid backbone, the cloning vector CloneJet pJET1.2/blunt was utilized (2974 bp; Thermo
Fischer Scientific, Massachusetts, USA). Two reporter genes were incorporated as ’inserts’ two
enable a bi-colored screening of correctly assembled plasmids (sfGFP from pYTK001, mRFP1
from pYTK090 [59]). Both genes were split into subparts to obtain a high size heterogenity
(79 bp to 2974 bp). As a terminator, the BioBrick BBa_B0015 was present in both reporter
genes to simulate an assembly with redundant sequences. A spacer sequence of 37 bp was
incorporated at the 3’-end of mRFP1 to disable the ligation of the mRFP1 (part 3, Figure 3.1B)
with the backbone (part 7, Figure 3.1B). For the in silico designs, Geneious was utilized
(v. 11.0.5, http://www.geneious.com, [52]). Amplification primers (Eurofins Genomics, Ebers-
berg, Germany) were 5’-modified by the T4-polynucleotidekinase/-buffer (New England Biolabs,
Ipswich, USA) prior to the amplification via PCR (Q5® High-Fidelity Polymerase, New England
Biolabs, Ipswich, USA). Each primer was phosphorylated in a single tube with a total volume
of 50µL, a primer-concentration of 1µM, 2mM ATP and 10U of T4-PNK for 1 h at 37 ◦C and
20min at 65 ◦C. The promoter of mRFP1 (part 1, Figure 3.1B) was made of an ordered for-
ward and reverse primer (lyophilized, salt-free). The primers for the promoter of mRFP1 were
phosphorylated separately prior to the annealing to dsDNA for 3min at 95 ◦C and 70 cycles
of 20 s with an incremental decrease of 1 ◦C. The backbone pJET1.2/blunt was PCR-amplified
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using a digested pJET1.2/blunt+lacZ plasmid to enable the detection of plasmid carry-over
by blue-white screening. All PCR products were treated by a DpnI-digested directly after the
cycling for 60min at 37 ◦C and an inactivation for 20min at 80 ◦C. For the toy-model plasmid,
the amplification primers are presented in Supplementary Tables 6.1. A GenBank file of the
plasmid is published in Schlichting et al. [95].
A baseline LCR assembly was mixed according to the recipe of de Kok et al. [16] to get a
reaction mixture with specific final concentrations of 1× ligase buffer, 0.5mM NAD+, 3 nM of
non-backbone parts, 0.45M betaine and 8%v/v DMSO. In contrast to de Kok et al. [16], the
concentration of the backbone pJET1.2/blunt was adjusted to 0.3 nM. The 10×-Ampligase®
reaction buffer was self-made and based on the recipe of the supplier (Lucigen, Wisconsin,
USA). Due to the unknown stability of nicotinamide adenine dinucleotide at −20 ◦C, it was
added separately afterwards. Bridging oligo sets were solved and mixed in nuclease-free water
with 1.5µM of each BO. The sets were heated up for 10min at 70 ◦C and cooled down on ice
before the addition to the LCR mixes. At last, 10U of Ampligase® (Lucigen, Wisconsin, USA)
was added. Afterwards, each LCR was split into 3µL reactions in separate reaction tubes. After
the cycling, the LCRs were cooled down on ice and were transformed in E. coli.
For the cycling, a thermal cycler (DNA Engine Tetrad®2), cycling block (96-well AlphaTM Unit)
and low-profile PCR stripes (all from Bio-Rad Laboratories GmbH, Muenchen, Germany) were
utilized. The heat and cooling rate for all LCRs were 3 ◦C s−1. The cycling was started by a
denaturation at 94 ◦C for 2min. Afterwards, the LCRs were cycled 25 × at 94 ◦C for 10 s, 55 ◦C
for 30 s and 66 ◦C for 1min. After cooling down the LCRs on ice, 30µL electro-competent or
chemically-competent NEB® 10-β E. coli cells (self-made batches; New England Biolabs, Ipswich,
USA) were added to each tube with the LCR mix. For the electroporation, the total volume was
pipetted to cuvettes for electroporation with a diameter of 1mm. The electroporations were
performed by applying an electric pulse of 2.5 kV. The chemical transformations were achieved
by using 96-well PCR-plates and a cycling block for the heat-shock. For the heat-shock, the
96-well plates were put on ice for 30min, followed by a 30 s heat-shock at 42 ◦C. After a cool
down on ice for 10min each transformation mix was transferred to 96-MTPs (flat bottom) with
170µL SOC medium per well for the recovery step at 37 ◦C for 1 h. The electroporation mix was
transferred to 470µL SOC medium and the transformed were recovered as described for the
chemical transformation. Finally, the transformation mix was plated on Lysogeny Broth (Miller)
plates with 1%m/v agar and 100µgmL−1 ampicillin. The plates were incubated for 15 h at
37 ◦C.
To observe the alterations of parameters, the efficiencies of all LCRs were determined by investi-
gating the phenotype of CFUs by fluorescence microscopy as depicted in Figure 1.4 (microscope:
Axio Vert.A1, Carl Zeiss Microscopy GmbH, Jena, Germany, 50×-magnification; LEDs for sfGF-
P/mRFP1: 470/540−580nm). To calculate the assembly efficiency, the phenotypes of all CFUs
derived by each LCR transformation were screened. For more than 100 CFUs per agar plate,
100 colonies were screened randomly by first specifying the CFUs of interest. The CFUs were
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then observed by fluorescence microscopy and the efficiency was calculated by dividing the
number of red+green CFUs by the amount of investigated CFUs. The amount of CFUs per LCR
was derived from the total CFUs on each agar plate and the volume of the plated cells. For
the validation of the phenotype-genotype correlation, plasmids from 120 CFUs with different
phenotypes were purified (Monarch® Plasmid Miniprep Kit; New England Biolabs, Ipswich,
USA) and analyzed by Sanger sequencing (Eurofins Genomics, Ebersberg, Germany).
2.2.16 Validation experiments for the improved LCR protocol
To validate the improved LCR protocols, two additional plasmids were designed and both were
split into three and seven parts (Supplementary Figures 6.15 and 6.16). The sequences of the
amplification primers for the validation plasmids are shown in Supplementary Tables 6.5 and
6.6. GenBank files of both plasmids are published in Schlichting et al. [95]. As reporter genes,
both plasmids consist of lacZ and one or two selection markers. Correctly assembled plasmids
result in a blue phenotype; misassemblies have a white phenotype and do not grow on agar
plates with the second antibiotic. As for the previous LCR investigations with the toy-model
plasmid, 3µL LCR were chemically transformed into 30µL NEB® 10-β E. coli cells.
Validation plasmid 1 (’VP1’) were assembled followed by a chemical transformation and plating
on 1%m/v agar plates containing 100µgmL−1 spectinomycin after 1 h of recovery. After the
incubation for 16 h at 37 ◦C, forty colonies were transferred to agar plates with 100µgmL−1,
50µgmL−1 kanamycin, 40µgmL−1 X-Gal and 200nM IPTG. The resulting colonies after 16 h at
37 ◦C with a blue phenotype were regarded as CFUs with the correct plasmid. Empty spots were
treated as colonies with a misassembled plasmid due to the lack of the kanamycin resistance.
From ten blue colonies of the agar plate with both antibiotics, the plasmids were isolated and
analyzed by Sanger sequencing. Additionally, four plasmids of colonies with the false phenotype
and/or kanamycin sensitivity were sequenced after Sanger.
Validation plasmid 2 (’VP2’) the chemically transformed cells were plated on 1%m/v agar
plates with 100µgmL−1 spectinomycin, 40µgmL−1 X-Gal and 200nM IPTG. After the incu-
bation for 16 h at 37 ◦C, all obtained CFUs were screened visually to detect a blue or white
phenotype. A blue phenotype was regarded as a correct assembly and white colonies as CFUs
with misassembled plasmids. Sanger sequencing of ten plasmids from colonies with the correct
phenotype and four plasmids from false phenotypes were isolated and analyzed by Sanger
sequencing.
Installation of the CloneFlow plugin for the automated bridging oligo design in Geneious
Together with bachelor students of informatics (TU Darmstadt) and Felix Reinhardt (phD
student Computational Biology and Systems, Fakultät der Biologie, TU Darmstadt), the software
was build for Geneious versions ≥ 10 with Java v8. The plugin also requires Python3. 7. 2
for the calculation of the BO Tms. The installation of CloneFlow is achieved by drag and drop
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of the installation file1 to the main window of Geneious or by selecting the file via
Tools→Plugins→Plugins And Features→install plugin from a gplugin
file.
After the successful installation, a pop-up window appears with information about the plugin
and ’CloneFlow Plugin’ is shown in the ’Installed Plugins’ list. Afterwards, the tool can be
started by clicking on ’CloneFlow’ in the ’Tools’ menu. Another option to start the plugin
is to add it by customizing the gray toolbar. Right click on the gray bar shows ’Customize’.
Subsequently, ’CloneFlow’ can be chosen for a continuous appearance in the toolbar. To design
BOs, the DNA parts of interest are preselected before starting the plugin or are added by a
search afterwards. The latter approach is described in more details in subsection 3.4.2.
Installation of the CloneFlow server for the design of bridging oligos with low secondary
structures
The CloneFlow server is a stand-alone tool for the upload and management of DNA parts
sequences and the automated BO design. It is a modular system and allows the user to design a
human-readable phosphorylation protocol for amplification primers, to find crosstalk optimized
BOs with a specified target Tm and to generate an LCR protocol in a csv-format (Figure 3.35A).
The server and can be set up on Linux systems or virtual machines with Ubuntu16, Ubuntu18
and Mint. The calculations in the server environment are based on Python3.5. An installation
file for setting up the server is available in subsection 6.3.1 and can be executed by the following
command:
sudo python3 installserver.py
By following the instructions in the installation terminal the server will be installed. All software
packages are installed automatically. Afterwards the pSQL database and the Django-based
server will be prepared to enable the storage of sequences and to allow the user management.
In the last installation step, the credentials for the log in as a superuser are created. For this,
a superuser name, password and an e-mail address have to be entered. The superuser data
is necessary to log in as an administrator of the CloneFlow server. If the installation was
successful, two terminals should be running in parallel. Afterwards, the local server can be
accessed by using the internet browser Mozilla Firefox only. This issue is located to the
security settings of other browsers where local servers are forbidden or disabled in the default
browser settings or browser-specific ports are allowed. Due to this, Mozilla Firefox is
the recommended browser. By opening Mozilla Firefox, CloneFlow can be accessed by
typing the default IP-address and port (127.0.0.1:8001) or by typing ’localhost’ and pressing
enter. The welcome page of CloneFlow is shown and the user can log in by using the credentials
1Installation file for the CloneFlow plugin available at https://gitlab.com/kabischlab.de/lcr-publication-
synthetic-biology/blob/master/LCR_Plugin_geneious_v1.1.zip [95]
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used to set up the superuser during the previous steps. The superuser is the administrator for
the CloneFlow server and has to prepare templates for the BO-design.
Before running a first job with CloneFlow, a few things have to be considered and customized.
Adding an e-mail address to receive notifications of finished CloneFlow jobs or to reset the
password for registered users is recommended but not mandatory. To use the right management
is a complex part and is only of interest if the administrator wants to restrict permissions for a
shared use with, i.e., colleagues of other working groups or guests. CloneFlow is based on
the open-source web framework Django. This framework offers a rights management system
and allows a superuser to create new groups, adjust the permissions and assign users to the
groups. For this, already existing users or a new one can be created and assigned to existing or
newly created groups. The rights management settings are only accessible as an admin or as a
member of the superuser group. In the administration area, various setting can be customized
by the admin to enable or disable rights for, e.g., single users or user groups. Especially the
admin has to care about the DNA library settings: by default, every new user has the right to
edit or delete DNA parts and BOs. This allows all users to delete sensitive data or are able to
edit metadata after the upload of the DNA parts or the design of BOs. Restoring these changes
is not possible and should be considered by the administrator.
2.2.17 Automated DNA assembly with the LCR
To enable the automated DNA assembly, a robotic platform was utilized (Figure 2.3). Besides
the cytometer, each device of the platform is utilized. The workflow for the LCR is based on the
results of the in vivo LCR optimization (section 3.1). The automated methods for dispensing,
transformation of E. coli and agar plating is described in the next paragraphs.
2.2.18 Combinatorial DNA dispensing with a nanoliter dispenser
By utilizing the nanoliter dispenser ’I-DOT’ (Figure 2.2A), up to 96 liquids, e.g., DNA parts,
BOs, ligase buffer, ligase, NAD+ and water, can be filled into the ’pure columns’ of the source
plate. On the bottom of each column is a 90µm orifice. By applying an air pressure pulse a
drop with a specific volume is transferred from the source well to the desired wells in the target
plate (Figure 2.2B). As an additional feature, parallel dispensing of eight liquids is further
accelerating the overall dispensing procedure (Figure 2.2C). The unit of the applied pressure
pulse is bar s−1 and is named ’Laske’-unit. The sum of drops per well results in the desired
volume and is automatically calculated by the device itself and the previously calibrated liquid
class.
To prepare the combinations for the LCR assembly, the nanoliter dispensing unit is utilized.
Depending on the physical properties of the liquid, a liquid class has to be created and assigned
to each liquid. The calibration of the liquid classes is error-prone due to manually produced
columns, batch-dependent differences and is considered as a parameter with a high impact on
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accurate dispensing of liquid-handling devices [1,10]. Although it was not investigated, the
accuracy of the dispensing can be increased by performing the calibration at least in triplicates
and by considering a low, mid and high Laske value (50, 175, 300 Laske). If the volume of a
liquid is constantly used for one reaction like, e.g., the buffer volume, the liquid class should
be adjusted for this specific volume only. This is achievable by first calibrate the liquid class as
described before. Afterwards, the liquid of interest has to be dispensed with the I-DOT into one
well of a target plate or onto the surface of the target tray of the device. The liquid volume can
be measured by aspirating it with a pipette. If the volume is too low or high, the parameters of
the liquid class are adjusted manually until the aspirated volume is equal to the desired volume.
For this workaround, it is mandatory to utilize a calibrated pipette.
To mix the LCRs, the library plate with all desired liquids is imported into the platform. The
dispensing robot ’Felix 1’ transfers the desired liquids after a resuspension step to the I-DOT
source plate in a column-wise pattern (Figure 3.37). For this, the user defines a dispensing
protocol including the names of the liquids. Furthermore, a second file with the positions of
the liquids in the library plate is created by the user. Based on both files, all desired liquids are
transferred to the I-DOT source plate followed by the dispensing into a 96-well PCR plate. A
user-defined csv-protocol is utilized to dispense the liquids. After the dispensing, drops of the
liquids can remain on the surface of the inner walls of the source wells due to an imprecise drop
release during the dispensing. Before the cycling, the PCR plate with the liquid is transferred
to the plate reader of the platform. By double orbital shaking, the drops on the walls are
released, collected on the bottom of each well and the total volume is mixed to ensure a more
homogeneous reaction mixture. To prevent the evaporation in the subsequent thermal cycling,
the dispensed volume is layered by paraffin. During the cycling (parameters shown in Figure 2.1
in subsection 2.2.10), the residual volumes of the I-DOT source plate are backfilled into the
library plate to enable an efficient and sustainable utilization of the DNA library.
2.2.19 Automated transformation of E. coli and dilution plating
Up to 96 LCRs are chemically transformed into E. coli by the heat-shock method [38, 39].
The optimal heat-shock duration of 30 s and an LCR-to-cells ratio of 1:10 were investigated in
section 3.2 (Figures 3.17 and 3.18). The user prepares a one-well plate or a 96-well/PCR plate
with the desired cell volume and stores it with a lid or not on the cooling position. Each well of
the PCR plate with the cycled LCRs is mixed with a user-defined cell volume. Afterwards, the
cell-LCR mix is incubated for 30min at 4 ◦C, the heat-shock is applied followed by an additional
incubation. To recover the cells, a specific volume of the medium is transferred to the wells.
For this, the volume is automatically calculated to not exceed a maximum volume of 200µL
per well. This volume depends on the sum of the user-defined volume of competent cells, the
reaction volume of the LCR and the volume of the paraffin layer. Finally, the suspension is
transferred to a 96-well plate for the recovery step.
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Figure 2.2: Nanoliter dispensing with the I-DOT. A. The I-DOT device from Dispendix GmbH with a
source and target plate. The target plate is placed underneath the source plate. To dispense a liquid,
the source plate is moved horizontally to place the source liquid above the target wells. B. Dispensing
principle for one liquid of interest. Maximal 80µL can be filled into one source well. After calibrating the
liquid class, a certain amount of drops is released from the source liquid by applying pressure pulses. In
total, eight source liquids are dispensed in parallel. The drops are formed due to an 90µm orifice on the
bottom of the source well. The sum of drops is determined for each source liquid by an LED-based drop
detection. C. Within 1min, 96 × 1µL of water can be dispensed from one source well. By utilizing eight
source wells with water in one column of the source plate, the duration is shortened to ca. 10 s due to
the presence of eight independent dispensing heads.
The figure is modified from the master thesis of Markus Susenburger: Susenburger, M., Computational
Optimization of the Ligase Cycling Reaction for Automation. Masterarbeit, 2018, TU Darmstadt.
After the recovery, the transformed cells are transferred to 4-well plates with agar and a selection
marker. In case that the expected number of colonies is too high for one well with agar, the
user can adjust the workflow to generate two plating dilutions per transformation. For this,
two volumes between 5 and 200µL can be chosen whereby the sum is restricted to be higher
than 200µL (maximal working volume for a well of the utilized 96 MTP). Based on this, each
transformed LCR will be split in the same pattern. Before transferring the transformed cells
to the agar plates, 100 to 500µL of the recovery medium are added to each well with agar to
support an equal distribution of the cells. Afterwards, the two predefined split volumes are
pipetted on the agar with the layer of recovery medium. The transformed cells are spread by the
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Figure 2.3: Robotic platform. Figure kindly provided by Thomas Zoll (PhD student of Prof. Dr. Kabisch).
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liquid medium on the surface of the solid agar and the following shaking step in the incubator.
After the last agar plate was stored in the incubator, the shaking continues for an additional
hour.
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3.1 In vivo optimization of the LCR
To optimize DNA assemblies for the construction of synthetic circuits, several in vitro and in
vivo issues during the DBTL cycles have to be considered. For the DNA assembly using the LCR,
the construct of interest is build in vitro by a ligase and thermal cycling of a defined mix of DNA
parts and BOs. Afterwards, the assembly mix is transformed into a microbial host for the uptake
and propagation of the circular product. Due to this, the LCR workflow is an in vivo method.
In the assembly steps of the LCR, a sequence-dependent crosstalk of the involved DNA parts
and BOs along with the applied thermal conditions are supposed to have an impact on the LCR
assembly. Furthermore, the influence of the transformation of the LCR into, e.g., E. coli, underlies
the endogenous abilities of the chosen host to process DNA by post-assembly alterations or
even ligations [54,117]. These assumptions are investigated and discussed in this chapter and
present the results of the published study of Schlichting et. al [95]. The study presented in
the following sections initially utilizes the LCR conditions published 2017 [11, 16] and are
called ’baseline conditions’. Based on these initial LCRs, the impact of several BO design rules,
their ∆G crosstalk and the inter-dependencies of the applied design rules and experimental
temperatures are investigated. For this, a toy-model plasmid system was developed and utilized.
This plasmid enabled a fast DBTL cycle and is based on fluorescence (Figure 3.1). Afterwards,
the new LCR conditions were validated by the assembly of two additional plasmids to confirm the
optimized protocol. Prior to performing the optimization experiments, the toy-model plasmid
was designed and a standard process of performing an LCR was investigated.
The toy-model plasmid with the repetitive terminator sequence was designed to simulate a
challenging assembly (Figure 3.1B). The plasmid consisted of the two reporter genes sfGFP
and mRFP1. Both were split into three subparts to design an assembly of the toy-plasmid with
DNA parts in range of 79 bp to 2974 bp. As the terminator, the BioBrick BBa_B0015 is present
in both genes. To get insights into the LCR, several BO sets were designed and experimental
parameters were varied to assemble the toy-model plasmid. For this, the phenotype of ∼100
CFUs per LCR were observed by fluorescence microscopy to estimate the efficiency for each
experimental setting. The number of colonies per LCR was determined by counting all CFUs per
plate. This amount was used for an extrapolation by using the dilution-factor. Within this study,
61 experimental conditions were utilized to determine improved assembly conditions for the
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Figure 3.1:Workflow for the in vivo LCR optimization experiments. A. Bridging oligo sets were designed
using general design rules with the focus on∆G-related BO-crosstalk while maintaining a Tm of 70±3 ◦C.
B. The BOs were utilized for the LCR-assembly of a seven or three parted toy-model plasmid with sfGFP
and mRFP1 as reporter genes. To simulate repetitive sequences, the same terminator BBa_B0015 (T)
was chosen for both reporter genes. A DNA-spacer S (37 bp) was incorporated at the 3’-end of mRFP1 to
disable the ligation with the plasmid backbone (part 7). A GenBank file of the plasmid is available in
the supplement of Schlichting et al. [95]. C. A negative impact of 8%v/v DMSO and 0.45M betaine
was oberserved for the toy-plasmid assembly. The p-values were derived from a Kolmogorov-Smirnov
test between the two sets of data shown in Supplementary Figure 6.4. D. No ∆G-related influence
was observed in the LCRs. The assembly was mainly affected by the target Tm of the BOs. This was
investigated by design new BOs and utilizing them for the assembly of the toy-plasmid. ampR: gene for
ampicillin resistance, eco47IR: gene for a restriction enzyme (reduction of religations of the backbone),
mRFP1: monomeric red fluorescent protein 1, ori: origin of replication, sfGFP: superfolder green fluorescent
protein, Tm: melting temperature.
This figure is modified after Schlichting et al. [95].
toy-model plasmid. Around 15000 CFUs were screened by fluorescence microscopy. Contrary
to the recommended backbone concentration of 3 nM [11, 16], 0.3 nM of the backbone was
added to each LCR reaction to reduce religations. This increase of the insert-to-backbone ratio
is described as beneficial for other DNA assembly methods [46,126]. In the control reactions
where the Ampligase® was omitted, no colonies with fluorescence were detected (Figure 3.2).
Furthermore, no carry-over of the pJET1.2/blunt backbone was revealed by blue-white screening
of ∼1000 CFUs without fluorescence. No carry-over is expected for the DNA parts of the reporter
genes sfGFP and mRFP1 due to a change of the antibiotic selection marker.
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(H: high crosstalk, L: low crosstalk, M: manually designed)
Figure 3.2: Boxplots of LCRs of a seven part toy-plasmid by utilizing BO-sets with high crosstalk (sets
H1-H6) and low crosstalk (sets L1-L6). Each LCR was performed as a quintuplet. The standard deviation
for each LCR is indicated by error bars. In addition to these twelve sets, a 13th set (’manually’ set
M) was utilized for the baseline LCR with DMSO and betaine. A. All LCRs without DMSO/betaine
resulted in higher efficiencies in comparison to the LCRs with both detergents. No correlation between
crosstalk and BO performance was found. Interestingly, BO-set dependent differences were found for the
baseline LCRs without DMSO/betaine, e.g., BO-set H1 resulted in a higher efficiency in contrast to the
utilization of BO-set L1. The negative control reactions with BOs but without ligase (Ctr1) and another
control reaction without BOs and ligase (Ctr2) resulted in no fluorescent colonies. B. LCRs without
DMSO/betaine resulted in more colonies in comparison to the baseline-conditions. The raw data of the
LCRs presented here are shown in Supplementary Figure 6.4. The sequences of all BO-sets are shown in
Supplementary Table 6.2.
This figure is plotted by using the raw data of Schlichting et al. [95].
As a mandatory prerequisite for the fluorescence-based is the correlation of the phenotype
and genotype of a colony. For this, the plasmids from 120 CFUs were isolated, sequenced and
analyzed. No true/false-positive and true/false-negative results were observed. Sixty colonies
with a bicolored phenotype (red AND green fluorescence) contained the toy-model plasmid
and its seven subparts in the desired orientation and order. To validate the colonies with the
false phenotypes ’only red’, ’only green’ and ’non-fluorescent’, twenty plasmids of each were
analyzed. They were lacking at least one of the sfGFP- or mRFP1-subparts and showed a red or
green fluorescence (but not both) or showed no fluorescence due to religations of the backbone.
Colonies with no fluorescence were also observed for plasmids lacking at least one subpart of
both reporter genes in other assemblies within this thesis. Point-mutations in the sequence
of the analyzed LCR products were regarded as alterations by the amplification primers, the
polymerase or E. coli and were not considered as LCR-related.
The sequence analysis of plasmids from CFUs with a ’only green’ phenotype revealed one or
more missing subparts of the mRFP1. Interestingly, the missing parts were not completely absent
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in the LCR product. Remnant basepairs at both ends of the missing DNA part were observed in
a range of 10 to 100 bp. For the 20 analyzed plasmids of CFUs with the phenotype ’only red’,
the sequences lacked the full sfGFP and the incorporated spacer sequence at the 3’-end of the
mRFP1. Obviously, E. coli recognizes the two identical terminator sequences and deletes it via
recA-independent recombination [5,21].
As already mentioned, sequence analysis of misassembled plasmids revealed remnant bases
or even longer fragments of the missing DNA parts. These issues are possibly related to the
heterogeneous mixture of the DNA parts and debris derived from their PCR amplification, the
utilized primers and templates. The negative impact of residual amplification primers in the
LCR is presented in more details in section 3.2 and Figures 3.10 and 3.11. Furthermore, E. coli
is able to circularize DNA in the transformation process [54,117]. The transformation of the
LCR mix results in a ligation by E. coli and the growth of colonies with the religated backbone
or plasmids with missing DNA parts. For example, this was detected in the negative control
reaction without utilizing a ligase and is shown in Figure 3.2. Concluding this, the carry-over of
the mentioned species of DNA along with the influence of E. coli results in misassemblies and
also in correctly assembled plasmids.
Overall, the fluorescence-based screening system is a robust and rapid method (screening of
ca. 500CFUs h−1) to obtain insights of LCR assembly efficiencies and the impact of varying the
experimental parameters. Furthermore, the correlation of the genotype of the assembled plasmid
with the phenotype of colonies offers a screening system without applying next generation
sequencing approaches. The discrimination of the phenotypes is achievable by several methods
like fluorescence microscopy or photometric analysis and the utilization of software tools for
the detection of fluorescent colonies (OpenCFU [32]; CellProfiler [8]).
3.1.1 Bridging oligo crosstalk and melting temperature
The assembly order in the LCR is defined by BOs and they are normally designed by the
experimenter. The design rules are based on published protocols [11,16]. One rule is to adjust
the BO-half length until it matches the target Tm of 70 ◦C. Nevertheless, the free energy ∆G is
presumed to be a parameter with a higher impact for oligonucleotide-based reactions [40,90].
In the LCR, the influence of ∆G is reduced by using 8%v/v DMSO and 0.45M betaine [11,16].
Nevertheless, this ∆G-related crosstalk and the need of ∆G-optimized BOs is unknown. In
this study, BOs were designed following the rules of de Kok et al. [16]: they were designed in
forward direction and the LCR-specific concentrations of 10mM Mg2+, 50mM Na+, 3 nM DNA
parts, 30 nM BOs and 0mM dNTPs. All BOs were ordered freeze-dried from Eurofins Genomics
(Ebersberg, Germany) as salt-free DNA oligonucleotides. A manually BO-set was designed with
Primer3 [111]. This tool is included in the software suite Geneious. For the Tm calculation
and salt correction of all BOs sets, the formulas of SantaLucia [89] were utilized. Primer3
only accepts one DNA concentration. The LCR experiment is based on different concentrations
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of DNA parts and BOs. Corresponding to this issue, only the BO concentration of 30 nM was





























Figure 3.3: Influence of DMSO and betaine in the LCR. All LCRs were performed as quintuplets using
the same batches of DNA parts, electrocompetent cells and a master-mix (excluding the BO-sets and
the ligase). A. For all three BO-sets (H1, L2 and the manually set) the DMSO/betaine-free LCRs were
more efficient. As observed in Supplementary Figure 3.2, the efficiency of the set ’H1’ was higher than
the manual set ’M’ and set ’L2’ in the baseline LCR (with DMSO and betaine). B. The omission of
DMSO/betaine highly increased the total amount of colonies. This is consistent with the results shown
in Supplementary Figures 3.2B and 6.6H for DMSO/betaine-free conditions: a lower Tm is beneficial
and resulted in more colonies. All BO sequences are shown in Supplementary Table 6.2. DB: DMSO and
betaine.
This figure is plotted by using the raw data of Schlichting et al. [95].
additional sets were designed by minimizing or maximizing ∆G-dependent crosstalk between
oligonucleotides with a target Tm in the range of 67 ◦C and 73 ◦C. The crosstalk is defined as
the sum of all minimum free energies (MFEs) when cofolding each BO of one set with each BO
in this set and with itself. As a temperature for the calculations, the annealing temperature of
the baseline LCR was utilized (55 ◦C [16]). For the design of the crosstalk minimized BOs, the
SantaLucia parameters [89] were utilized for the Tm calculation and salt correction as described
for the manually set. In contrast to the manually designed one, the DNA part concentration was
also adjusted to fit the experimental parameters. For all BO designs, the influence of DMSO
and betaine were not included. Sets with low crosstalk are denoted by an ’L’ and sets with
high crosstalk by an ’H’. All BO-sets, sequences and melting temperatures for the crosstalk
investigations are provided in Supplementary Table 6.2. Further information for the calculation
of the crosstalk is given in the supplement of Schlichting et al. [95].
One manually designed BO-set and twelve automatically designed ones (Supplementary Ta-
ble 6.2) were utilized to assemble the seven part split of the toy-model plasmid (Figure 3.1B)
and to investigate the influence of BOs with high and low crosstalk. For this, the baseline
protocol (Table 3.1) with and without 8%v/v DMSO and 0.45M betaine were applied.
For the LCRs with both detergents, 3.6× lower efficiencies and 99× fewer colonies per 3µL
LCR were obtained for assemblies with DMSO and betaine (p < 0.001, Figure 3.1C; raw data
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in Supplementary Figure 6.4). For a validation, the diverse LCRs of BO set ’H1’ and ’L2’ were
repeated in a more consistent approach with the same batch of DNA parts and the same batch
of electrocompetent cells (Figure 3.3 and Supplementary Figure 6.11). The LCRs were analyzed
graphically to investigate the origin of those diverse results. First, no ∆G-related impact was
observed for the LCRs with or without DMSO and betaine (Supplementary Figures 6.5, 6.6, 6.7,
6.8, 6.9 and 6.10). Furthermore, the need for a guanosine or cytosine at the 3’-end of the BOs
was not proven as mandatory and is contrary to the literature [16].
The success rate of LCRs with DMSO and betaine were shown to be dependent on the utilized
BO-set. The utilization of the BO-set ’L1’ resulted in lower efficiencies in comparison to ’H1’
(Figure 3.2A). According to the graphical analysis, this difference is related to the higher
average Tm per BO-half of the latter set (Supplementary Figure 6.6C). The impact of the melting
temperature of the BOs was further observable for the other utilized sets. Obviously, higher Tms
are beneficial for the LCRs with DMSO/betaine. Additionally, a higher Tm than 72 ◦C is supposed
to result in more efficient assemblies. This is theoretically confirmed by the Tm-recalculation of
the BO-set utilized by de Kok et al [16]. Considering the calculation parameters (SantaLucia
1998 for the Tm calculation [89] and Owczarzy et al. [72]), the BO-set of their study supposed
to have a melting temperature of 70 ◦C but a value of 72.2 ◦C was recalculated. Applying the
formulas of the study presented here (SantaLucia 1998 [89] only), the average Tm of this
BO-set is 74.8 ◦C. These comparisons are depicted in Figure 3.4. Concluding the investigations
of LCRs with DMSO and betaine, a Tm higher than 68 ◦C per BO-half was advantageous for
the assembly reaction. The manually BO set (’M’) was designed with a target Tm of 70 ◦C by
utilizing Primer3 of the in silico software Geneious, the Tm formula of SantaLucia 1998 [89]
and the salt correction of Owczarzy et al. [72]. The average Tm shown in Supplementary
Figure 3.4B is lower than the expected Tm of 70 ◦C. Geneious allows the user to adjust only
one DNA concentration for the Tm calculation. This value is utilized for both the DNA part and
oligonucleotide concentration and results in a lower Tm in comparison to the formulas applied
in this study.
Besides the too low Tm of the BOs, an additional hypothesis of low LCR efficiencies in the
baseline LCR is related to temperature interval of the annealing step at 55 ◦C and the following
ligation step at 66 ◦C. Already bound BOs during the annealing will be separated until the
ligation temperature is reached and may results in less templates for the ligase. According
to this, in LCRs with BOs with a lower Tm are supposed to be more affected and this should
negatively influence the results in comparison to sets with higher Tms. In Figure 3.5, this theory
was validated by reducing the ligation temperature for LCRs with BO-sets with high and low
melting temperatures. Although the ligase is described as being less active at the decreased
ligation temperature of 60 ◦C1, the assembly efficiency was increased for LCRs utilizing BOs
with a higher Tm. This was validated by using three BO-sets with different melting temperatures
1according to the manufacturer 70 ◦C is the optimal temperature of the utilized ligase:
https://www.epibio.com/docs/default-source/forum-archive/forum-03-1—nucleic-acid-ligation.pdf?sfvrsn=6
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Figure 3.4: Effect of salt corrections on the melting temperature. The results for the LCRs with 8%v/v
DMSO and 0.45M betaine are shown. Thirteen BO-sets were utilized (H1-H6: high crosstalk; L1-L6
low crosstalk; M: manually designed set). The thermodynamic calculation parameters for A. and B.
were derived from SantaLucia [89]. For the salt correction, two different algorithms were utilized. A.
SantaLucia [89] salt correction. B. Owczarzy [72] salt correction (utilized in de Kok et al. [16]). The
optimized melting temperature is indicated by the dotted line and is obtained from recalculating the
optimized BO-set of the de Kok et al. study [16]. BO: bridging oligo, CFU: colony forming unit, DMSO:
dimethyl sulfoxide, Tm: melting temperature of one BO-half.
This figure is plotted by using the raw data of Schlichting et al. [95].
(Figure 3.5). Increasing the annealing temperature, which would also decrease the interval,
was assumed to be disadvantageous due to accelerated separation of bound BOs and was not
investigated.
Various mechanisms are thought to be disadvantageous for the low amount of colonies in LCRs
with DMSO and betaine. First, a lower assembly efficiency directly results in less plasmids.
Second, the utilization of both detergents negatively influences the electroporation process
and is shown in Supplementary Figure 6.11. An already cycled LCR reaction without DMSO/-
betaine was mixed with both substances followed by the electroporation. In contrast to the
transformation of the LCR without DMSO/betaine (but with A. dest.), 3-4× less colonies with a
similar efficiency were obtained. This effect is probably related to the decreased volume-ratio
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of transforming 3µL LCR in 30µL competent cells. In contrast to this, 2.5µL LCR are added
to 50µL cells in the published protocols [11,16]. Strain-dependent influences of detergents
like DMSO on transformations were already described and are related to their electrophysical
properties [38]. This issue is assumed to explain the observed negative impact of the chosen
LCR-cells ratio. Direct negative effects of DMSO and betaine on the utilized E. coli strain are not
plausible due to no detectable impact on the strain if chemically transformation was performed
(Supplementary Figure 6.14). In case of LCRs with DMSO and betaine, the yield of colonies
can be increased by a dialysis step of the LCR for 30min using aq. dest. and a nitrocellulose





























Figure 3.5: Impact of the ligation temperature on LCR performance with DMSO and betaine. All LCRs
were performed as quintuplets. For the BO-set L2, a lower ligation temperature of 60 ◦C is beneficial
for the efficiencies and total amount of colonies. This set had a lower Tm of 68.6 ◦C compared to the
manually designed set ’M’ with a Tm of 71.4 ◦C and the set H1 with a Tm of 71.9 ◦C. Due to the lowered
ligation temperature, more BOs of set L2 remained attached to the DNA parts to guide the ligase. All BO
sequences are shown in Supplementary Table 6.2.
This figure is plotted by using the raw data of Schlichting et al. [95].
strategy is negligible for the assembly of the predefined split of the toy-model plasmid. Of more
interest, the addition of DMSO and betaine is not recommended for the assembly of the seven
parted toy-model plasmid. Due to this, the applied experimental conditions like the annealing
step, ligation step and target Tm of BOs have to be validated as being optimal for the new LCR
without the DMSO and betaine.
3.1.2 A higher annealing temperature increases the amount of correct colonies
An approach to experimentally define the optimal annealing temperature of oligonucleotide-
based molecular reactions like, e.g., PCRs, is to perform a thermal cycling with a temperature
gradient. This was applied for the LCR to investigate the influence of the annealing temperature.
Furthermore, three BO sets with an average Tm of 67.8 ◦C, 69.9 ◦C and 71.8 ◦C were designed
from the already existing BO pool for the crosstalk investigations to determine the impact of
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different Tms (sequences in Supplementary Table 6.3). The BO sets were used to assemble the
seven parted toy-model plasmid in an annealing temperature range of 56.5 to 70.6 ◦C followed
by a chemical transformation of NEB® 10-β E. coli. As shown in Figure 3.6B, the efficiency of
Set 1 (67.8°C) Set 2 (69.9°C) Set 3 (71.8°C)
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Figure 3.6: Gradient-LCR: adjustment of the annealing temperature for a DMSO/betaine-free LCR
assembly of the seven part toy-model with three BO-sets. The annealing temperatures steps were 56.5,
57.7, 59.2, 61.5, 64.4, 67.8, 70.6, 72.9, 74.4 and 75.6 ◦C. The means are connected by a line. A. As
already observed in B (and Figure 6.6H), the total amount of colonies was increased with a lower BO-Tm.
Overall, the LCRs using these BO-sets resulted in a global maximum of colonies in a range of ∼68 ◦C with
2×more colonies (also shown in Supplementary Figure 6.12). B. For the three BO-sets the LCR-efficiency
was at a similar level. It started decreasing at an annealing temperature of more than 70.6 ◦C. The LCRs
were performed as triplets using the same DNA-parts and chemically competent cells. BO: bridging oligo,
CFU: colony forming unit, DMSO: dimethyl sulfoxide, Tm: melting temperature of a BO-half.
This figure is plotted by using the raw data of Schlichting et al. [95].
the three utilized BO sets were similar in the annealing temperature range of 56.5 to 70.6 ◦C
but seemed to decrease at higher temperatures. Consistent with previous results (Figure 6.6H),
the number of colonies was reduced when a BO-set with a higher Tm was utilized (Figure 3.6A).
Interestingly, a maximum amount of CFUs was observed for all LCRs in the range of 66-71 ◦C and
was further validated for the BO sets ’67.8 ◦C’ and ’71.8 ◦C’ (Supplementary Figure 6.12). Within
this range, the highest activity of the applied ligase is described and this assumes a positive
effect of prolonging the overall duration for ligations by increasing the annealing temperature
in the LCR. The increased annealing temperature doubled the colony yield for every LCR setup
without decreasing the efficiency. Nevertheless, the total amount of CFUs at an annealing at
67.9 ◦C was dependent on the average Tm of the utilized BO-sets and can be observed in more
details in Supplementary Figure 6.13: the set ’67.8 ◦C’ resulted in ca. 115 CFUs whereas the
other sets ’69.9 ◦C’ and ’71.8 ◦C’ resulted in ca. 80 and 50 colonies. Further, a slightly higher
efficiency was observed for the LCRs with the ’67.8 ◦C’-set.
41
3 Results and discussion
These results imply that a further decrease of the average Tm of BOs is advantageous for the
yield of CFUs and the assembly efficiency. The validation experiments for this hypothesis utilized
newly designed sets within a BO-Tm range of 62 ◦C to 67.3 ◦C to assemble the same seven part
split of the toy-model plasmid at the annealing temperature of 66 ◦C. The sequences of the





























Average melting temperature of bridging oligos halves / °C
Figure 3.7: To decrease the BO-Tm from 67.3 ◦C to 62.0 ◦C is disadvantageous for LCRs at the annealing
temperature of 66 ◦C. As reference, the BO-set ’69.9 ◦C’ from Figure 3.6 was utilized. Further decrease
of the BO-Tm did not improve the LCR at the optimized annealing temperature of 66 ◦C. In comparison
to the results shown in Figure 3.6, the LCR with the BO-set ’69.9 ◦C’ was less efficient due to loss of
function by repeated freeze-thaw cycles of the DNA parts and/or BOs. The sequences of the BO-sets
’62.0 ◦C’ to ’67.3 ◦C’ are shown in Supplementary Table 6.4. The LCRs were performed as triplets using
the same DNA-parts and chemically competent cells. BO: bridging oligo, CFU: colony forming unit,
DMSO: dimethyl sulfoxide, Tm: melting temperature of a BO-half.
This figure is plotted by using the raw data of Schlichting et al. [95].
efficiencies for the reference set ’69.9 ◦C’ were depleted (Figure 3.7) in comparison to the results
shown in Figure 3.6 although the same batch of DNA parts, LCR ingredients and competent
cells were utilized. Probably, this is due to the additional freeze-thaw cycle in between the
experiments which are known issues for DNA, oligonucleotides and BOs [15,81]. Nevertheless,
the investigations of a further decrease of the BO-Tm revealed no further optimization potential
for the BO-design of LCRs without 8%v/v DMSO and 0.45M betaine (Figure 3.7).
3.1.3 Optimized LCR protocol is beneficial for another toy-model plasmid split
To validate the optimized experimental conditions, the toy-model was split into the DNA parts
sfGFP, mRFP1 and the backbone. The three parts were assembled by applying the baseline and
optimized LCR protocol shown in Table 3.1. Additionally, the seven part split was assembled
with both LCR protocols. The manually designed BO-set was utilized for the baseline conditions;
the set ’67.8 ◦C’ of the gradient-LCR approach was used for the optimized LCR. All BOs were
newly ordered and fresh aliquots of the ligase buffer, NAD+ etc. were utilized. Both assemblies
were transformed chemically in NEB® 10-β E. coli cells. As expected, the assembly of both splits
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yielded more colonies and higher efficiencies for the optimized LCR protocol (Figure 3.8). The
efficiencies of the seven part split was further decreased in comparison to the results presented
before in Figure 3.6 and supports the hypothesis of a loss of function due to additional freeze-
thaw cycles of the DNA parts. Nevertheless, the optimized protocol improved the assembly.
To investigate the impact of the transformation method, the same LCRs were additionally























































Figure 3.8: Results of the baseline and improved LCR-protocol for the toy-model plasmid (’TP’). A. For
the three part split, the same LCRs were transformed in chemical (’CH’) and in electrocompetent cells
(’EP’) to prove that the results are independent of the transformation method.B. For the seven part LCR
only electroporation resulted in CFUs. For all LCRs, 3µL were transformed in 30µL cells. All LCRs were
performed as triplicates. BO: bridging oligo, CFU: colony forming unit, DMSO: dimethyl sulfoxide, Tm:
melting temperature of one BO-half.
This figure is plotted by using the raw data of Schlichting et al. [95].
transformed in electrocompetent NEB® 10-β E. coli cells by electroporation (Figure 3.8A).
No colonies were obtained for the seven part split by using chemical transformation and is
supporting the theory of the negative impact of freeze-thaw cycles. For the three part split, the
choice of the transformation method does not affect the LCR efficiency but shows an impact
on the CFU yield. Chemical transformation resulted in 2.5× more colonies for the optimized
protocol whereas the electroporation resulted in 3.5× more CFUs (Figure 3.8A). According
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to the investigations with another split of the utilized plasmid for the LCR optimizations, the
optimized conditions are valid. Nevertheless, a validation of these findings requires additional
comparative experiments by applying both protocols for constructs with different sequences.
3.1.4 Validation of the optimization experiments
Two validation plasmids were designed and split into a three part and seven part split. One
reporter gene was the lacZ, which enables a blue white screening of colonies. Additionally, one
or two selection markers were incorporated in the final sequence. The plasmids, amplification
primers and BOs and are shown in Supplementary Figures 6.15 + 6.16 and Supplementary
Tables 6.5,6.8, 6.6 and 6.9. By applying the baseline protocol, the improved protocol and a
protocol with a higher target Tm for the BO design (’75 ◦C’) in LCRs with DMSO and betaine
the impact of the suggested improvements were investigated. The latter protocol is derived
from the results shown in Supplementary Figures 6.7 and 3.4 where a higher Tm was assumed
to be beneficial for LCRs with DMSO and betaine.
Table 3.1: Summary of the LCRs for the validation experiments using the toy-model plasmid and the
validation plasmids 1 and 2 (Figure 3.1B, Supplementary Figures 6.15 and 6.16). Each plasmid was split
into three and seven parts which were assembled by using the baseline and improved LCR protocol. The
LCRs were transformed in chemically competent cells by a heat-shock. For results indicated by an ∗, the
LCRs were transformed by electroporation due to low or no colonies when chemical transformation was
used. BO: bridging oligo, CFU: colony forming unit, DMSO: dimethyl sulfoxide, Tm: melting temperature
of a BO-half using the calculation of SantaLucia [89], TP: toy-model plasmid, VP1/2: validation plasmid
1 or 2. This table is modified after Schlichting et al. [95].
Factor Unit LCR protocol TP VP1 VP2
Baseline 75 ◦C Improved Protocol 3 parts 7 parts 3 parts 7 parts 3 parts 7 parts
Efficiency (%)
DMSO %v/v 8 8 / Baseline 37±6 0±0∗ 88±4 17±29∗ 98±2 93±12
Betaine M 0.45 0.45 / Improved 47±6 17±7∗ 96±1 98±3∗ 95±0 93±3
Annealing ◦C 55.0 55.0 66.0 Total CFUs (per 3µL LCR)
Target Tm ◦C 70.0 74.8 67.8 Baseline 250±46 6±3∗ 125±8 1±1∗ 365±63 12±2
Improved 559±33 30±14∗ 493±19 323±70∗ 2023±331 189±26
By applying three protocols for the LCR assembly of the two validation plasmids ’VP1’ and ’VP2’,
the impact of the improved experimental conditions were investigated. For both plasmids and
splits, the improved LCR methods yielded more correct colonies (Figure 3.9 and Table 3.1). The
efficiency was clearly improved for the seven part split of ’VP1’. No further positive effects for
the efficiency were observed due to the high efficiency of the baseline LCR (>95%). Related
to this, the detection of an improved result is rather not possible. In contrast to this, the
improved LCR conditions are beneficial for the total amount of CFUs. Dependent on the plasmid
and split, 2× to 10× more colonies were obtained. Less positive effects on the efficiency and
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amount of CFUs were observed for the ’75 ◦C’ protocol (Supplementary Figures 6.17 and 6.18).
Nevertheless, two new protocols for LCRs with or without DMSO and betaine were validated as
being advantageous whereby the protocol for LCRs without both additives was superior due to
lower costs for the shorter BOs, less supplements, higher LCR efficiencies and higher yields of
CFUs.
Sequence analysis of the assembled validation plasmids ’VP1’ and ’VP2’ was performed to
enable and to prove the utilized phenotype-genotype screening. Ten plasmids of the seven part
assemblies with a correct phenotype ’blue’ and ’resistent to the antibiotic(s)’ were sequenced
after Sanger. No false-positive results were revealed for both whereas the analysis of four
sequences from each validation plasmid were partly false-negative. Four false phenotypes ’white’
of ’VP1’ and three false phenotypes of ’VP2’ were related to mutations in the promoter region of
the lacZ. Due to its size of 80 bp it was ordered as oligonucleotides. Probably, the mutations
are related to the synthesis of this part and are not related to the LCR. The fourth plasmid
of ’VP2’ lacked two subparts of the lacZ and was regarded as true-negative. Nevertheless, the
LCR assembly investigations using both validation plasmids is a robust method to verify the
protocol-derived differences of the LCR assemblies. The false-negative colonies are increasing
the almost high efficiencies and not the total amount of CFUs. As discussed before, the assembly
efficiency is not the relevant criterion to interpret the results of the validation experiments.
General issues like the size of the plasmid, genetic context, amount and size of DNA parts,
purification grade and freeze-thaw cycles, a robust LCR assembly is influenced by the thermal
experimental conditions and the target Tm of the utilized BOs. In this study, two new and
optimized LCR protocols were developed and validated by assembling six splits of three plasmids
and by comparing them to the published protocol. In contrast to the literature [11,16], the
utilization of 8%v/v DMSO and 0.45M betaine in the LCR is disadvantageous for all investigated
assemblies. To omit both detergents, to increase the annealing temperature from 55 ◦C to 66 ◦C
and to decrease the target Tm for a BO-half from 75 ◦C to 68 ◦C is the recommended protocol
to optimize LCR assemblies.
3.1.5 The improved LCR protocol is applicable for other LCR constructs
To investigate DNA assemblies, no rapid detection system for assemblies and misassemblies is
described in the literature. The utilization of the toy-model plasmid with the fluorescent reporter
genes sfGFP and mRFP1 is the first in-vivo approach which enables a fast and robust method to
reveal misassembled and correctly assembled plasmids. Based on this, the impact of varying pa-
rameters is detectable by a fast and easy-to-adapt readout. This can be achieved by fluorescence
microscopy or cytometry and is also applicable for other DNA assembly investigations.
The described toy-model system was utilized to investigate the role of ∆G-related crosstalk of
BOs in the LCR. No impact of the BO-crosstalk was observed for the assembly of a seven part
split and is assumed as negligible for LCR assemblies with predefined splits and DNA parts. An
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Figure 3.9: Comparison of the baseline and the improved LCR protocol for assembling the A. three
part and B. seven part split of the toy-model plasmid (’TP’) and the validation plasmids 1 (’VP1’) and 2
(’VP2’). The improved protocol increased the total amount of (correct) colonies for all assemblies. The
efficiencies were also improved, although the LCRs of the three part splits were similar for both protocols.
LCRs were performed as triplicates and were transformed by chemical transformation. For the seven
part split LCRs of the toy-model plasmid ’TP’ and validation plasmid ’VP1’ the LCRs were transformed by
electroporation due to low or no colonies when chemical transformation was used. CFU: colony forming
unit.
This figure is plotted by using the raw data of Schlichting et al. [95].
impact is conceivable for de novo designs of constructs where the ligation sites are not predefined.
This was already reported for other DNA assemblies [37]. Besides this, the LCR of the toy-model
plasmid is highly affected by the supplements DMSO and betaine, the Tm of the BOs and the
temperatures for the annealing and the ligation step of the thermal cycling. Two new and
optimized LCR protocols were derived from the results and were transferred to the assemblies
of two additional plasmids. Both improved protocols were verified as being beneficial whereby
the LCRs without DMSO and betaine were superior.
The recommended LCR protocol utilizes no DMSO/betaine and is based on an annealing step at
66 ◦C and the target Tm of 68 ◦C for each BO-half. The latter parameter is highly dependent of
the utilized Tm calculation formulas: a target Tm of 68 ◦C is relevant for applying the calculations
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of SantaLucia [89]; other systems differ significantly from this target Tm. To estimate the target
Tm in another user-defined system, the Tm of the sequence ’TCCTCCCTGCAAGACGGTG’ can be
calculated. Afterwards, this value is the target Tm of the new system. Furthermore, to use a
guanine or cytosine at the 3’-end of the BOs is not mandatory for high efficient assemblies and
is contrary to the literature [16].
To conclude, a new toy-model plasmid was developed and utilized to investigate new im-
proved protocols for the LCR assembly whereby the protocol without DMSO/betaine is the
recommended one. This protocol was validated by the assembly of three plasmids and two
different splits each. To ensure a robust assembly, a step-by-step protocol is offered on page 131.
Furthermore, a software plugin was developed to design BOs with the optimal Tm (www.git-
lab.com/kabischlab.de/lcr-publication-synthetic-biology). This plugin is described in more
details in subsection 3.4.2. Further, more results of the in vivo optimizations are described in a
guide for robust LCR assemblies in section 3.2.
A bottleneck of the presented in vivo screening system is the transformation of E. coli. Although
it offers a fast readout method, this approach is accompanied by a high workload due to the
generation of competent cells, plating and colony counting. To accelerate this, flow cytometry
can be applied to omit the need of plating and counting. Another approach is to utilize cell-free
systems [96] to screen for assemblies and misassemblies and to allow more insights in the LCR.
This in vitro method was developed and applied for LCRs and is described in section 3.3. Prior
to this, general guidelines for LCR assemblies are described and discussed in the next section.
3.2 Guidelines for robust in vivo LCR assemblies
To enable a robust LCR assembly it is mandatory to support the experimenter in the laboratory.
Within this thesis, several bottlenecks and influencing parameters were obtained which can
tremendously influence the success of an LCR assembly. As a summary, the following guidelines
are helping the experimenter in achieving highly efficient LCR assemblies. These guidelines are
based on information given in the literature or data of this thesis. For more detailed insights it
is recommended to read the publications of Pachuk et al. [74], de Kok et al. [16], Chandran et
al. [11], Robinson et al. [81] and the results presented in section 3.1. For the following LCR
assemblies, the three part split of the toy-model plasmid was utilized (shown in Figure 3.1B).
3.2.1 Primer design, phosphorylation and ordering
Influence of amplification primers
Although it is not mentioned in the literature as an issue for LCRs, the carry-over of amplification
primers can theoretically cause misassemblies: usually, PCRs are not primer-limited reactions
and residual primers are remaining in the reaction mixture after the amplification. Depending
on the purification method for these PCR products, the residual primers can be leftover in
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the purified DNA part. Due to this, primers are transferred in low concentrations to the LCR
where they can hybridize with the BOs. If so, the ligase will join the hybridized primers to
the DNA-parts. This was hypothesized in subsection 2.2.15 (page 24) after the investigation
of LCR misassemblies: residual bases at the 5’- and 3’-ends of missing subparts in a seven
parted assembly were still existent and in a scale of 10 to 100 bp. In the first steps of the
LCR, the ligation of a primer to a DNA part is only possible for reverse amplification primers
due to the forward design of BOs. In the next cycles, also the forward amplification primers
can be ligated. Finally, dead ends are build in the LCR which results in no fully assembled
construct in the LCR. Those misassembled DNA chains are probably ligated by an unspecific
blunt-end activity of the utilized ligase or by E. coli after the transformation and result in
colonies with incomplete plasmids. Although the carry-over of primers from the utilized DNA
part purification was not quantified, a proof-of-principle was performed to validate the negative





























Addition of reverse primer to simulate carry-over / nM
Figure 3.10: A three parted LCR of the toy-model plasmid was prepared (plasmid shown in Figure 3.1B).
Different concentrations of the reverse amplification primer for mRFP1 were added to the LCR mix right
before the cycling. For this, a volume of A. dest. to fill up the total volume of an LCR mix was substituted
by the primer to simulate a primer carry-over of 0, 3.5, 35 and 350nM. Primers were solved in A. dest..
The ’×’ symbolizes the mean. CFUs: colony forming units, mRFP1: monomeric red fluorescent protein 1.
to the LCR assembly of a three parted plasmid can highly decrease the LCR assembly efficiency
(Figure 3.10). For example, the impact of the lowest primer concentration of 3.5 nM (carry-over
of 0.7% if a primer concentration of 500 nM is used for a PCR reaction) decreased the amount
of CFUs from 180 to 120 and the efficiency from 90% to 80%. An impact of the forward
primer was not observed (Figure 3.11) and is probably related to the forward design of the
BOs. Only the reverse primer hybridizes with the BO. This complex is build during the LCR
by the thermal cycling followed by the participation in the ligation process. The primer of the
BO-and-primer complex can directly be ligated in the first ligation cycles and this results in
dead ends in early stages of the LCR. The proof-of-principle investigation shown in Figure 3.11
simulates the existence of only one reverse primer in a three parted LCR. Presumed that the
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reverse primer of each PCR part is carried-over in an LCR, a high negative influence on the
assembly results is expected. According to this, the existence of amplification primers in LCRs is
a plausible reason for misassemblies and also one factor for decreasing efficiencies of assemblies
with an increasing number of parts.
Several approaches are dealing with the avoidance of the carry-over of amplification primers
in subsequent steps and are mainly achieved by gel excision or a digestion step after the
PCR [27,62,119]. For the enzymatic digestion, the exonuclease I [60] and VII [12] are utilized
to digest primers after the PCR. Although the digestion of residual amplification primers can
decrease the carry-over, this is not straight-forwarded for the every-day use due to additional
experimental steps and higher costs. The more rational way to reduce possible effects of residual
amplification primers in the LCR mix is to optimize the grade of the PCR product by a gel
extraction. Another approach is to design amplification primers with a relative low melting
temperature in comparison to the melting temperature of the BOs. This supports the primer
separation from the template in the LCR and though reduces unwanted hybridizations and
ligations. The difference of the melting temperatures of the primers and BOs has to be as high
as possible. For this, the melting temperature of the primers should be at 55 ◦C or less and the
melting temperature of each BO-half at 68 ◦C for LCR conditions presented in section 3.1 to
ensure high efficient PCRs and LCRs. Nevertheless, it is not proven to be a realistic issue in the
LCR due to the fact, that the carry-over was not quantified so far. To utilize labeled primers and
separate them from the PCR mix after the amplification allow an investigation of this issue and






























Addition of forward primer to simulate carry-over / nM
Figure 3.11: A three parted LCR of the toy-model plasmid was prepared (plasmid shown in Figure 3.1B).
Different concentrations of the forward amplification primer for mRFP1 was added to the LCR mix. For
this, a volume of A. dest. to fill up the total volume of an LCR mix was substituted by the primer to
simulate a primer carry-over of 0, 4.4, 44 and 438nM. The ’×’ symbolizes the mean. CFUs: colony
forming units, mRFP1: monomeric red fluorescent protein 1.
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5’-phosphorylations of the DNA parts
5’-phosphorylated ends of the DNA parts are mandatory for the ligation of the utilized prokaryotic
ligase [20,71]. For linear constructs it is not necessary to use phosporylated primers for the
’left’ 5’-end of the first DNA part and the ’right’ 5’-end of the last DNA part. All other parts
need phosphorylations on both 5’-ends. In general, the phosphorylation can be achieved by
an enzymatic modification prior to the LCR and is the recommended approach. For this, the
T4-polynucleotide kinase (T4-PNK) is the common way to add a 5’-phosphate-group to the DNA
parts and is described in detail in the LCR protocol on page 131. Although it is possible to
perform the modification with the dsDNA parts itself [11], it is recommended to phosphorylate
the primers and to subsequently perform the PCR amplification. The phosphorylation efficiency is
higher for short and single-stranded DNA in comparison to long and double-stranded DNA [108].
Additionally, low concentrations of primers in the phosphorylation reaction and freshly prepared
ATP are increasing the yield of phosphorylated oligonucleotides. It is possible to phosphorylate
a primer pair for one PCR product in one reaction for 1 h at 37 ◦C plus 20min denaturation at
65 ◦C using a final concentration of 1µM primer and 2mM ATP. Before adding the ATP and
the enzyme, it is beneficial to heat up the phosphorylation mix for 5min at 70 ◦C and to cool it
down on ice for at least 1min to ensure a high percentage of unfolded primers.
An alternative route to get 5’-phosphorylated ends is to order modified primers or modified
synthetic genes. This is useful, and also recommended, if the same DNA part is utilized multiple
times (e.g., backbones, selection markers and reporter genes) or constructs build by a high
number of parts. Although the assembly of enzymatically phosphorylated DNA parts routinely
results in the desired construct, a high positive impact of the utilization of synthetically 5’-
modified primers was investigated in comparison to enzymatically modified oligonucleotides
(Figure 3.12). Nevertheless, the synthetic modification tremendously increases the costs for
one DNA part and this has to be taken into account for LCR assemblies. Interestingly, the
utilization of unphosphorylated 5’-primers resulted in similar efficiencies in comparison to the
T4-PNK modified primers (Figure 3.12). This is probably related to the ability of E. coli to
phosphorylate and ligate the unphosphorylated DNA parts by endogenous mechanisms during
the transformation process and have to be further investigated by transferring these results to
additional assemblies of other constructs.
Amplification primers and BOs are normally ordered from commercial suppliers. They are
offering different types of purification grades and also offer special ’cloning’-primers with a
higher purity. To order the oligonulceotides in a high purity is not assumed to be necessary
for the LCR assembly. Nowadays, the synthesis of oligonucleotides is a standard process with
low error rates. A ’low’ purification grade of primers and BOs are sufficient for assemblies.
This grade is also sufficient for primers with overhangs. To solve them in A. dest. is preferred
over using TRIS-EDTA-buffer due to the MgCl2-dependent ligation in the LCR [98]. Afterwards
the storage at ≤−20 ◦C is recommended. To accelerate the overall assembly process it is
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Phosphorylation method for amplification primers
Figure 3.12: The amplification primers for the DNA parts of a three parted LCR were 5’-phosphorylated
by the supplier Eurofins and compared to the enzymatically modified ones (T4-PNK). The latter modifica-
tion method result in A. tremendous lower amount of total CFUs and a B. lower efficiency. Interestingly,
unphosphorylated DNA parts were also assembled to the correct plasmid. The ’×’ symbolizes the mean.
CFUs: colony forming units, T4-PNK: T4-polynucleotide kinase.
convenient to first order the amplification primers and afterwards the BOs. The BOs are much
longer in comparison to the amplification primers (ca. 45-70 bases vs. 15-20 bases). The
synthesis for longer oligonucleotides is more complex [70] and though the time of delivery
of all oligonucleotides depends on the success of the BOs synthesis. For the LCR assemblies
in this thesis the time during ordering and arrival of the BOs sometimes took weeks. To split
the order allowed the PCR amplification in the meanwhile. Amplification primers are normally
delivered within 2-3 days. To first order the shorter primers allows the experimenter to amplify
the DNA parts while the oligonucleotide supplier produces the BOs. This approach probably
saves time for the assembly but is accompanied by additional delivery costs and burden for the
environment.
3.2.2 Bridging oligos
Some general advises has to be considered if other design rules than the improved conditions
presented in section 3.1 are utilized. The BOs have the purpose to determine the order of
the LCR assembly and are designed to build stable duplexes with the unwound ends of the
DNA parts. To facilitate this, the interaction of the thermodynamic properties of the BOs, the
experimental temperatures and the duration of the LCR cycling steps (denaturation, annealing
and ligation) have to be adjusted if the bridging oligos are designed with custom parameters.
These interdependencies were already described in section 3.1 and are further discussed in the
following paragraphs.
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Design rules for bridging oligos
The melting temperatures of DNA differ if DMSO and betaine are used. As shown in section 3.1
it is not recommended to utilize DMSO or betaine in the LCR. For these LCRs, the annealing
temperature has to be increased to 66 ◦C in comparison to the baseline condition of 55 ◦C
published by de Kok et al. [16]. Furthermore, it is recommended to adjust a target Tm of 68 ◦C
for the design of each BO-half for LCRs without 8%v/v DMSO and 0.45M betaine. For this
it is also necessary to use a thermostable ligase with a temperature optimum around 70 ◦C.
Betaine and DMSO are decreasing the melting temperature of the BOs by accelerated strand
separation [65,112]. If both are omitted, more energy is needed to unfold them and afterwards
they are able to build more stable duplexes with the DNA parts at higher temperatures. An
increase of the annealing temperature to 66 ◦C is beneficial (Figure 3.6). Additionally, the higher
temperature is closer to the optimum of the utilized Ampligase®1. In contrast, to modify the
annealing temperature is not relevant for LCRs with DMSO and betaine. A higher annealing
temperature would lead to less BO/DNA-part hybridizations and less template for the ligase.
As already mentioned, the target Tm for the BO design mainly depends on the utilization of
DMSO, betaine, the thermal conditions and the Tm-calculation formula. The omission of DMSO
and betaine results in the highest LCR efficiencies (Figure 3.9). Nevertheless, it was also showed
that higher melting temperatures are beneficial for LCRs with DMSO and betaine (Figures 3.8,
6.17 and 6.18). Based on the utilized Tm-calculation formula, the target Tm for each BO-half
has to be adjusted. It is recommended to utilize one of the following parameter sets for an LCR
without or with DMSO/betaine. For both designs, and if adjustable for the applied software
tool, the salt concentrations (monovalent: 50mM, divalent: 10mM), BO-concentration (30 nM
and DNA part concentration (3 nM) have to be set according to the utilized conditions. The
decreased concentration of the backbone (0.3 nM) is not considered for the calculations.
Without 8%v/v DMSO and 0.45M betaine:
1. Tm-calculation + salt correction of SantaLucia [89]≈68 ◦C
2. Tm-calculation of SantaLucia [89] + salt correction of Owczarzy [72]≈65 ◦C
With 8%v/v DMSO and 0.45M betaine:
1. Tm-calculation + salt correction of SantaLucia [89]≈75 ◦C
2. Tm-calculation of SantaLucia [89] + salt correction of Owczarzy [72]≈72 ◦C
As a critical criterion, the choice of thermodynamic formulas for the Tm-calculation of a BO is
also influencing the assembly efficiency. Depending on the formula, for example the nearest-
neighbour method from SantaLucia [89], BOs can be designed with a Tm of 68 ◦C for each
half. If another formula is used with the same parameters and to recalculate the Tm of the
previous designed BO-half, the Tm differs by a few degrees. This is demonstrated in Figure 3.4.
1http://www.epibio.com/docs/default-source/forum-archive/forum-03-1—nucleic-acid-ligation.pdf?sfvrsn=6
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Depending on the experimental settings of the LCR, too high or low melting temperatures of
the BOs will have a negative impact on the assembly. Nevertheless, it is possible to use all
formulas for the design of BOs but the target Tm has to be specified for each calculation system.
To simplify this, the sequence of an already designed BO-half with a target Tm of 68 ◦C can
be utilized. First, to calculate the Tm sequence 1 by using any thermodynamic formula with
adjusted salt and DNA concentrations results in a specific value. This value is the target Tm in
the utilized system for a BO-half in LCRs without DMSO and betaine.
According to the literature, the BOs should have at least one G or C at the 3’-end [11,16]. In the
LCR investigations in section 3.1, no correlation of using BOs with or without a G or C at the
3’-end was observed (Figures 6.7, 6.8, 6.9 and 6.10). Thirteen BO sets were designed for the
assembly of a seven part plasmid (plasmid shown in Figure 3.1B). Each set consisted of seven
BOs with the minimum of zero G/C-3’-ends and the maximum of six G/C-3’-ends. A guanosine
or cytosine at the 5’-end is also not necessary.
Impact of bridging oligo storage and age
The multiple usage of BOs for several assemblies is one benefit of the LCR. Further, to prepare
mastermixes with all necessary BOs for the multiple assembly of the same construct is possible.
This mastermix can be reused multiple times with multiple freeze-thaw cycles in between and
was the standard approach for the LCRs shown here. Mastermixes of BOs are also mentioned
as advantageous for high throughput approaches in the literature [81]. To prepare aliquots of
BOs or mastermixes and to store them at −20 ◦C is recommended due to a negative impact of
freeze-thaw cycles of oligonucleotides [15,81]. The influence of the repeated freeze-thaw cycles
can be estimated in Figure 3.13. For the assembly of a three parted LCR different production
batches with the same production scale of 0.05µM and a salt-free purification were utilized.
The BOs of production batch 1 was freeze-thawed multiple times within 26 months. In contrast,
the production batch 2 was utilized a few times. Although the freeze-thaw cycles of both BO
batches were not counted, the utilization of the 26 months old batch resulted in less CFUs and
is probably related to the additional freeze-thaw cycles. It is also plausible that the purity of
the batches is different due to an improved purification method by the manufacturer Eurofins.
Further investigations have to be performed to validate the effects of the BO age and freeze-thaw
cycles. Nevertheless, the results of this initial experiment are supporting the hypothesis given
by the literature that freeze-thaw cycles of BOs have a negative impact on LCR assemblies.
Interestingly, the LCRs without BOs resulted in colonies and supports the hypothesis of an
unspecific blunt-end activity of the ligase and/or the ligation by E. coli. A discrimination is not
possible due to the no separate investigation. The transformation of E. coli is always the final
step of this LCR approach.
1Bridging oligo half for the calibration (68 ◦C with the Tm calculation and salt correction of SantaLucia [89]):
TCCTCCCTGCAAGACGGTG
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Age of bridging oligos
Figure 3.13: Two batches of different bridging oligo ages were used for the assembly of a three part split
of a plasmid (Figure 3.1B) to investigate the influence of storage and different production batches. The
bridging oligos were ordered from the same manufacturer in the same scale (0.05µM) and purification
grade (salt-free), were solved in A. dest. and stored at −20 ◦C. The production batch 1 was applied for
more LCRs in comparison to the production batch 2. The latter oligonucleotides were frozen and thawed
less times. Assemblies without bridging oligos resulted in CFUs and is probably related to the capability
of E. coli to ligate DNA. For the LCRs, 3µL LCR were transformed in 30µL chemically competent E. coli
cells. The ’×’ symbolizes the mean. CFUs: colony forming units.
3.2.3 DNA parts
In general, the design of cloning methods, respectively DNA assemblies, is a complex and
complicated process. Sequence-related problems like homologous regions or palindromic
repeats can hamper the assembly and even the previous steps like PCR amplifications or gene
synthesis have to be considered as bottlenecks. There are free-available webtools with the focus
on these issues and are not the scope of this thesis. Nevertheless, the following guideline helps
the experimenter to circumvent usual problems in the wet-lab.
PCR amplification is a critical step in the LCR assembly
There are two approaches to generate the DNA parts for the LCR assembly: 1) the PCR ampli-
fication and 2) to order synthetic genes. For the PCR amplification, to utilize a high-fidelity
polymerase has to be the standard due to low polymerase-related mutations of the products.
Additionally, it is important to use a polymerase which does not add overhangs. Overhangs
or chewed-back ends of PCR products cannot be ligated in the LCR due to its sensitivity to
additional based or gaps at the nick of the ligation site [97]. The impact of this is higher
for assemblies with an increasing number of parts. For example, if two fragments with 5%
overhangs each have to be assembled, the probability that two PCR products without overhangs
are in proximity for a ligation event is 90%. If six fragments with 5% overhangs should be
assembled, the probability is highly decreased: the chances that DNA parts without overhangs
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are present for a full assembly is only 74%. This error rate can be further increased by other
DNA species which are able to hybridize with the BOs. This includes unspecific PCR products,
PCR templates, PCR amplification primers and DNA debris from shearing.
For PCR purifications using no gel extraction it is highly recommended to perform a DpnI-
restriction digestion (or other appropriate digestion) directly after each PCR with a methylated
PCR template. This is not possible if a Dam-methylase deficient strain was used for plasmid
propagation [67,79]. If possible, to split the resistance marker gene or/and the ORI is recom-
mended to avoid a carry-over of PCR template into the LCR. If the PCR products were purified
by gel extraction, a digestion is not mandatory as long as the size of the PCR template is not
similar to the specific product. Otherwise, a digestion have to be performed prior to the excision.
To elute the DNA parts, TRIS-EDTA buffer of the commercial kits is necessary to ensure stable
storage conditions and to prevent a digestion by nucleases [22]. For short-time usage or if they
are aliquoted, the usage of TRIS-buffer without EDTA or A. dest. only is recommended. The
ligase utilizes Mg2+-ions for the ligation [98] and these divalent cations can be complexed by
EDTA. This probably hampers the efficiency of the LCR.
For highly efficient assemblies, all DNA parts have to be added to the LCR mix in the same
ratio. In order to achieve this, the precise measurement of the eluted DNA part concentration
is important. Standard quantification by using spectrophotometric measurements based on
absorbance is sufficient as long as no unspecific PCR products are present. This can be ensured
by gel excision. To get more accurate concentrations, it is recommended to apply other methods
like spectrofluorometry, quantitative PCR or capillar electrophoresis to measure the specific PCR
product only. After the purification, aliquotation of the DNA parts is necessary to prevent a loss of
function by repetitive freezing and thawing. Repeated freeze-thaw cycles of DNA parts [86,93]
and BOs [81] are negatively influencing the LCR efficiency and should be avoided.
In case of using de novo sequences for an assembly, gene synthesis is necessary. If the synthetic
DNA parts should directly be used for the LCR, the sequences have to be ordered with 5’-
phosphorylated ends. Enzymatic phosphorylation of double stranded DNA is less efficient and
for this it is necessary to adjust the phosphorylation protocol described for ssDNA (protocol
on page 131). Altough it was not investigated, a thermal denaturation for 5min at 95 ◦C and
cool-down in ice is recommended for DNA parts prior to the phosphorylation. Afterwards, to
perform the phosphorylation for 1 h followed by the subsequent denaturation step should result
in DNA parts with a high grade of phosphorylated ends. If unphosphorylated synthetic parts are
used as template for a PCR, 5’-phosphorylated primers has to be utilized for the amplification.
3.2.4 Ligase cycling reaction
The LCR can be utilized for linear and circular assemblies. Nevertheless, to directly use an
LCR for genetic engineering approaches is not recommended due to unspecific side products.
Nevertheless, the LCR can be utilized as template for PCRs to generate the desired product.
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Figure 3.14: A three parted plasmid (Figure 3.1B) was assembled by the LCR in 10, 25, 50 and 100
cycles. For the HiFi Taq ligase, 100 cycles resulted in a total loss of volume due to the overall experimental
duration of ca. 4 h although low-profile 96-PCR tubes were utilized. A. The standard ligase of this thesis
’Ampligase®’ was utilized. B. To compare the influence of another thermostable ligase, the HiFi Taq
ligase of NEB was utilized. After 100 cycles, the total volume of the LCR evaporated. The ’×’ symbolizes
the mean. CFUs: colony forming units.
Afterwards, a purification by gel excision is recommended. As a general protocol for the LCR,
the purified DNA parts are mixed with the buffer, BOs and NAD+ as showed in the following
list:
• 30nM of each BO
• 3nM of each DNA insert
• 0.3 nM of the backbone1
• 1× Ampligase® ligase buffer
• 0.5mM NAD+
• 0.3UµL−1 U of Ampligase®
• fill up to 25µL with A. dest.
The preparation of the LCR is based on standard handling for molecular in vitro reactions in
the wet-lab. To thaw the DNA parts, BOs/BO master-mix, supplements and buffer following
by mixing and spinning them down before the transfer to the LCR reaction is necessary to
ensure homogeneous solutions by resolving precipitates. The LCR mix has to be prepared on
ice and the ligase is added last. After mixing and spinning down the mix the thermal cycling is
started. Afterwards, the direct transformation of the LCR into the host or a PCR with the LCR
1A 10× reduction of the vector concentration to 0.3 nM results in more correct colonies and higher efficiencies.
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as a template is recommended. It is possible to freeze the LCR at −20 ◦C but it has to be mixed
after thawing. To prepare the LCR mix and freeze it for a future cycling is not recommended.
To utilize the LCR as a template for PCRs to amplify linear products is an appropriate route
to generate linear copies for the genetic modification of microbial hosts or subcloning. The
utilization of 1µL of a 1:10 to 1:100 diluted LCR resulted in the expected PCR products. Mostly
this LCR-PCRmethod results in several unspecific PCR products due the existence of intermediate
products in the LCR-mix where the amplification primers can hybridize. Additionally, there is
also a carry-over of the BOs because they are not incorporated during the LCR assembly. They
will serve as forward-primers in the PCR. To perform a digestion with exonucleases I or VII
before the PCR is helpful to reduce the effects of the BOs. Nevertheless, to transfer the PCR on





























DNA part concentration in LCR / x-fold
Figure 3.15: A two parted plasmid was assembled by the LCR. The DNA concentration of the DNA
inserts and the plasmid backbone were increased and compared to the baseline concentration of 3 nM
DNA inserts and 0.3 nM backbone (condition ’1’). The ’×’ symbolizes the mean. CFUs: colony forming
units.
Higher concentrations of DNA parts and higher transformation volumes are beneficial for
LCR assemblies
The LCR enables high efficient DNA assemblies with low amount of DNA parts (3 nM in a
standard reaction). Nevertheless, an increase of the DNA part concentration can improve the
assembly. To demonstrate this, 2.5× and 5× higher concentrations of DNA parts (inserts and
plasmid backbone) were used for an assembly of a two and three part split of the same plas-
mid. The concentration of the BOs was not varied. As shown in Figures 3.15 and 3.16, the
increased DNA part concentrations yielded in more colonies but similar LCR efficiencies. Addi-
tionally, a heat-shock duration of 30 s is considered as sufficient for the chemical transformation
(Figure 3.18). To transform 2.5 to 5µL in 25 to 50µL electro- or chemically competent cells
normally results in colonies. The effects of transforming different volumes of LCR in 50µL
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DNA part concentration in LCR / x-fold
Figure 3.16: A three parted plasmid (Figure 3.1B) was assembled by the LCR without DMSO and
betaine. The DNA concentration of the DNA inserts and the plasmid backbone were increased and
compared to the baseline concentration of 3 nM DNA inserts and 0.3 nM backbone (condition ’1’). The
’×’ symbolizes the mean. CFUs: colony forming units.
chemically competent cells are presented in Figure 3.17. The amount of colonies increased
with an increasing transformation volume and was already described for transformations of
E. coli [54]. A decrease of the number of CFUs were observed for volumes ≥6µL. This is
probably related to the increased of DMSO and betaine in transformation mix. In section 3.1 it
was demonstrated that the transformation of 3µL of an LCR with 8%v/vDMSO/0.45M betaine
in 30µL electrocompetent cells is decreasing the amount of colonies (Figure 6.11). Although
this was not an issue for chemically transformations of the same volumes (Figure 6.14), DMSO
and betaine probably negatively influences chemical transformations at higher concentrations.
In general, the limiting effects for electroporations and chemical transformations can be circum-
vented by performing the dialysis of the LCR or to utilize at least a 10:1 ration of cells and LCR
for chemical transformations. To perform a dialysis directly before the transformation by using
a nitrocellulose membrane and A. dest. yields more colonies (not shown).
Storage of the Ampligase®, the 10× reaction buffer and 10mM NAD+
Two enable a robust usage of the LCR, the effects of two Ampligase® production batches
(Lucigen, Wisconsin, USA) with different ages were investigated. After arrival, the ligase
was aliquoted and stored at −20 ◦C. As shown in Figure 3.19, no impact of the batches was
observed by comparing the assembly results of a three part split of the toy-model plasmid
(plasmid shown in Figure 3.1B). Additionally, the influence of self-made Ampligase® buffer
was investigated. According to the results shown in Figure 3.20, the utilized 10× buffer with
200mM trihydroxyaminomethan (TRIS)-HCl (pH 8.3), 250mM KCl and 0.1% Triton® X-100
is stable at the storage conditions of 4 and −20 ◦C. Furthermore, the results of the two batches
’new’ and ’24 months’ are similar. This suggests a robust production of a self-made buffer and
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LCR volume in 50 µl chemically competent cells / µl
Figure 3.17: Different volumes of the same LCR with 8%v/v DMSO and 0.45M betaine were trans-
formed in 50µL chemically competent E. coli cells. A heat-shock of 30 s at 42 ◦C were applied for the






























Heat shock duration / s
Figure 3.18: Heat-shock duration for chemical transformation. For each transformation, 5µL LCR were
transformed into 50µL cells. The heat-shock was performed at 42 ◦C. The ’×’ symbolizes the mean.
CFUs: colony forming units.
an unproblematic storage at ≤4 ◦C. The latter allows the continuous usage in a cooling position
of a robotic platform as long the buffer is protected from evaporation.
For some ligases the NAD+/ATP is already supplemented in the reaction buffer. NAD+ is not
stable for longtime and is sensitive to repeated freeze-thaw cycles, UV-light or heat [125]. To
prepare a self-made buffer without the substrate based on the recipe of the ligase supplier is
recommended for longterm usage. Both substrates should be freshly prepared or aliquoted and
stored at −80 ◦C. The buffer without NAD+/ATP can be aliquoted and stored for longtime at
−20 ◦C or 4 ◦C (Figure 3.20). For the LCR reaction, the NAD+/ATP is added separately to each
LCR. To investigate the impact of the storage of NAD+ for the ligase ’Ampligase®’, several ages
of 10mM NAD+ stock solutions were compared. The batches were prepared by solving NAD+
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Age of the ligase
Figure 3.19: Two batches of different Ampligase® ages were used for the assembly of a three part split
of a plasmid (Figure 3.1B) to investigate the influence of the storage at −20 ◦C and different production
batches. For this, 3µL LCR were transformed in 30µL chemically competent E. coli cells. The Ampligase®
was aliquoted after arrival and aliquoted before the storage at −20 ◦C. Fresh aliquots were used for
the investigations. The ’×’ symbolizes the mean. 1: Ampligase® production batch 1, 2: Ampligase®
production batch 2. CFUs: colony forming units.
in A. dest. by utilizing the same stock powder (stored at −20 ◦C) followed by aliquotation and
storage at −20 ◦C. Aliquots from these batches were stored in the freezer and were thawed for
the first time for an LCR assembly to obtain the stability. Interestingly, the impact of NAD+ with
an age ≤ 24 months does not have a clear influence on the LCR (Figure 3.21). A high impact of
an age of 36 months and LCRs without the addition of NAD+ was observed. The latter condition
resulted in correct assembled plasmids and is probably related to residual NAD+ in the purified
Ampligase®. The reduced amount of colonies if the 36 months old NAD+ is probably related
to the fact, that the concentration of intact NAD+ is lower in comparison to the NAD+ in the
purified enzyme. Nevertheless, a negative influence of a longterm storage of 10mM NAD+ at
−20 ◦C was determined and have to be considered as a crucial bottleneck if a > 24 months old
NAD+ solution is used in LCRs.
To sum up, the success rate of LCR assemblies is influences by design rules and experimental
settings. Mainly, the LCR is assumed as beingmost effective if the BOs and annealing temperature
is nearby the optimum of the utilized ligase. In this thesis, the utilized ligase ’Ampligase®’
has its highest activity around 70 ◦C and BOs with a similar value for each half resulted in
the most efficient assemblies. To match the desired target Tm for a BO-half, the calculation
algorithm have to be chosen carefully. Depending on the chosen formula, the sequence can
differ significantly. Prior to the design, the chosen system have to be calibrated by utilizing
a golden-standard BO-half. This sequence is known to be one of the best BO-halves for the
described DMSO/betaine-free LCRs in this thesis with a Tm of 67.8 ◦C when the Tm calculation
and salt correction of SantaLucia was applied [89]. If available in the utilized tool, the salt
concentrations (monovalent: 50mM, divalent: 10mM), BO-concentration (30 nM) and DNA
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Age of the ligase buffer
Figure 3.20: Two batches of different Ampligase® buffer ages were used for the assembly of a three
part split of a plasmid (Figure 3.1B) to investigate the influence of storage at different temperatures
and different production batches. The 24 months old buffers are derived from the same batch and were
split for the storage in the fridge (4 ◦C) and freezer (−20 ◦C). For the LCRs, 3µL LCR were transformed
in 30µL chemically competent E. coli cells. The buffers were prepared as 10× stocks according to the
manufacturers instructions and included 200mM TRIS-HCl (pH 8.3), 250mM KCl and 0.1% Triton®
X-100. MgCl2 was not included in the buffers but was added separately to the LCR mixes. Fresh aliquots
































Figure 3.21: Four batches of 10mM NAD+ with different ages were compared by assembling a three
part split of a plasmid (Figure 3.1B) to investigate the influence of the storage at −20 ◦C and different
production batches. For this, 3µL LCR were transformed in 30µL chemically competent E. coli cells.
Fresh aliquots of the different NAD+ batches were used for the investigations. Each aliquot was derived
from a separate production batch from the same NAD+ stock (powder at −20 ◦C). The ’×’ symbolizes
the mean. 1: Ampligase® production batch, 2: Ampligase® production batch 2. CFUs: colony forming
units.
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part concentration (3 nM) have to be set. The lowered concentration of the backbone (0.3 nM)
is not considered for the calculations.
Unfortunately, the chosen workflow for the improved LCR protocol included the laborious
utilization of transformations of E. coli, plating on agar plates and the colony screening by
fluorescence microscopy. Additionally, the influence of E. coli in the assembly process and a
hypothesized unspecific activity of the ligase are not distinguishable when this in vivo LCR
screening is applied. To omit the transformation and the subsequent steps would tackle both
drawbacks to further gain insights into this assembly method and to raise the rapid prototyping
of genetic constructs to a next level. This can be achieved by substituting all in vivo steps of the
current LCR workflow by utilizing a cell extract for a CFPS of the reporter genes.
3.3 In vitro LCR
The target-oriented and efficient implementation of synthetic genetic circuits into living organ-
isms requires methods for the assembly of DNA. Of special importance are methods which enable
a high throughput and are not prone to errors. As particularly promising, the LCR [11, 16]
is a candidate to fulfill these prerequisites. Nevertheless, the LCR assembly still has a wide
potential for optimization, especially with regard to yield, accuracy, speed and a larger number
of DNA fragments. Unfortunately the DBTL cycle presented so far in this thesis is highly slowed
down by the transformation of E. coli, the subsequent plating and colony screening. As a
classical in vivo method, LCRs with varying parameters are transformed into E. coli followed
by the determination of the assembly efficiency by fluorescence screening of the transformants
(Figure 1.4 in chapter 1). This in vivo LCR readout is a limiting factor for high throughput
approaches. Furthermore, no discrimination of in vitro and in vivo issues is possible due to the
fact that the in vitro assembled DNA is processed by E. coli. To adress these limitations, an in
vitro LCR method based on a TXTL system was developed. In vitro results are generated by
combining the LCR, the rolling circle amplification (RCA) and CFPS by using a cell extract from
E. coli [14,106] (Figure 3.22). This method was developed with the support of the bachelor
student Darius Zibulski (Entwicklung einer Zellextrakt-basierten in vitro Ligase-Cycling-Reaction.
Bachelorarbeit, 2019, TU Darmstadt).
3.3.1 Cell free protein synthesis for rapid protoyping
To determine the effects of varying the parameters in the LCR assembly, an in vitro LCR method
based on CFPS was developed by utilizing a cell extract of E. coli. This extract enables an in
vitro transcription and translation of the assembled GOI followed by the fluorescence readout in
384-well PCR plates by a plate reader. By using the nanoliter dispenser I-DOT, a 384-well cycler
and a 384-well PCR plate, the technically lowest LCR volume was experimentally determined.
Less than 300nL evaporated during the 25 LCR cycles if a foil made of aluminium was utilized
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Figure 3.22: Workflow of the in vitro LCR. A circular construct is build by the LCR with a maximum
DNA concentration of 0.3 nM. Afterwards the rolling circle amplification (RCA) is applied to randomly
amplify the LCR product including the reporter gene. The increased DNA quantity enables the readout
after a cell free protein synthesis via an E. coli cell extract for an in vitro transcription and translation
(TXTL). h: hours, CFPS: cell free protein synthesis, RFU: relative fluorescence unit.
for sealing the 384-well PCR plate. Due to this, the lowest possible volume of one LCR are 300nL.
According to the manufacturer and literature, 5.7µL of the RCA components (GenomiPhi™ V2
DNA Amplification Kit) and 20µL of the E. coli extract are used for one in vitro LCR. To be
more efficient, the reaction volume should be decreased to enable more CFPS reactions with the
same batches of the RCA kit and self-made cell extract. To achieve this, several experimental
setups were investigated to decrease the total volume with a high signal-to-noise ratio and
are described in the following paragraphs. To set up the experimental workflow, 0.3 nL of a
0.3 nM plasmid with a known quantity was utilized. To use an LCR for those initial experiments
would be inappropriate due to an unknown concentration of circular product. Afterwards this
experimental setup has to be transferred to LCR assemblies. This is shown and discussed in
section 3.3.4.
The CFPS is based on a cell extract and DNA or mRNA as template for the TXTL. The cell
extract consists of the complete protein synthesis machinery and can be extracted from di-
verse prokaryotic and eukaryotic hosts [14]. By mixing the cell extract with nucleotides (e.g.,
adenosine triphosphate (ATP)), amico acids, tRNAs and coenzymes, the GOI can be transcribed
and translated in vitro to the protein of interest in a scale of µgµL−1 [14]. In comparison
to the literature [106], the protocol for the production of the cell extract was shortened to
one day with the help of Francois-Xavier Lehr from the AG Koeppl (step-to-step protocol in
section 6.1.4). Additionally, for the sonification step two protocols were used to investigate
if a higher input of energy increases the amount of cell extract (Supplementary Figure 6.20).
The impact of 900 J attends to be less favorable. Because of this, the cell extract batch derived
from the 700 J sonification step was used for all following in vitro LCRs. In general, to enable
a readout by combining the LCR, RCA and CFPS seems to be plausible. As described in the
literature, the maximal product concentration in the LCR (0.3 nM) is not sufficient to generate
a signal in the CFPS [61,106]. This was confirmed in an initial experiment (Figure 3.23). To
increase the concentration in the LCR is possible but would lead to a higher consumption of DNA
parts. To apply a dialysis step after the RCA improves the signal due to less salt perturbations
during the CFPS (Figure 3.23) but this approach is not automation friendly and would limit the
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Figure 3.23: Kinetics and 3h measurements with a plate reader of 0.3 nM plasmid p10024 (Supple-
mentary Figure 6.19) and different experimental setups. A. Kinetics were determined by measuring
the fluorescence signal of sfGFP every minute. The maximal product concentration in an LCR (0.3 nM),
results in no significant signal in comparison to the negative control without plasmid (data of the control
reaction not shown). By applying the RCA directly after the LCR, a signal was detectable. A dialysis
step after the RCA for 20min against A. dest. led to a 2× higher signal. The shading of the curves
is representing the standard deviation. The fluorescence was measured every 60 s.B. The presented
signals presenting the measurements after 3 h. All measurements were performed as sextuplicates (n=6).
Control reactions without plasmid were negative and are not shown. RCA: rolling circle amplification,
RFU: relative fluorescence unit, sfGFP: super folder green fluorescent protein.
This figure is plotted by using the raw data of the bachelor thesis of Darius Zibulski.
experimental throughput. To optimize the signal in the CFPS, the concentration of DNA has to
be increased by an alternative way. For this, the RCA [17] was applied (Figure 3.22) by using
the GenomiPhi™ V2 DNA Amplification Kit (GE Healthcare UK Limited, Buckinghamshire, UK).
This kit consists of two buffers, the sample and reaction buffer, and the enzyme mix. Although
the concentrations of salts, random oligonucleotide hexamers and enzyme concentration are
unknown, this kit was applied for the signal amplification in the in vitro LCR method.
3.3.2 Signal amplification by the rolling circle amplification
Based on the RCA method, DNA can be amplified in high quantities by the phi29 polymerase.
This polymerase was already applied for several molecular biology approaches [44, 48, 64,
78, 101], including cell free systems [56], and offers a possibility to increase the amount of
template DNA for the LCR-CFPS method. The phi29 polymerase is highly processive and can
amplify up to 70 kbp [87]. Additonally, and in comparison to other polymerases used for, e.g.,
PCRs, this polymerase is able to convert dsDNA to ssDNA by strand displacement. The RCA
takes advantage of both and enables an isothermal amplification of the LCR product at relative
low temperatures (30 ◦C) (Figure 3.22). As shown in Figure 3.23, the utilization of the RCA
increased the TXTL derived signal. A dialysis against A. dest. further doubles the signal but is
not applicable for automation and will not be further considered in the investigations. For the
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analysis of the following results, boxplots of the measurements after 3 h of the CFPS at 29 ◦C
will be utilized as shown in Figure 3.23B. Furthermore, an optimal amplification time of 90min
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Figure 3.24: A. An in vitro LCR of a linear form of the plasmid p10024 with sfGFP does not result
in a higher signal in comparison to the negative control without DNA (’0 nM circular plasmid’). For
all, a total volume of 3.6µL were used for the measurements in a plate reader. The presented signals
presenting the measurements after 3 h. All measurements were performed as sextuplicates (n=6). As
template for the RCA, 0.3 nM of the isolated plasmid p10024 or a linear PCR product was used. In the
PCR product the sfGFP was split in the middle. B. The results of baseline protocol (according to the
manufacturers) and the optimized in vitro LCR protocol. The signals represent the measurements after
3 h. All measurements were performed as sextuplicates (n=6). As template for the RCA 0.3 nM of the
isolated plasmid p10024 was used. Control reactions without plasmid were negative and are not shown.
RCA: rolling circle amplification, RFU: relative fluorescence unit, sfGFP: super folder green fluorescent
protein.
This figure is plotted by using the raw data of the bachelor thesis of Darius Zibulski.
3.3.3 Defining the experimental setup
In several experiments the RCA and CFPS were altered to reduce the total volume of the final
reaction. The main goal of the optimizations was related to design an experimental concept
which allows an automated high throughput readout in 384-Well PCR plates with a low total
volume to economize the volume of the expensive RCA kit and the self-made cell extract.
As already discussed in section 3.3.1 the lowest volume for the LCR of 25 thermal cycles is
technically limited to a volume of ≥300nL. This volume automatically results in a total volume
of 26µL for one in vitro LCR reaction if the baseline protocol is utilized (Table 3.2). Although
this generates to the highest signal, a trade-off between signal-to-noise ratio and the lowest
reaction volume has to be found. Step-by-step the volume of the phi29 kit and cell extract
were decreased. This resulted in a ca. 7× lower total volume and a 2.5× signal decrease
(Figure 3.24B). A comparison between the baseline protocol, the protocol with recommended
conditions by the manufacturers, and the optimized protocol for the automation approach is
65
3 Results and discussion
shown in Table 3.2 and Figure 3.24B. Additionally, the data for all experimental modification
steps are referenced in Table 3.2.
Table 3.2: Baseline and optimized protocol for the in vitro LCR. The LCR/plasmid was added to one
well of a 384-well PCR plate and cycled for 25 cycles. Afterwards the RCA components were added to
each well with the DNA and the plate was incubated for 90min at 30 ◦C followed by the addition of the
CFPS components into the same wells and an incubation for 3 h at 29 ◦C. The fluorescence measurements
of both protocols are shown in Figure 3.24B. 1 in comparison to the volume used in the baseline protocol.
2 final concentration of dNTPs in the vitro LCR. CFPS: cell free protein synthesis, RCA: rolling circle
amplification
LCR protocol
Factor Baseline Optimized (reduced volume)1 Corresponding data
0.3 nM LCR/DNA 0.30µL 0.30µL macroscopic observation
RCA (GenomiPhi™ kit)
sample buffer 2.7µL 0.62µL (23%) Figure 6.21
reaction buffer 2.7µL 0.62µL (23%) "
enzyme mix 0.30µL 0.09µL (30%) Figures 6.21 and 6.23
10 mM dNTPs [1mM]2 / 0.18µL (/) Figures 3.24B and 6.22
CFPS
cell extract 9.09µL 0.82µL (9%) Figure 6.24
energy buffer 10.91µL 0.98µL (9%) "
Total volume 26µL 3.61µL (13%)
Normalized RFU signal 1 0.4 Figure 3.24B
3.3.4 In vitro LCR investigations
By applying the optimized in vitro LCR protocol (Table 3.2), several experimental parameters
of the LCR were investigated to gain more insights into this assembly method. To investigate
optimal parameters for the LCR, a quantification of an increasing or decreasing amount of circular
product is mandatory prerequisite. This relation was shown by measuring the fluorescence signal
of known plasmid concentrations in a range of 0-0.6 nM (Figure 3.25B). Unfortunately, the
deviation was high and this specific workflow did not allow a precise quantification. Nevertheless,
an internal comparison of varying the parameters by comparing the means/medians is possible.
Besides the DNA quantification, it is a prerequisite that the linear form of the utilized reporter
gene sfGFP results in no signal. This was investigated by performing an in vitro LCR of 0.3 nM
circular plasmid and with a 0.3 nM linear PCR product of the plasmid. In the PCR product,
the linear form of the plasmid p10024, the sfGFP was split in the middle. This resulted in a
signal which was similar to a negative control without DNA (Figure 3.24A). This proofs the
presented workflow of an in vitro LCR (Figure 3.22) as a method for rapid prototyping in a
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Figure 3.25: A. The amplification time for the RCA of 0.3 nM circular plasmid was varied between
0 and 90min. The CFPS was measured in the plate reader. The signals represent the measurements
after 3 h. All measurements were performed as sextuplicates (n=6). As template for the RCA 0.3 nM of
the isolated plasmid p10024 was used. Control reactions without plasmid were negative and are not
shown. B. Approach to quantify DNA by the fluorescence signals. In general more DNA in the CFPS
results in higher signals until 0.3 nM plasmid and no further increase if the concentration is increased
from 0.3 nM to 0.6 nM. Nevertheless, due to the small pipetting volumes and manual pipetting the
deviation is high. No quantification is possible due to this but shows a proof of principle if a more accurate
liquid handling is utilized. For all protocols, 3.6µL were used for the measurements in the plate reader.
The presented signals presenting the measurements after 3 h. All measurements were performed as
sextuplicates (n=6). As template for the RCA 0.3 nM of the isolated plasmid p10024 was used. RCA:
rolling circle amplification, RFU: relative fluorescence unit, sfGFP: super folder green fluorescent protein.
This figure is plotted by using the raw data of the bachelor thesis of Darius Zibulski.
section 3.2, a prolonged annealing step at 66 ◦C is advantageous for in vivo LCRs. This was also
utilized as a validation experiment for the in vitro LCR. For this, the annealing time was varied
in five steps from 20 to 40 sec. As expected the shortest annealing step of 20 sec resulted in a
lower signal in comparison to the baseline condition of 30 sec and an even longer step of 40 sec
(Figure 3.26A). Furthermore, the concentration of BOs was modified in a range of 0 to 60 nM.
Interestingly the Ampligase™ seems to have an unspecific activity which can be observed from
the control reaction without BOs and the reaction without BOs and Ampligase™ in Figure 3.26B.
The signal of the first experimental setup was higher than the negative signal without DNA at
all (not shown). The addition of BOs still increases the signal as expected. As hypothesized by
de Kok et al. [16], a lower concentration of BOs than 30nM is disadvantageous. This was not
confirmed or dis-confirmed in the in vitro LCR: lower concentrations (10 and 20nM) resulted
in similar or slightly higher signals. Furthermore, a higher concentration of 40 nM is regarded
as advantageous but a further increase lowered the signals.
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Figure 3.26: A. A linear form of the plasmid p10024 were ligated via the optimized in vitro LCR
protocol (Table 3.2) followed by the in vitro readout. Shorter annealing in comparison to the baseline
condition in the LCR (30 sec) resulted in less signal. An annealing step of 40 sec increased the signal.
For all, a total volume of 3.6µL were used for the measurements in the plate reader. The presented
signals presenting the measurements after 3 h. All measurements were performed as sextuplicates (n=6).
Control reactions without DNA and an LCR without Ampligase™ were negative and are not shown. B. A
linear form of the plasmid p10024 was ligated with several bridging oligo concentrations and measured
via the optimized in vitro LCR protocol (Table 3.2). The control reaction without bridging oligos and
Ampligase™ resulted in less signal in comparison to the LCR without bridging oligos only. Probably the
enzyme ligates the linear plasmid. Nevertheless, the addition of bridging oligos increases the signal.
Bridging oligo concentrations higher than 10nM are not improving the in vitro LCR. For all, a total
volume of 3.6µL were used for the measurements in the plate reader. The presented signals presenting
the measurements after 3 h. All measurements were performed as sextuplicates (n=6). A control reaction
without DNA was negative and is not shown. RFU: relative fluorescence unit, sfGFP: super folder green
fluorescent protein, w/o: without.
This figure is plotted by using the raw data of the bachelor thesis of Darius Zibulski.
3.3.5 Cell free in vitro LCR for high throughput approaches
To accelerate LCR investigations an CFPS system was utilized and combined with the RCA. The
volume for one reaction was decreased to 3.6µL and enables a high throughput DBTL-cycle in
non-optical 384-well PCR plates. All steps for one in vitro LCR can be performed serially in one
well: first the LCR including the cycling followed by the addition of the RCA components and
the isothermal amplification and, finally, the addition of the E. coli cell extract for the CFPS.
This procedure takes up to ca. 6 h from assembly to the readout. In comparison to the in vivo
method, this in vitro approach allows the generation of results in a shorter time period with
more robust results due to the ease of performing more experimental replicates. To conclude,
the in vitro LCR is the favorable approach in comparison to the in vivo workflow to investigate
this assembly method and can also be transferred to other cloning techniques.
So far, proof of principle experiments for the LCR were performed and confirmed by published
data and/or hypotheses for in vivo LCR optimizations. Furthermore, this in vitro method can be
utilized for diverse applications like, e.g., the characterization of genetic circuits and elements,
protein engineering, library screening of promoters and other regulatory elements or to gain
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knowledge to build an in silico model for the LCR. To further optimize and cheapen the in vitro
LCR, the GenomiPhi™ V2 DNA Amplification Kit for the RCA has to be substituted by a defined
buffer, oligonucleotide concentration, dNTP concentration and by using the phi29 polymerase
from an enzyme stock solution.
3.4 Automated bridging oligo design and DNA assembly
3.4.1 CloneFlow: Software Platform for LCR assemblies
The robust and correct assembly of DNA is one of the main bottlenecks in synthetic biology.
In the last decades, many tools for in vitro or in vivo assemblies were developed and used to
build DNA constructs (e.g. Gibson assembly [34], Golden Gate assembly [24,25], CPEC [80],
BASIC [102], etc.). For synthetic biology most of these methods have limitations in reuseability
of DNA parts (e.g., specific modifications, remnant scars in the final construct, maximum of
parts, total size). The modification- and scar-free ligase cycling reaction (LCR [11, 16, 74])
offers the chance to overcome these limitations. The LCR fits perfect for automated one-pot
gene assemblies and robotic platforms. To optimize the assembly, an improved LCR protocol
was already investigated in section 3.1. Besides the optimized in vitro reaction conditions, the
defined, reproducible, automated and fast design of BOs is another crucial part. Currently, no
software tool for the design of BOs is available and all oligos have to be designed manually by
the experimenter. This is prone to errors due to the impact of the utilized formulas for the Tm
calculation and a tremendous limitation for automation approaches.
To support the SynBio community, software solutions were build in interdisciplinary cooperations
with Felix Reinhardt, Sven Jager and Michael Schmidt from the Computational Biology and
Systems group of Prof. Dr. Kay Hamacher (Fakultät der Biologie, TU Darmstadt), Prof. Dr.
Johannes Kabisch and the help of bachelor students of informatics (Bachelorinformatiker-
Praktikum, TU Darmstadt). Two tools will be described in the next sections. These tools are
used to design and create BOs and/or to guide the wet-lab experimenter to achieve high-
efficient LCR assemblies. Both tools are named CloneFlow. First, a Java-based Geneious1
plugin was developed to generate BOs for linear and circular LCR assemblies. These BOs are
designed by choosing the target Tm and user defined parameters. This software tool was already
published in Schlichting et al. [95]. As a second software tool, a Django2 and Python3.5-
based server named ’CloneFlow’ was build which allows the design of BOs with low inter-
and intramolecular crosstalk within a specific Tm range for linear and circular LCR constructs.
Further, the CloneFlow-Server allows the user to build DNA libraries consisting of DNA parts
and already designed BOs. In the next sections, the CloneFlow plugin for Geneious and the
CloneFlow server are presented in more details.
1>v. 11, http://www.geneious.com, [52]
2Django (Version 2.2.6) [Computer Software]. (2013). Retrieved from https://djangoproject.com
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Figure 3.27: CloneFlow plugin for Geneious. 1. On startup, a window with three tabs is visible.
The ’Input Settings’ tab is an area to choose the DNA parts for the BO design. The content of the second
and third tab will be shown in Figures 3.30 and 3.31. 2. The ’Local’ folder of Geneious was chosen as
the working directory to search for DNA parts.3. All linear sequences of the folder and all subfolders are
shown. Sequences of the category ’oligonucleotide’ are not included. Only dsDNA parts with a size ≥
100 bp appear. 4. By enabling the combinatorics, groups of DNA parts can be defined. More information
in Figure 3.29.
3.4.2 CloneFlow plugin for the in silico software Geneious
Based on the findings for the in vivo LCR optimization in section 3.1, a plugin for the in silico
cloning software Geneious was developed to automate the BO design and was published in
Schlichting et al. [95]. The default parameters for LCRs without 8% DMSO and 0.45M betaine
and the optimized annealing and ligation at 66 ◦C are considered. The target Tm for each
BO-half is 68 ◦C in the calculation system of SantaLucia [89]. After the installation of the plugin,
DNA parts can be selected by searching in folders of Geneious or by preselecting the parts of
interest before starting the plugin. The preselected sequences are imported automatically into
the CloneFlow plugin. After setting the order of assembly, the BOs are created and saved in
the actual working folder of Geneious. As an additional feature, groups of DNA parts and their
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logical order can be defined (e.g., promoter, CDS, terminator). The members of these groups are
used for a combinatorial LCR design with the predefined assembly order. Furthermore, the LCR
constructs are generated with the annotations of each DNA part and additionally the designed
BOs are mapped on the assembled sequence. Allover, this plugin enables an automated in silico
LCR assembly for the improved LCR protocol shown in Table 3.1.
1.
2.
Figure 3.28: Defining the order of assembly in the CloneFlow plugin. 1. Five sequences were chosen
for the assembly of one construct and added to the assembly list presented in 2.. The assembly order is
defined by the order showed here (from top to bottom). The order can be modified by clicking on a part
and shifting it up or down or to delete it. More parts from other folders can be added by repeating the
steps shown here and in Figure 3.27.
Automated bridging oligo design for LCR assemblies
To support the robust DNA assembly by the LCR, the design of BOs with a defined target Tm
is a crucial step due to the broad presence of calculation formulas and salt corrections [4,72,
73,89,91,92,94,104,105,120]. Depending on the utilized system, the Tm calculation of the
same sequence differs significantly and has an impact on the experimental reproducibility [75].
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Figure 3.29: Combinatorial LCR design with CloneFlow. DNA groups can be defined (e.g., promoter,
CDS, terminator). To each DNA group, DNA parts can be assigned by clicking on ’Add’ while the desired
DNA parts and DNA group is marked. The order of DNA groups specifies the order of assembly. Each
member of group 1 ’Promoter’ will be ligated with each member of group 2 ’CDS’ and each member of
group 2 will be ligated to each member of group 3 ’Terminator’. This allows a combinatorial and rational
LCR design.
The effects of miscalculated BOs were also shown in section 3.1 (for example in Supplementary
Figure 3.4). Due to this, the importance of an in silco BO design tool, which considers the
improved in vivo LCR conditions presented in section 3.1, prevents the user to utilize falsely
created BOs and low efficient LCR assemblies. The first approach to generate BOs with the
CloneFlow plugin is to select the DNA parts of interest and to start the tool. The parts are
directly assigned to the list ’Order of DNA-parts’ (Figure 3.28). Afterwards, more parts are
assignable by selecting a folder of interest and to utilize the search funtion. Another approach
is to start the plugin without a preselection and to utilize the search function only. The latter
method is mandatory for combinatorial LCR designs. All dsDNA sequences with a size ≥ 100 bp
are listed and can be added to the DNA part list consisting of the preselected sequences or to an
empty list (Figure 3.28).
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1.
2.
Figure 3.30: Parameter settings for the BO design. The recommended parameters for LCRs without
DMSO and betaine (improved protocol in Table 3.1) are utilized automatically as default parameters.
1. A leeway to generate BOs with the target Tm is mandatory due to the rare event that a BO perfectly
matches the adjusted target. 2. CloneFlow can design circular or linear LCR products. By disabling
this checkbox, the LCR assemblies are linear.
As depicted in Figure 3.27, CloneFlow can be utilized to search for the desired DNA sequences.
All double stranded sequences in Geneious are regarded as a DNA part as long as the size is
equal or larger than 100 bp. Less basepairs than this limit possibly lead to overlapping BOs or
to BOs with a too low target Tm. To create one BO-half with a target Tm of 68 ◦C for a DNA part
with a GC-content of ca. 45%, 33 bp are needed. This amount of basepairs is also mandatory
for the design of another BO-half at the other end of the same DNA part. Otherwise, the BOs
for the bridge from part A to B and B to C are overlapping and this probably hampers the
LCR. Furthermore, the limit of 100 bp per DNA part is necessary to enable a leeway for other
sequences with, e.g., a lower GC-content than the mentioned one. A lower GC-content lowers
the effective Tm per base [89] and more basepairs are needed to fulfill the target Tm criteria of
68 ◦C. Concluding this, the search mode of this plugin only shows dsDNA sequences with a size
≥100 bp. If a too short or ssDNA sequence is selected before starting the CloneFlow plugin,
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Figure 3.31: Output settings of the CloneFlow Plugin. 1. The output folder can be chosen. If ’standard
folder’ is activated, the files will be saved in the current working directory in Geneious. 2. Bridging
oligos and the automatically designed LCR constructs are saved in the chosen output destination. By
default, the BOs and the constructs are named with a unique numeric ID, the date and time of the design.
The ID is upcounted by 1. A user-defined pre- and suffix can be added to the name and the starting
value for the ID-counter can be adjusted. The assembled constructs are named by the same pattern and a
user-defined pre- and suffix can be defined. One tsv-file is generated and saved in the chosen destination
folder to summarize the design with the utilized design values adjusted in the ’parameter settings’ tab,
the BO names and sequences, the DNA part names and the sequence of the assembled construct. 3. For
a combinatorial design, the output files can be modified by enabling or disabling the checkboxes. 4.-7. If
unchecked, no information about the utilized parameters will be created. Furthermore, the utilized DNA
parts sequences are not copied.
the sequence will be ignored and an error message with additional information is shown.
Combinatorial design is a feature to allow the rapid design process of e.g., synthetic circuits,
and was already utilized for other DNA assembly techniques [26,69,100,109]. For the LCR,
no combinatoric design tool is described. CloneFlow offers this feature by selecting the
combinatorics option shown in Figure 3.29. The DNA groups are defined by typing user-
defined group names, for example promoter, CDS and terminator, followed by the assignment
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of members. This can be achieved by following the assignment steps in the previous paragraphs.
Figure 3.32: Output of the CloneFlow plugin. The utilized DNA parts for the assembly, the BOs, the
product and the file with the design parameters are generated as the default output for the circular
assembly of one construct. The annotation and the direction of each DNA part is transferred to the
circular product. Furthermore, the BOs are mapped on the sequence. In the description of a BO it is
written which DNA parts the BO spans.
Each DNA group can contain an unlimited amount of DNA parts and even duplicates. Further,
a part can be assigned to one, several or all groups. After the assignment of the members, all
possible combinations are designed whereby the order of the DNA groups is fixed according to
the adjustments of the user (’Order of DNA-groups’ in Figure 3.29). CloneFlow is not able
to use logical design rules for the combinatorics. As shown in Figure 3.29, each member of
the first group ’Promoter’ is ligated to each member of the second group ’CDS’, each member
of the seconds group ’CDS’ is ligated to each member of the group ’Terminator’. To swap the
order of the first and second DNA group would also result in all possible assemblies but the
design would not be logical. If linear constructs are designed, the ligation of the last and first
group members will be omitted and no BOs are created. Before the BO design is started, the
design rules can be modified (Figure 3.30). The default parameters are loaded automatically
by the CloneFlow plugin and are based on the LCR optimizations described in section 3.1
75
3 Results and discussion
Figure 3.33: Calculation information file of CloneFlow. In this file, the sequences and names of
the designed BOs, the utilized parameters and the assembled sequence is shown. This is the default
output for the output settings shown in Figure 3.31. The parameter ’nnTable’ represents the utilized Tm
calculation formula, ’dnac1’ the BO concentration and ’dnac2’ the DNA part concentration. ’Tris’ and ’K’
are not utilized in the LCR but values are expected from the formulas.
and on the salt concentrations of the utilized Ampligase® buffer. Nevertheless, all parameters
are adjustable to allow user-defined designs. Circular LCR designs are the default setting but
can be disabled to enable linear constructs. To enable a curtain leeway for the calculation of
BOs, a ’Temperature tolerance’ parameter was included in the Tm calculations. The utilized
calculation formulas design BOs with non-integer values and it is a rare event, that the Tm of a
BO-half matches exactly the target Tm. The tolerance value of ±3 ◦C is mandatory to enable the
CloneFlow tool to find BOs with the closest Tm to the target Tm. To choose a higher tolerance
interval would increase the calculation time needed to create the pool of all possible BO-halves
for one ligation site. The chosen BO-half would be the same but the overall duration for the
design would be prolonged. A smaller tolerance value would increase the risk to find no BO.
After choosing the DNA parts, the order of assembly, the design parameters for the BOs and the
output folder can be modified (Figure 3.31). To create custom names of the BOs and constructs
is available. For both, a counter function is utilized which upcounts each designed BO and
construct to prevent redundant IDs. By default, the same counter function is utilized for the
results. For example, for the circular assembly of three DNA parts, this results in a construct
with the ID ’1’ and the BOs ’2’, ’3’ and ’4’. In addition to this, the feature ’Separate name for the
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final sequence’ creates two independent counters and this would result in construct ’1’ with
the BOs ’1’, ’2’ and ’3’. Furthermore, a report file is generated with details of the assembly.
The user can modify this file as shown in Figure 3.31. Last, the report file can be disabled at
all and the user can choose if the utilized DNA parts are copied into the output folder or not.
Finally, the design can be started. CloneFlow generates circular or linear constructs of one
Figure 3.34: Combinatoric in silico LCR assembly with the CloneFlow plugin. A report file is generated
in the folder ’combinatorics’ with the list of the unique BOs of all designs. Each subfolder consists of one
assembly and the output presented in Figure 3.32.
or combinatorial assemblies. The designed BOs and the assembled sequence are saved in the
chosen output folder of Geneious or the current working directory. The default output of a
four part assembly is shown in Figure 3.32. The utilized DNA parts are also copied into the
folder to backtrace the design. As an additional feature, the names of the DNA parts are utilized
for the description of each BO and the assembled construct. The latter sequence is generated by
the plugin including the annotations of the DNA parts and the mapped BOs. Furthermore, a
report file with more metadata is provided (Figure 3.33). In case of a combinatorial design, an
additional report file is printed and saved in the parent folder (Figure 3.34). This file consists of
checks all designed BOs for all processed combinations of one assembly and only the unique BOs
are listed. Redundant BOs are deleted in this list if, for example, one DNA part is substituted by
another one and the other parts are still the same. In this case, two other BOs are created and
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the others remain. This offers the possibility to reduce the financial costs for the LCR designs
when the same DNA parts are used multiple times in the same order.
Overall, the CloneFlow plugin supports the rapid build process of LCRs by the in silico design of
BOs and assembled sequences by considering the improved conditions presented in section 3.1.
Combinatorial approaches are supported to allow a fast generation of synthetic circuits and is
based on DNA libraries. Nevertheless, no logical combinations are designed by this tool itself
and depends on the knowledge of the user. In the future, the plugin can be further improved
by implementing design rules for the construction of more rational designs. On the other
hand, the DNA groups can be populated logically if existing switches, gates and computational
design tools are utilized to build logical synthetic circuits [51,69,116,123]. For those tools it is
mandatory to follow the annotation and design rules of the synthetic biology open language
(SBOL) approach [30]. To utilize the existing tools to build the DNA groups, including the
sequences and annotations, and import them into CloneFlow offers a chance to build logical
circuits with the CloneFlow plugin.
3.4.3 Stand-alone CloneFlow server
CloneFlow offers the user to create DNA part libraries and to use them for the design of BOs.
For this it is necessary to upload the DNA parts before the user can start with the design process.
Usage of a fasta or mfasta-file is possible in the upload area of the server (Figure 3.35B). All
parts of one fasta/mfasta-file can be assigned to a group (i.e., if all parts in the file are promoters,
they can be assigned to the group ’promoters’). Each DNA part can also be added to at least one
group afterwards or it can be removed from groups. Further, every part will get a unique ID
from the CloneFlow system. One more advantage of CloneFlow is to save, search, find and
regroup every member of the DNA library. If required, only special members can be assigned to
an admin group to get permissions for renaming and regrouping the libraries. Based on these
libraries, the parts can be chosen for in silico assemblies in the calculation area. After choosing
the DNA parts of interest, the order of the LCR assembly and the design parameters can be
adjusted to design the BOs.
For the design of BOs several parameters has to be adjusted like the Tm, different salt concentra-
tions of the utilized buffers and the calculation formulas (Figure 3.35B). CloneFlow provides
default parameter tables for the BO design and optimization and can be seen or edited in the
admin area. The admin has to name a design parameter set. Automatically, this parameter set
can be utilized from all other users. Otherwise, no calculation of BOs is possible so far. The
utilized parameters for every design can also be observed after the job is done in the home area.
Nevertheless, the admin can edit the default parameters and share them with all other users
or can create new parameter sets. Users with restricted rights are allowed to use the provided
parameter sets from the admin after they were assigned to these users/groups or to create and
save their own parameter sets in the calculation area. The parameter sets are chosen directly
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before starting the jobs and will be described in the next paragraphs.
Single stranded oligonucleotides in the LCR are building a stable ’bridge’ between the denatured
ends of two DNA parts and are called BOs. One strain of two DNA parts and the connecting BO
are presenting a double stranded DNA with a single nick (shown in Figure 1.3 on page 6). This
serves as a template for an enzymatic ligation and will end in the desired construct. To specify
the assembly order of the assembly, the BOs are utilized. In contrast to other cloning techniques,
there is no need to reamplify or resynthesize the DNA parts with specific overhangs to build more
than one construct. By using the same DNA parts of the library, new BOs have to be ordered only
to redefine the order of the assembly. This advantage is depicted in Figure 1.1. An additional
amplification or order is avoided and this lowers the costs and allows a high sustainable way to
save time, workload and money. Every BO in CloneFlow has a system-defined and numeric
unique ID which can be used to label the BO. After the CloneFlow job is done, the user will get
an e-mail notification and a link to the BOs, design parameters, used DNA parts and sequences.
The BOs and the parameters can be downloaded as a csv-file. For a high stability of the
hybridized BO and DNA part the Tm of the BOs have to fit the experimental temperatures and is
a trade-off of specificity and efficiency. Further, the utilization of secondary structure inhibitors
like or betaine can increase the assembly efficiencies for some LCR designs [16]. The target
Tm for each BO-half depends on the experimental conditions and utilized calculation formulas,
This is based on a comprehensive theoretical and experimental research and is described in
more details in section 3.2.
Outlook
The CloneFlow plugin is functionable and was already utilized for some BO design in this
thesis. In contrast, the server is still under development to enable a construction of DNA libraries
and BO libraries where. The combinatorial design has to be implemented as described for the
CloneFlow plugin in subsection 3.4.2. Additionally, the design of amplification primers can
be another useful feature to further strengthen the server. Further, only a prototype feature to
generate a human-readable LCR dispensing protocol is implemented. This protocol is based on
the experimental parameters of de Kok et al. [16] and the published protocol with DMSO and
betaine. In the CloneFlow server, the BO design is optimized to calculate the minimal folding
energies. As shown in section 3.1, this crosstalk seems to be negligible for LCR assemblies with
predefined parts. Nevertheless, for de novo assemblies where the final construct is designed
but not the DNA parts themselves, this feature is a promising approach for optimized LCRs.
This was already shown to be beneficial for Golden Gate assemblies [37]. The final construct
was designed in silico by joining the desired DNA parts. Afterwards this sequence was split
into subparts by detecting 4 bases long linkers with the lowest ∆G of all possible junctions.
According to this study, a ca. 4× increase of the efficiency and amount of colonies were obtained
for the assembly with the ∆G optimized linker A non-functional prototype of the software is
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Figure 3.35: A. Input and the supposed output of the CloneFlow server. After a user input, several
modules can be utilized to create the output of a phosphorylation protocol for amplification primers,
crosstalk optimized BOs with a specific target Tm and an LCR protocol in csv-format. The design of
the amplification primers and the assembled sequence is not implemented so far. B. CloneFlow serves
as a DNA archive for the scientist and the whole group. All DNA part sequences can be uploaded in a
(m)fasta format. They can be named and assigned to self-defined groups (origin of replication, promoter,
RBS or CDS). CloneFlow also offers an adjustable right management to rename, delete or regroup
every entry. Based on this library, linear and circular DNA constructs can be designed. Bridging oligos
are designed automatically for linear or circular constructs following user-specified parameters (target
Tm, salt and DNA concentrations, kinetic parameters). Otherwise, the general rules published in the
literature will be used by default [16]. The combinatorial design is not implemented so far. BO: bridging
oligo, CDS: coding sequence, RBS: ribosome binding site.
offered for de novo LCR designs by the authors1 and further supports the need for∆G optimized
BOs of assemblies without a predefined split.
In the future, the CloneFlow server can offer the design of crosstalk minimized BOs for
LCR designs but mainly addresses assemblies of synthetic constructs with a total size of more
than 2000 bp. This size is approximately the maximum of current synthetic genes [43]. If
the designed construct is smaller, the sequence can be ordered synthetically without a need
of a DNA assembly. To calculate several splits with high and low BO crosstalk, the toy-model
plasmid sequence for the LCR optimization in section 3.1 can be utilized. By utilizing the
in vitro LCR described in section 3.3, the success rates of the assemblies can be quantified
1http://ibiocad.igb.illinois.edu/ (no https allowed for the homepage!)
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to determine the influence of the splits. Afterwards, the in vivo LCR should be applied for
the most diverse results to verify them. Based on this, the CloneFlow server can be further
developed to optimize this random split model and to automate the BO design and ordering
and to generate machine-readable LCR protocols. The improved LCR protocol investigated
in section 3.1 and the computer-aided design of BOs presented in subsection 3.4.1 are the
scaffold for the rapid and automated LCR assembly of genetic constructs. A low efficiency
results in a higher screening effort after the transformation. In case of an assembly efficiency
of 10%, 29 colonies have to be picked to obtain the correct sequence with a probability level
of 95%, six colonies with the efficiency of 40% and only two CFUs if 80% of the colonies
contain the correct sequence. For non-automated assemblies, the efficiency has no significant
impact due to the fact that picking a few colonies after one assembly is a routine. In contrast
to this, a rapid assembly via automation approaches highly suffers from low efficiencies. For
example, for 100 assemblies with an efficiency of 40%, the plasmid of 600 colonies have to
be analyzed to obtain the correct sequence. This is accompanied by 600 plasmid cultivations,
isolations, restriction analysis and sequencing, and would increase the need for additional space
for, e.g., picking robots and incubators. An increased efficiency of 80% would tremendously
lower the screening effort to 200 colonies. To tackle this, the LCR protocol was optimized
for a high efficient assembly by omitting DMSO and betaine and by adjusting the BO-Tm and
annealing temperature (section 3.1). Furthermore, the automated and combinatorial design of
BOs and LCR constructs were achieved to standardize and accelerate the design-build steps of
the DBTL-cycle (subsection 3.4.1).
For the automation, the robotic platform of the CompuGene project and Prof. Dr. Johannes
Kabisch was utilized for the automated LCR assembly (platform is shown in Figure 2.3 of
chapter 2). The workflow for the assembly results in the plating of the transformed LCRs into
E. coli (Figure 3.36). The maximum amount of transformations for one assembly round is
96. Additionally, the transformed cells can be split into two user-defined volumes after the
recovery two enable a plating of two plating dilutions per transformation. So far, the automated
workflow presented in the following abstracts was only validated without performing LCRs and
transformations. Nevertheless, the workflow was developed and verified by utilizing dummy
dispensing protocols and empty MTPs to simulate the assembly.
3.4.4 Automation of the LCR with a robotic platform
To utilize DNA libraries is mandatory for a high sustainable and rapid automated DNA assem-
bly. It reduces the hands-on time for the experimenter to amplify DNA parts or to reorder
BOs. Nevertheless, the stability of DNA libraries is doubtful due to the negative impact of
repeated freeze-thaw cycles, contaminations with nucleases [82] or cross-contaminations and
was regarded as a crucial limitation in the in vivo LCR investigations (section 3.1). To store
the DNA at 4 ◦C is possible but increases the effects of DNA degradation by nucleases [82] and
81
3 Results and discussion
LCR assem
bly
Import DNA library, enzyme, buffer,
BOs (96 components in 96 MTP)
Platestore:
Felix 1
Pick and transfer components
from MTP to I-DOT plate
I-DOT
Dispense all components in a com-
binatorial manner into one 96 PCR plate
I-DOT plate with 'pure
columns' on platestore
dispensing protocol+




Add 10 µl paraffin to each
well of PCR plate 
T-Robot (cycler)
LCR reaction (25 cycles)
paraffin in one well plate
(stored on Felix 2)
Felix 2
Add x µl chemically competent E. coli
cells to each well of PCR plate and mix
ch. competent
cells in 1-WP from
cooling pos. 1
volume of cells (x) per
transformation
T-Robot, cooling position 2
Heat shock for 30s at 42°C,
Incubate 10 min at 4°C
Felix 2
Add recovery medium to each
well of 96 MTP, transfer cells
Cytomat
Incubate for 1 h at 37°C, 1000 rpm
Felix 1
Add LB  and transfer one/two volumes
per transformation to 4-well plate
4-WP with agarlates
from hotel (in total 
3x16=48) 
Split volume; adjust split
volume and LB volume
Cytomat
Incubate for 15 hours at 30°C,
store in hotel afterwards
Hotel
Store 4-well plates in hotel until 29




in one well plate





volumes after ca. 19h
Cooling→T-Robot→Cooling
Incubate 30 min at 4°C, heat shock 
for 30s at 42°C, incubate 10 min at 4°C
≥29 plates ≤29 plates
















Figure 3.36: Workflow design for the automated in vivo LCR with the robotic platform. In total, 96
constructs could be assembled and transformed automatically within 19 h. So far, the workflow presented
here was validated by running the platform with plates without liquids or agar. 1-WP: 1-well plate, 4-WP:
4-well plate.
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an evaporation of the solvent. As a radical solution, Robinson et al. [81] automated the LCR
by amplifying the DNA parts on demand by the platform itself or for one assembly round to
circumvent the described limitations.
According to the complexity of the freeze-thaw cycles and storage effects, the influence of
reusing the same aliquots of DNA parts is assumed to be disadvantageous for the LCR assembly
efficiency. The overall impact has to be validated in additional investigations with the scope
on freeze-thaw cycles, storage temperature, storage buffer and DNA part size. Furthermore,
the degradation of oligonucleotides, respectively, BOs, and the repeated freeze-thaw cycles
of NAD+ are known issues [15,81,125] and these further decrease the approach of utilizing
library plates. As a trade-off, all components can be split into several library plates with the
same layout to reduce the amount of freeze-thaw cycles. This workaround is more laborious
and needs additional storage capacities. Another approach would include the utilization of
automated PCRs and a synthesizer for the BOs. Furthermore, an accessible freezer is mandatory
to automatically get and store the library plates.
PCR plate (96 wells, low-profile) 
Dispensing protocol (csv-file):
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Figure 3.37: Combinatorial LCR design in the robotic platform. A 96-well library plate with DNA parts,
BOs, enzyme buffer, enzyme, water and NAD+ is utilized to transfer the desired liquids to the pure
columns of the I-DOT source plate. For this, the position of each liquid in the library plate is specified
by a source file (csv-format). This file consists of the names and positions of the desired liquids and is
manually created beforehand by the user for the automated and column-wise transfer to the I-DOT source
plate. Afterwards, the source plate is utilized by the I-DOT for a dispensing into a 96-well PCR plate.
The volumes and combinations are specified by a dispensing protocol (csv-file). Up to 96 combinations
are mixed in 1-2min. Afterwards, the PCR plate is transferred to the cycler. Finally, the liquids in the
I-DOT source plate are backfilled into the corresponding wells of the library plate.
3.4.5 Transformation of E. coli
To utilize chemically competent cells and the heat-shock for transformations of E. coli is an
easy-to-automate method but results in a lower transformation efficiency in comparison to
electroporations [38]. Additionally, the transformation efficiency tremendously decreases
if thawed cells are refrozen and utilized an additional time [36]. Residual cells should be
discarded or reused soon without an additional freeze-thaw cycle in between. Due to this it
is recommended to prepare a 96 MTP or 96 PCR plate with cell aliquots equal to the amount
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of LCRs and an excess cell volume of 10%. Furthermore, the cells are stored on the cooling
position before starting the robotic workflow. Until their utilization, ca. 2 h elapses. An impact
of this duration on the transformation efficiency is not described in the literature and was
not investigated. Escherichia coli adapts to the lower temperature after a few hours [2]. This
reactivated metabolism assumes an impact on the transformation efficiency by, i.e., alterations
of the cell membrane. Nevertheless, a technical solution by utilizing an accessible freezer for
automated thawing in close temporal proximity to the heat-shock is recommended.
The volume of recovery medium depends on the humidity of the agar plates and the percentage
of the agar. So far, to add the default volume of 250µL medium is considered as sufficient to
receive agar plates with evenly distributed colonies after the growth. Nevertheless, the plating
is still a bottleneck of the automated LCR workflow. Too high volumes of the recovery medium
result in a liquid layer on the agar plates at the end of the incubation step. This hampers the
formation of colonies. This is probably related to the humidity chamber of the incubator. To
incubate the agar plates with an empty water reservoir is suggested to accelerate the evaporation
of the liquid without compromising the output of evenly distributed colonies.
In case of the maximal amount of 96 transformations and two dilutions for each transformation,
48 4-well agar plates have to be prepared for the sum of 192 platings. The height of the agar and
the added recovery medium for the plating is influencing the probability of cross-contaminations.
Due to this, the maximal agar volume per well was investigated. The volume has to be 5mL to
10mL to ensure no cross-mixing during the shaking and no drying of the agar. Furthermore,
more than 29 agar plates can not be stored in the incubator due to the limited storing positions.
By calculating the amount of LCRs from the dispensing protocol and by considering if the plating
volume is split into one or two volumes, the amount of total 4-well agar plates are automatically
calculated. Before populating the incubator, the agar plates with plated cells are stored in an
empty stack of the hotel. Only the last 29 agar plates will then be stored in the incubator. This
workaround enables the automated assembly of 96 constructs. Further, the user can remove
the agar plates with cells from the hotel and incubate them somewhere else. Afterwards, the
residual plates are automatically stored and incubated by the robotic platform.
The presented LCR workflow was developed by utilizing the corresponding devices of the
plattform and the software suite of Analytik Jena. So far, all steps were tested by running the
workflow in a dry mode with no liquids. To validate the workflow, 96 assemblies have to be
designed to assemble them by the robotic platform.
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The DNA assembly of desired genetic constructs is the scaffold of modern biology. A broad
variety of techniques are described and utilized all over the world. In most laboratories, the
assembly method of choice mainly depends on one decision-making step in early days of each
facility. Each method has a right to exist and normally results in the desired sequence within a
few days. Nevertheless, the assembly technique for automation approaches underlies curtain
demands. As prerequisites for this laborious build-process, one-pot assemblies of an unlimited
number of modular building bricks, the DNA parts, low pre-planning and low post-assembly
screening effort are desirable. Unfortunately, most automation approaches are utilizing error-
prone methods by inserting DNA bias into the final sequence or by the limited reusage of DNA
parts due to specific DNA part modifications. Furthermore, the design of the DNA parts is
cumbersome or requires a construct-specific and sequential assembly strategy. To overcome
these limitations, a universal and simple DNA assembly method was utilized in this thesis and is
based on concatenating unmodified DNA parts. This is achieved by guiding a prokaryotic ligase
to the nicks in between two DNA parts by temporarily connecting them by a complementary
bridge made of DNA. These bridges are called bridging oligos (BOs) and are 40 to 70 bases long
single-stranded DNA. To shuffle the order of DNA parts in the final sequence, only new BOs
are added to the reaction mixture. In contrast to other methods, there is no need to reorder or
reamplify the DNA parts. Allover, this assembly method supports the rapid build process for
biology by fulfilling the criteria ’reusable’ and ’scarless’ and is named ligase cycling reaction
(LCR) [11,16,74,83].
The automation of the LCR includes the
1. in silico design of BOs and final constructs followed by the
2. device-aided assembly in the wet-lab to generate constructs.
Both were addressed by utilizing the software Geneious and the robotic platform of the
CompuGene project and Prof. Dr. Johannes Kabisch. First, the protocol of the LCR assembly
was optimized to ensure more efficient DNA assemblies and to decrease the screening effort
to a minimal level (section 3.1). The optimization experiments based on a plasmid with two
fluorescent reporter genes to determine the assembly efficiency and the total number of colonies.
Both reporter genes consisted of the same terminator sequence. The plasmid was split into 79
to 2974 bp subparts to simulate a challenging assembly. Based on this toy-model plasmid, the
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efficiency and total number of colonies were determined to rate the success of each assembly
condition. Although the protocol was validated by assemblies of additional plasmids, the
robustness of the LCR is still related to unknown issues. The ability of E. coli to utilize and alter
the DNA in the following transformation step and the blunt-end activity of the utilized ligase
’Ampligase®’ are thought to cause an unpredictable assembly behavior. Both were observed in
the results of this thesis and are shown in Figures 3.19 (page 60) and, respectively, Figure 3.13
(page 54). Nevertheless, the optimized protocol is clearly improving the results of in vivo LCRs
even if E. coli and the ligase are utilized (Figure 3.9). If the improved protocol is beneficial
for all LCR assemblies has to be validated. According to the results presented in this thesis the
reasons for the improved LCR protocol seem to be related to sequence-unspecific issues like
the omission of DMSO/betaine and the more favorable reaction temperature for the involved
ligase. Nevertheless, the three utilized plasmids for the assemblies are not covering a broad
range in total size or amount of parts. More plasmids need to be designed and assembled by
using several protocols.
The speed of the in vivo LCR workflow is limited by the associated effort of transforming each
LCR in E. coli and to screen the so derived colonies (both workflows shown in Figure 1.4 on
page 7). Instead, a cell-free LCR was developed by linking the cell free protein synthesis with
a DNA amplification step, the rolling circle amplification (RCA). A protocol was designed to
enable high-throughput assays in a total volume of 3.6µL (section 3.3). Furthermore, all steps of
the in vitro LCR are performed in non-optical 384-well PCR-plates instead of using significantly
more expensive optical plates. To conclude, the time-consuming transformation, plating and
colony screening steps were substituted by the addition of a cell extract of E. coli. This enabled
an in vitro readout of LCRs whereby the assembly criteria of the in vivo LCR ’efficiency’ and
’total CFUs’ were substituted by quantifying a fluorescent signal derived by a cell free protein
synthesis (CFPS). As another feature, a high number of biological repetitions can be achieved to
avoid underpowered experimental designs. By this, the influence of the annealing time in the
LCR and the blunt-end activity of the ligase were validated (Figure 3.26) as hypothesized for
the in vivo LCR. Unfortunately, the in vitro LCR is performed with undefined conditions due
to the RCA kit. This kit has to be substituted by a polymerase and defined reaç tion buffers to
lower the financial effort for this method and to further optimize the protocol. Furthermore, it
is highly recommended to utilize a nanoliter dispensing unit to mix the reactions. By this, a
lower deviation of the results was observed (Supplementary Figure 6.25).
Second, the new LCR protocol was validated and the derived new rules and parameters were
included in the development of a software plugin for Geneious (subsection 3.4.2). This tool
enables the automated design of BOs and the final sequence of the construct. As a special feature,
the plugin is capable of performing a combinatorial design with members of predefined DNA
groups including the output of all final sequences and unique BOs. Unfortunately, the minimal
DNA part size is limited to 100 bp in the current version of the plugin due to an increased the
risk of overlapping BOs. Further, the default target Tm can probably not be reached during the
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design. Due to both issues, the software plugin automatically omits too small sequences for LCR
designs. To further increase the flexibility of the LCR, the lower size limit has to be investigated
experimentally or an appropriate specific strategy has to be developed. For latter, a part with
a size of 6 bp was successfully incorporated in initial experiments by utilizing the vivo LCR
approach. The BO design was performed manually by ignoring the small part. The designed BO
was spanning from the 3’-end of the previous part to the 5’-start of the next part with the desired
target Tm each. A control reaction without the ligase also resulted in the desired construct and
supports the theory, that E. coli participate in the assembly. By this, the host can be utilized to
assemble small DNA parts and to enable a strategy for the in silico and in vivo LCR assembly.
Finally, the optimized LCR protocol was transferred to the robotic platform for an hypothetical
and automated assembly approach (section 3.4). Besides the cytometer, all devices of the
platform (shown in Figure 2.3 on 31) are utilized for the automated assembly of 96 constructs
within 19 h. A nanoliter liquid handling unit, the I-DOT, automatically dispenses liquids from
a DNA library plate into a 96-well PCR plate by following a user-defined dispensing protocol.
Afterwards, all residual volumes of the utilized liquids are refilled into the library plate. This
supports the automated multiple usage of DNA parts and increases the sustainability of already
amplified or synthesized building bricks. Nevertheless, the automated design of the dispensing
protocol and linking it to the positions of the liquids in the DNA library plate is not incorporated
in the workflow. This increases the risk to transfer the false liquids into the source wells of the I-
DOT plate. One workaround to prevent this is to add the desired liquids and their initial volumes
to a database first. The user should only design the dispensing protocol with the unique names
or IDs of the liquids. By a search, the liquid will be automatically transferred from the library
plate to the I-DOT plate followed by the dispensing. After the backfill from the I-DOT plate to
the library plate, the volumes of each utilized liquid has to be recalculated and is based on the
dispensed volume plus an additional volume due to loss during the liquid transfer processes in
the platform. For future applications, a fridge or freezer has to be incorporated into the robotic
platform to enable the automatic handling of the library plates. For transforming more than 96
LCRs into E. coli, additional space for storing the agar plates is required. This would also include
the utilization of additional PCR plates with LCRs. So far, the workflow can generate only
one 96-well PCR plate with the maximum of 96 LCRs. In the case of more LCRs, the existing
workflow has to be further developed and an accessible freezer or fridge and an additional
thermal cycler has to be implemented. Another option to increase the number of LCRs in one
run is to utilize a 384-well cycler (heating-block) and corresponding PCR plates. Nevertheless,
the automated LCR workflow enables the user to assemble 96 LCRs in one run. To pick and
screen the derived colonies, fluorescent genes can be incorporated as a visual selection marker
to enable a fluorescence based colony screening. For this, a UV-light chamber and a colony
picker has to be incorporated into the platform. Another approach utilizes the plate reader of
the platform to detect colonies and their fluorescence and to use the pipetting robot ’Felix 1’ for
the colony picking. This is already under development in the group of Prof. Dr. Kabisch and the
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PhD student Thomas Zoll. A successful implementation would increase the flexible usage of the
platform, would circumvent the implementation of additional devices and enable the automated
colony screening, picking and cultivation directly after the growth of colonies. To gain more
insights into the LCR, the in vitro approach offers a chance to accelerate the rapid prototyping
of DNA-constructs, the characterization of synthetic circuits and to generate statistically robust
results for modeling approaches. For this, the already implemented workflow for the in vivo
LCR can be adapted.
In total, the automated DNA assembly was achieved by a) investigating an improved LCR
protocol and potential bottlenecks, b) by an automated, fast and combinatorial design of LCR
assemblies and BOs and c) by transferring the improved LCR to a robotic platform to design
a hypothetical workflow for the assembly of 96 3µL LCR-reactions within 19 h. So far, the
automated LCR workflow was tested by running all steps without liquids, cells and agar. This
still has to be validated by performing the full capacity of 96 assemblies to prove the applicability
of the hypothetical workflow.
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Supplementary Figure 6.1: Efficiency and total number of CFUs depending on crosstalk and melting
temperatures. The data is from the LCRs without DMSO and betaine of the seven parted toy-plasmid.
All LCRs were performed as quintuplets. Sets with a minimized folding energy perform better than the
remaining sets, but the reason is likely their low melting temperature and not their low crosstalk. Their
crosstalk evaluated by HTm and Hconc does not differ from the other low-crosstalk sets, which further
suggests that the melting temperature is the main reason for the performance. This figure is adapted
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Supplementary Figure 6.2: Efficiency and total number of CFUs depending on crosstalk and melting
temperatures of BO sets with crosstalk optimized towards high (H) or low (L) values plus one manually
designed set (M). The data is from the LCRs with 8%v/v DMSO and 0.45M betaine of the seven parted
toy-plasmid. All LCRs were performed as quintuplets. The optimization criterion for each set can be seen
in the crosstalk plots, e.g. sets L1 and L2 appear at the very left of the MFE crosstalk plot because they
were optimized for low MFE crosstalk. High-crosstalk sets perform better than low-crosstalk sets because
greater crosstalk is usually accompanied by greater melting temperatures; this counteracts the effect of
DMSO and betaine, which lower the melting temperature. Ultimately, secondary structure was inhibited
so much by DMSO and betaine that crosstalk could not occur and the BOs could barely attach to their
complementary DNA parts. Thus the melting temperatures were a better criterion for performance than
crosstalk. MFE: minimal folding energy. This figure is adapted from Schlichting et al. [95].
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6.1 LCR Optimization
6.1.1 Phenotypes of the colonies obtained by the LCRs with the toy-model plasmid
A. B.
C. D.
Supplementary Figure 6.3: The four observed phenotypes of CFUs after the transformation of the
LCRs of the toy-model plasmid. The "colony 2" with the red and green phenotype contained the correct
sequence of the toy-model plasmid. The magnification of the images is 40×. A. Brightfield image of
four colonies. B. Image of the colonies shown in A with (colonies 1 and 2) and without sfGFP. C. Image
of colonies shown in A and B with and without mRFP1 (colonies 2 and 3). D. Overlay of the images
A-C. CFU: colony forming unit, mRFP1: monomeric red fluorescent protein 1, sfGFP: superfolder green
fluorescent protein. This figure is adapted from Schlichting et al. [95].
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6.1.2 Optimization experiments with the toy-model plasmid
Supplementary Figure 6.4: Overview of raw data of the experiments to investigate and calculate the
influence/omission of DMSO and betaine of the seven parted toy-plasmid (Supplementary Figure 3.2).
All LCRs were performed as quintuplets. Bridging oligo sets with minimized (L1-L6) crosstalk, maximized
(H1-H6) crosstalk and the manually designed set (M) are presented. The negative control reactions with
BOs without ligase (Ct1) and without BOs and ligase (Ct2) resulted in no fluorescent colonies and were
only performed for the LCRs with DMSO/betaine. For the LCRs without DMSO and betaine the amount
of CFUs presented here were corrected by multiplying them with the correction factor of 50. All CFUs
were counted, but only the phenotypes of about 100 CFUs per LCR were determined. White bars indicate
CFUs where the phenotype was not determined. All BO sequences are shown in Supplementary Table 6.2.
BO: bridging oligo, CFU: colony forming unit, DMSO: dimethyl sulfoxide, Tm: melting temperature of a




Supplementary Figure 6.5: Overview of the seven parted LCR of the toy-model plasmid by utilizing
six bridging oligo-sets (BO-sets) with low crosstalk and six BO-sets with high crosstalk. Each BO-set
was used five times to assemble the toy-model plasmid (Figure 3.1B) by using the baseline-conditions
with 8%v/v DMSO/0.45M betaine and without both detergents. For all LCRs, 3µL were transformed
by electroporation in 30µL NEB® 10-β E. coli cells. For more detailed results of each BO-set refer to
Supplementary Figures 6.4 and 3.2. A. The baseline-conditions with DMSO and betaine resulted in
low efficiencies and low amounts of colonies. No correlation between crosstalk and BO performance
was found. B. LCRs without DMSO and betaine resulted in more colonies and higher efficiencies in
comparison to the baseline-conditions. The sequences of all BO-sets are shown in Supplementary
Table 6.2. BO: bridging oligo, CFU: colony forming unit, DMSO: dimethyl sulfoxide. This figure is






Supplementary Figure 6.6: Graphical analysis of the bridging oligo sets (BO-sets) utilized for the
assembly of a seven parted toy-plasmid, based on the results shown in Supplementary Figure 3.2.
A+B. No crosstalk-dependent effects of the BOs were observed for the LCR with (A) and without (B)
DMSO/betaine. Both clusters (L1-L6 and H1-H6) were distinguishable by the crosstalk but without
affecting the LCR efficiency and total amount of colonies. Slightly higher efficiencies and more colonies
were observed for the cluster of the sets H1-H6 when DMSO/betaine was used. C+D.: The average
melting temperature of the BO-sets influenced the LCRs. Higher Tms resulted in higher efficiencies and
more colonies when DMSO and betaine were used (C). Without DMSO and betaine, all BO-sets resulted
in similar efficiencies suggesting no impact of crosstalk of BOs with the DNA parts in the LCR-assembly
of the seven parted toy-plasmid. More colonies were observed for sets L1-L6. In contrast to LCRs with
DMSO and betaine (C), the total amount of colonies was found to be increasing with decreasing melting
temperatures. All Tms presented here were calculated by using the formula of SantaLucia [89] for the
Tm calculation and salt correction. The manual set ("M", used for LCRs with DMSO and betaine) was
designed in Geneious with the same algorithms and a target temperature of 70 ◦C. The difference of
∼1.5 ◦C in comparison to the target Tm of 70 ◦C is due to the lack of an option to specify the DNA part
concentration in the software. The raw data of the LCRs presented here are shown in Supplementary
Figure 6.4. This figure is adapted from Schlichting et al. [95].
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6.1 LCR Optimization
Supplementary Figure 6.7: Graphical analysis of LCRs with 8%v/v DMSO and 0.45M betaine of the
seven parted toy-plasmid and the influence of various predictors on the efficiencies by utilizing different
bridging oligo sets. All LCRs were performed as quintuplets. The standard deviation for each LCR is
indicated by error bars. All BO sequences are shown in Supplementary Table 6.2. BO: bridging oligo,
DMSO: dimethyl sulfoxide, G/C end: 3’-end of one BO ending with the nucleobase guanine or cytosine,
Tm: melting temperature. This figure is adapted from Schlichting et al. [95].
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Supplementary Figure 6.8: Graphical analysis of LCRs with 8%v/v DMSO and 0.45M betaine of
the seven parted toy-plasmid and the influence of various predictors on the total amount of colonies by
utilizing different bridging oligo sets. All LCRs were performed as quintuplets. The standard deviation
for each LCR is indicated by error bars. All BO sequences are shown in Supplementary Table 6.2.
BO: bridging oligo, CFU: colony forming unit, DMSO: dimethyl sulfoxide, G/C end: 3’-end of one BO
ending with the nucleobase guanine or cytosine, Tm: melting temperature. This figure is adapted from
Schlichting et al. [95].
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6.1 LCR Optimization
Supplementary Figure 6.9: Graphical analysis of LCRs without 8%v/v DMSO and 0.45M betaine
of the seven parted toy-plasmid and the influence of various predictors on the efficiencies by utilizing
different bridging oligo sets. All LCRs were performed as quintuplets. The standard deviation for each
LCR is indicated by error bars. All BO sequences are shown in Supplementary Table 6.2. BO: bridging
oligo, DMSO: dimethyl sulfoxide, G/C end: 3’-end of one BO ending with the nucleobase guanine or
cytosine, Tm: melting temperature. This figure is adapted from Schlichting et al. [95].
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Supplementary Figure 6.10: Graphical analysis of LCRs without 8%v/v DMSO and 0.45M betaine
of the seven parted toy-plasmid and the influence of various predictors on the total amount of colonies by
utilizing different bridging oligo sets. All LCRs were performed as quintuplets. The standard deviation
for each LCR is indicated by error bars. All BO sequences are shown in Supplementary Table 6.2.
BO: bridging oligo, CFU: colony forming unit, DMSO: dimethyl sulfoxide, G/C end: 3’-end of one BO
ending with the nucleobase guanine or cytosine, Tm: melting temperature. This figure is adapted from
Schlichting et al. [95].
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6.1 LCR Optimization
Supplementary Figure 6.11: DMSO and betaine negatively affect the LCR of the seven parted
plasmid. The LCRs to investigate the impact of DMSO and/or betaine were performed as triplicates.
To investigate the direct influence of DMSO and betaine on the electroporation process, the LCRs were
performed as quadruplets (indicated with an *). The standard deviation for each LCR is indicated by
error bars and the manual set "M" was used. The combination of DMSO and betaine negatively affects
the efficiency and the total amount of colonies (comparing the results for DMSO/betaine with none of
both). Further investigation revealed a direct negative impact of DMSO/betaine in the electroporation.
An LCR was performed without DMSO/betaine. Both detergents were added before the electroporation
to simulate the transformation conditions (8%v/vDMSO and 0.45Mbetaine, mix of 3µL LCR and 30µL
competent cells). As a control ddH2Owas added. All BO sequences are shown in Supplementary Table 6.2.
BO: bridging oligo, CFU: colony forming unit, DMSO: dimethyl sulfoxide. This figure is adapted from
Schlichting et al. [95].
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BO set Tm :
67.8 ◦C
71.8 ◦C
Supplementary Figure 6.12: Total amount of colonies for the bridging oligo sets "67.8 ◦C" and
"71.8 ◦C" in the annealing temperature range of 65-67 ◦C (larger temperature range shown in Fig-
ure 3.6A+B). All LCRs were performed as triplicates. The standard deviation for each LCR is indicated
by error bars. All BO sequences are shown in Supplementary Table 6.3. BO: bridging oligo, CFU: colony
forming unit, DMSO: dimethyl sulfoxide, Tm: melting temperature of one BO-half. This figure is adapted
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Supplementary Figure 6.13: LCR without DMSO and betaine at the annealing temperature of
67.9 ◦C using three bridging oligo sets (Tm =67.8, 69.9 and 71.8 ◦C). All LCRs were performed as
triplicates. The standard deviation for each LCR is indicated by error bars. A larger range of the
annealing temperature is shown in Figure 3.6A+B. A. The efficiencies of the LCRs were similar. B. The
total amount of colonies increased with lower melting temperatures of the BOs. BO: bridging oligo, CFU:
colony forming unit, DMSO: dimethyl sulfoxide, Tm: melting temperature of one BO-half. This figure is
adapted from Schlichting et al. [95].
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6.1 LCR Optimization
Supplementary Figure 6.14: DMSO and betaine in chemical transformations. All transformations
were performed as triplicates. The standard deviation for each LCR is indicated by error bars. The plasmid
pUC19 was mixed with DMSO and/or betaine or aq. dest. followed by chemical transformation of E. coli.
DMSO had a negative impact whereas betaine had a positive impact on the number of colonies. Adding
both yielded similar results as adding neither. CFU: colony forming unit, DMSO: dimethyl sulfoxide. This
figure is adapted from Schlichting et al. [95].
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6.1.3 Sequences of the toy-model plasmid and the utilized amplification primers
and bridging oligos
Supplementary Table 6.1: Oligonucleotides for the amplification of all toy-model plasmid parts
(shown in Figure 3.1B). 1 The complete part was ordered as two oligonucleotides, which were phos-
phorylated and annealed to double stranded DNA before the LCR (described in the methods). 2 For
sequencing from the vector into the inserts. fw: forward direction, mRFP1: monomeric red fluorescent
protein 1, rv: reverse direction, sfGFP: superfolder green fluorescent protein. This table is adapted from
Schlichting et al. [95].
Toy-Plasmid Part OligoID Sequence (5’→3’)
mRFP1 (Addgene: pYTK090)






part 2 (mRFP1-part 2) 10127-fw ATGGCGAGTAGCGAAGACG
10128-rv GTCCTGGGTAACGGTAACAAC
part 3 (mRFP1-part 3) 10129-fw TCCTCCCTGCAAGACGG
10132-rv TATAAACGCAGAAAGGCCCAC
sfGFP (Addgene: pYTK001)
part 4 (sfGFP-part 1) 10108-fw GAAAGTGAAACGTGATTTCATGCG
10110-rv TGAACTTCAGCGTCAGTTTAC
part 5 (sfGFP-part 2) 10111-fw TCTGTACTACTGGTAAACTGC
10112-rv TGTGGCTGTTAAAATTGTATTCC
part 6 (sfGFP-part 3) 10113-fw ATGTTTACATCACCGCCG
10109-rv TATAAACGCAGAAAGGCCCAC
pJET1.2/blunt (Thermo Fisher)





Supplementary Table 6.1: Oligonucleotides for the amplification of all toy-model plasmid parts
(continued)





Supplementary Table 6.2: Oligonucleotides for crosstalk LCRs (results shown in Supplementary
Figures 3.2 and 6.6). All melting temperatures (Tms) presented here are calculated for each BO-half using
the formula of SantaLucia [89] for the Tm-calculation and the salt correction. Tm: melting temperature
of a BO-half. This table is adapted from Schlichting et al. [95].






































Supplementary Table 6.2: Oligonucleotides for crosstalk LCRs (continued).










































Supplementary Table 6.2: Oligonucleotides for crosstalk LCRs (continued).
Bridging Oligo Set (Tm
per BO-half)
OligoID Sequence (5’→3’)







































Supplementary Table 6.2: Oligonucleotides for crosstalk LCRs (continued).











































Supplementary Table 6.2: Oligonucleotides for crosstalk LCRs (continued).










































Supplementary Table 6.3: Bridging oligo sets for the gradient-LCR (composed of bridging oligos
for crosstalk experiments; Supplementary Table 6.2). The results of the gradient-LCRs are shown in
Figure 3.6A+B. All melting temperatures (Tms) presented here are calculated for each BO-half using
the formula of SantaLucia [89] for the Tm-calculation and the salt correction. Tm: melting temperature









































Supplementary Table 6.4: Bridging oligo sets with temperatures in the range of 62.0 ◦C to 67 ◦C.
The results of the LCRs are shown in Figure 3.7. All melting temperatures (Tms) presented here are
calculated for each BO-half using the formula of SantaLucia [89] for the Tm-calculation and the salt

















































































Supplementary Figure 6.15: Plasmid 1 ("VP1") for the validation experiments of the improved LCR
conditions (Figure 3.9, Table 3.1). The plasmid was split in three and seven parts. Only if all parts were
assembled the cells were able to replicate, were resistant to spectinomycin and turned blue by using the
blue-white screening. Part 7 was PCR-amplified from the already existing plasmid build for scar-free
deletions in Bacillus subtilis [118]. The lacZ gene was inserted to enable a blue-white screening and was
derived from the TALEN Kit 2.0 from Addgene [9]. In comparison to the original flanking regions of the
lacZ some mutations were present due to subcloning. *: Part 6 was amplified from the existing validation
plasmid 2 ("VP2") shown in Supplementary Figure 6.16. The kanR gene was derived from [99]. Before
PCR-amplification, all templates were digested by restriction enzymes. Afterwards, all PCR-products
were additionally digested by a DpnI-digestion. lacZ: β-galactosidase, ori: origin of replication, specR:
































Supplementary Figure 6.16: Plasmid 2 ("VP2") for the validation experiments of the improved LCR
conditions (Figure 3.9, Table 3.1). The plasmid was split in three and seven parts. Only if all parts were
assembled the cells were able to replicate, were resistant to spectinomycin and kanamycin and turned blue
by using blue-white screening. Parts 1-3 were derived by PCR-amplification of a plasmid from Wenzel et
al. [118] and . Part 3 (*) begins in the lacZ of the plasmid derived from TALEN Kit 2.0 from Addgene [9]
and ends in the plasmid derived from Wenzel et al. [118]. Parts 4-7 were PCR-amplified from the already
existing plasmid build for scar-free deletions in Bacillus subtilis [118]. Before PCR-amplification, all
templates were digested by restriction enzymes. Afterwards, all PCR-products were digested by DpnI.
lacZ: β-galactosidase, manP: D-mannose permease (for Bacillus spp.), ori: origin of replication), specR:











































Supplementary Figure 6.17: Results of the baseline, 75 ◦C and improved LCR-protocol for the
validation plasmid 1 ("VP1"). For the seven part split the same LCRs were transformed in chemical cells
and electrocompetent cells (indicated by an ∗) due to no CFUs for the baseline and 75 ◦C protocol when
chemical transformation was used. For all LCRs, 3µL were transformed in 30µL cells. As a negative
control, the LCR-mix without BOs and without Ampligase® was used and resulted in no colonies (not
shown). All LCRs were performed as triplicates. CFU: colony forming unit. This figure is adapted from







































Supplementary Figure 6.18: Results of the baseline, 75 ◦C and improved LCR-protocol for the
validation plasmid 2 ("VP2"). All LCRs were transformed in chemical competent cells. For this, 3µL were
transformed in 30µL cells. As a negative control, the LCR mix without BOs and without Ampligase®
were used and resulted in no colonies (not shown). All LCRs were performed as triplicates. BO: bridging
oligo, CFU: colony forming unit. This figure is adapted from Schlichting et al. [95].
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Step-by-step protocol for the ligase cycling
reaction




The ligase cycling reaction (LCR) is a scarless and efficient method
to assemble plasmids from fragments of DNA. This assembly method
is based on the hybridization of DNA fragments with complementary
oligonucleotides, so-called bridging oligos (BOs), and an experimental pro-
cedure of thermal denaturation, annealing and ligation. In this study, we
explore the effect of molecular crosstalk of BOs and various experimental
parameters on the LCR by utilizing a fluorescence-based screening system.
The results indicate an impact of the melting temperatures of BOs on the
overall success of the LCR assembly. Secondary structure inhibitors, such
as DMSO and betaine, are shown to negatively impact the number of
correctly assembled plasmids. Adjustments of the annealing, ligation and
BO-melting temperature further improved the LCR. The optimized LCR
was confirmed by validation experiments. Based on these findings, a step-
by-step protocol is offered within this study to ensure a routine for high
efficient LCR assemblies.
Reagents – amplification of DNA fragments:
∗ proof-reading polymerase, no T/A overhangs
∗ phosphorylated primers for the amplification of DNA fragments
(use T4-polynucleotide kinase (T4-PNK; New England Biolabs,
Ipswich, USA) and T4-PNK buffer (10×) or order as syntheti-
cally modified oligos
– LCR:
∗ Ampligase® thermostable DNA (Lucigen, Wisconsin, USA) lig-





6.1.5 Protocol for the LCR assembly
130
Amplification of
DNA fragments – use phosphorylated amplification primers for the amplification of DNA
fragments (inserts and backbone)
– phosphorylation of the amplification primers by T4-PNK (on ice):
2 µL of 100 µM primer
+ 5 µL 10× T4-PNK buffer (1x)
+ 1 µL 10 000 U ml −1 T4-PNK (10 U)
+ 2 µL 100 mM ATP (4 mM)
+ 41.0 µL aq. dest/MilliQ∑
50 µL of 4 µM primer
– incubate for 1 h at 37 ◦C and 20 min at 65 ◦C
– use 6.25 µL of each phosphorylated amplification primer in a 50 µL
PCR (primer concentration in PCR: 500 nM)1,2
– Recommended: DpnI digestion of all parts before the purification
– store parts at −20 ◦C; prepare aliquots for multiple usage of the same
part (loss of function due to repeated freeze-thaw cycles [1, 2])
Bridging Oligo
Design For the LCRs the addition of DMSO/betaine is NOT recommended. The
target-Tm of the BO design depends on the algorithms you are applying
(1):
– SantaLucia 1998 (Tm calculation and salt correction [3])
∗ target Tm ≈ 67.8 ◦C
or
– SantaLucia 1998 (Tm calculation [3]) and Owczarzy 2008 (salt cor-
rection [4])
∗ target Tm ≈ 65.2 ◦C
or
– Geneious (www.geneious.com, [5]):
∗ a Geneious-plugin for the design of bridging oligos is available at
www.gitlab.com/kabischlab.de/lcr-publication-synthetic-biology




∗ restrictions in adjusting parameters for DNA-part concentration
(only ”Oligo” can be adjusted)
∗ to get correct melting temperatures use 114 nM for the input of
”Oligo”
∗ then use SantaLucia 1998 [3] for the Tm calculation and salt
correction (Owczarzy 2008 [4] is not available for the calculations
in Geneious versions≤ 11.0.5)
∗ target Tm ≈ 67.8 ◦C
5'3'
bridging oligo
target TmDNA 1 DNA 2
half 1 half 2
Figure 1: Scheme of the bridging oligo design. Half 1: 100% complementary to
the 5-end of the first DNA part. Half 2: 100% complementary to the 3-end of
the second DNA part.
Ligation – use inserts:vector ratio of 10:1 (use 0.3 nM of the backbone) to re-
duce the background (religation of the backbone occurs due to the
phosphorylation of all parts)
– for 25 µl (in brackets: final concentration):
DNA inserts (3 nM of each fragment)
+ vector (0.3 nM)
+ 0.5 µL of each 1.5 µM bridging oligo (30 nM of each oligo)
+ 2.5 µL 10× Ampligase® buffer (includes 0.5 mM NAD+)
( + 1.25 µL of 10 mM NAD+ (0.5 mM))3
+ 1.5 µL of 5 U µL−1 Ampligase® (7.5 U)
fill up with aq. dest to 25 µL
– use low-profile tubes or low-profile PCR plates (96-well) in a cycler
for volumes of less than 10 µL
– for more than 25 cycles of small volumes (≤ 10 µL): use 384-well
plates
– start cycling (figure 2)
Initial denaturation : 94°C 2 min
Denaturation : 94°C 10 s
Annealing : 66° C 30 s
Ligation : 66°C 1 min
Hold : 10°C ∞
25-50x




– store at -20 °C or directly use for transformation of chemically- or
electrocompetent cells or use LCR-mix as template in a PCR (1 µl of
1:100 dilution works in general)
Notes 1. This is the recommended primer concentration for the Q5® High-
Fidelity Polymerase (New England Biolabs, Ipswich, USA). Proba-
bly, the concentration has to be adjusted for your polymerase. For
this please ask your supplier.
2. For some PCRs the sum of the forward and reverse primers 12.5 µL
in a total PCR-volume of 50 µL can result in no product. In those
cases, a dialysis of the phosphorylated primers for 20 min with aq.
dest. and a floating membrane (Merck-Millipore™Membrane Filter,
0.025 µm; order-#: VSWP02500) is helpful.
3. Self-made 10×-buffer without NAD+ is recommended. NAD+ is sen-
sitive to freeze-thaw cycles, long-term storage and light exposure.
Prepare a stock solution of NAD+ and store in aliquots at −80 ◦C up
to 6 months. 10× Ampligase® buffer: 200 mM TRIS-HCl (pH 8.3),
250 mM KCl, 100 mM MgCl2, 0.1% Triton X-100.
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Supplementary Table 6.5: Oligonucleotides for the amplification of all validation plasmid 1 parts
(shown in Supplementary Figure 6.15). For the amplification of the parts of the three part split, the
oligonucleotides of parts 1 (fw)+3 (rv), 4 (fw)+6 (rv) and 7 (fw and rv) were used. 1 The complete
part was ordered as two oligonucleotides, which were phosphorylated and annealed to double stranded
DNA before the LCR (described in the methods). 2 Part 6 begins in the lacZ of the plasmid derived from
the TALEN Kit 2.0 from Addgene [9] and ends in the plasmid derived from Wenzel et al. [118]. 3 For
sequencing from the vector into the inserts. fw: forward direction, kanR: kanamycin resistance gene,
lacZ: β-galactosidase, rv: reverse direction. This table is adapted from Schlichting et al. [95].
Part OligoID Sequence (5’→3’)
kanR (pMSE3, [99])


















lacZ (pTAL3_His, Addgene: TALEN Kit 2.0)


























Supplementary Table 6.5: Oligonucleotides for the amplification of all validation plasmid 1 parts
(continued)













Supplementary Table 6.6: Oligonucleotides for the amplification of all validation plasmid 2 parts
(shown in Supplementary Figure 6.16). For the amplification of the parts of the three part split the
oligonucleotides of parts 2 (fw)+4 (rv), 5 (fw)+6 (rv) and 7 (fw)+1 (rv) were used. 1 The complete
part was ordered as two oligonucleotides, which were phosphorylated and annealed to double stranded
DNA before the LCR (described in the methods). 2 Part 3 begins in the lacZ of the plasmid derived
from the TALEN Kit 2.0 from Addgene [9] and ends in the plasmid derived from Wenzel et al. [118]. 3
For sequencing from the vector into the inserts. fw: forward direction, ori: origin of replication, lacZ:
β-galactosidase, rv: reverse direction, specR: spectinomycin resistance gene. This table is adapted from
Schlichting et al. [95].
Part OligoID Sequence (5’→3’)
lacZ (pTAL3_His, Addgene: TALEN Kit 2.0)



















































Supplementary Table 6.6: Oligonucleotides for the amplification of all validation plasmid 2 parts
(continued)






Supplementary Table 6.7: Bridging oligonucleotides for the assembly of the three parted and seven
parted toy-plasmid consisting of mRFP1, sfGFP and pJET1.2/blunt by using the baseline and improved
protocol (results and protocols shown in Figure 3.9). The BO-set for the baseline LCR consists of BOs of
the manual set shown in Supplementary Table 6.2. The BO-set for the improved LCR consists of BOs of the
"67.8 ◦C"-set of the gradient-LCR (Supplementary Table 6.3). All melting temperatures (Tms) presented
here are calculated for each BO-half using the formula of SantaLucia [89] for the Tm-calculation and
the salt correction. 1 Bridging oligos with a target Tm of 70.0 ◦C for each half, with 8%v/v DMSO and
0.45M betaine and the experimental annealing temperature of 55 ◦C. 2 Bridging oligos with a target
Tm of 67.8 ◦C for each half, without DMSO and betaine and the experimental annealing temperature of

















































Supplementary Table 6.8: Bridging oligos for the assembly of the validation plasmid 1 (Supple-
mentary Figure 6.15; results shown in Figure 3.9). All melting temperatures (Tms) presented here
are calculated for each BO-half using the formula of SantaLucia [89] for the Tm-calculation and the
salt correction. 1 Bridging oligos with a target Tm of 70.0 ◦C for each half, with 8%v/v DMSO and
0.45M betaine and the experimental annealing temperature of 55 ◦C. 2 Bridging oligos with a target
Tm of 74.8 ◦C for each half, with 8%v/v DMSO and 0.45M betaine and the experimental annealing
temperature of 55 ◦C. 3 Bridging oligos with a target Tm of 67.8 ◦C for each half, without DMSO and
betaine and the experimental annealing temperature of 66 ◦C. DMSO: dimethyl sulfoxide, Tm: melting





































































Supplementary Table 6.9: Bridging oligos for the assembly of the validation plasmid 2 (Supple-
mentary Figure 6.16; results shown in Figure 3.9). All melting temperatures (Tms) presented here
are calculated for each BO-half using the formula of SantaLucia [89] for the Tm-calculation and the
salt correction. 1 Bridging oligos with a target Tm of 70.0 ◦C for each half, with 8%v/v DMSO and
0.45M betaine and the experimental annealing temperature of 55 ◦C. 2 Bridging oligos with a target
Tm of 74.8 ◦C for each half, with 8%v/v DMSO and 0.45M betaine and the experimental annealing
temperature of 55 ◦C. 3 Bridging oligos with a target Tm of 67.8 ◦C for each half, without DMSO and
betaine and the experimental annealing temperature of 66 ◦C. DMSO: dimethyl sulfoxide, Tm: melting





































































Cell extract from E. coli and cell free protein
synthesis (CFPS) of LCRs
Niels Schlichting, Darius Zibulski
Abstract
To produce the cell extract from E. coli a short version of the published
protocol [1] was developed. The cell extract can be generated within one
day and is closely related to the protocol for competent E. coli. Afterwards
the extract can be utilized to analyze the LCR in vitro. Before adding
the cell extract an additonal DNA amplification by the rolling circle am-













Figure 1: Scheme of the in vitro LCR. A LCR will be amplified by the rolling
circle amplification (RCA) followed by an in vitro transcription and translation
step (TXTL) for a cell free protein synthesis (CFPS) by adding the cell extract
from E. coli.
Reagents – LCR:
as described in Schlichting et al. [2]
– rolling circle amplification (RCA):
GenomiPhi™ V2 DNA Amplification Kit (GE Healthcare UK Lim-
ited, Buckinghamshire, UK)
– cell extract and buffer:
all reagents were ordered as described in the protocol of Sun et al.
[1]
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1 Cell extract generation
Preculture – 50 mL 2x YT+phosphate medium
– add appropriate antibiotics; for E. coli Rosetta EL22 add 34 µg mL−1
chloramphenicol and 50 µg mL−1 kanamycin
– inoculate preculture and incubate overnight at 37 ◦C and 200 rpm
Main culture – 800 mL 2x YT+phosphate medium + antibiotics + 50 mL preculture
in a 5 L flask
– inoculate main culture at 37 ◦C and 200 rpm
– let grow to OD600 of 3 to 3.5 (3.5 to 4.5 h)
– prepare ice boxes and cool down the centrifuge for the harvesting and
1 L S30A buffer without DTT
– put 2 mL of 1 M DTT on ice for thawing
Harvesting – all following steps are performed on ice/4 ◦C!
– split the suspension in 4 centrifuge beakers with 200 mL each and
centrifuge them for 12 min at 5000 g to get pellets
– decant the supernatant and put the beakers on ice
– add 2 mL of 1 M DTT to prechilled 1 L S30A buffer to get a final
concentration of 2 mM DTT
– resuspend each pellet with 40 mL S30A-buffer + 2 mM DTT by shak-
ing or vortexing (cool down after ca. 10 sec of shaking/vortexing)
– centrifuge for 12 min at 5000 g to get pellets and repeat the resuspen-
sion and centrifugation step (same volume of S30A buffer + DTT)
– after the two washing steps resuspend each pellet with 10 mL S30A-
buffer + DTT
– weigh two 50 mL centrifuge falcons and cool them in ice
– pool the suspensions in the weighed 50 mL centrifuge falcons and
centrifuge them for 20 min at 3499 g (max. g of the utilized rotor) to
get pellets
– decant supernatant and centrifuge again for 2 min at 2000 g
– remove residual supernatant with a pipette and weigh the falcons to
calculate the mass of the pellets
– add a volume of S30A buffer + DTT to each pellet which is equal to
the mass of the pellet (e.g.: 1 g pellet = 1 mL buffer)





– make sure that the suspension is homogenous and no clumps are
leftover
– split the suspension in 2 mL microcentrifuge tubes with max. 1 mL
per tube
Lysis – put the 2 mL microcentrifuge tubes in a beaker with ice water
– ensure that the tubes are in contact with the ice water during the
sonification!
– place the tip of the sonotrode into the upper third of the tube
– make sure that the sonotrode has no contact to the tube
– lyse the cells: 10 sec pulse-10 sec pause with an amplitude of 50 %;
check in between if the wall of the tube is still in full contact to the
ice water and if the ice is not already melted!
– the sum of energy for each tube should be around 700 J
– after the sonification the suspension should be more aqueous and
close to transparent
– the success of the sonification can be checked by observing the cell
viability by microscopy
Extract – centrifuge the 2 mL microcentrifuge tubes for 10 min at 12 000 g and
4 ◦C
– use pipettes to save the supernatant and transfer it to new 2 mL
microcentrifuge tubes
– avoid the transfer of cell debris/clumbs! Repeat the centrifugation
step if necessary
– incubate the tubes with the supernatant for 80 min at 37 ◦C and
220 rpm in a thermoshaker
– centrifuge the tubes for 10 minutes at 12 000 g and 4 ◦C
– pool all supernatants and aliquote the cell extract on ice
– freeze the cell extract with liquid nitrogen
– store the tubes at −80 ◦C
2 Ligase cycling reaction
– follow the protocol published in Schlichting et al. [2]
– the maximum product concentration of one LCR is 0.3 nM (concen-
tration of the backbone in the LCR)
– use 0.3 µL of each LCR for one in vitro assay
– the concentration of 0.3 nM does not lead to a detectable signal in
the CFPS
– the DNA has to be amplified in an additional step before the CFPS
(Figure 1): the rolling circle amplification (RCA)
3
6.2 In vitro LCR
147
3 Rolling circle amplification
Reagents – 0.3 nM LCR
– GenomiPhi™ V2 DNA Amplification Kit (GE Healthcare UK Lim-
ited, Buckinghamshire, UK):
∗ sample buffer (stored at −20 ◦C)
∗ reaction buffer (stored at −20 ◦C)
∗ enzyme mix (stored at −80 ◦C)
– 10 mM dNTPs
– low-profile PCR tube or 384-Well PCR plate
Amplification – use 0.3 µL of a 0.3 nM LCR per reaction
– add 0.62 µL of the sample buffer
– incubate for 3 min at 95 ◦C
– put tube/plate on ice and add
∗ 0.62 µL of the reaction buffer
∗ 0.18 µL of 10 mM dNTPs
∗ 0.09 µL of the enzyme mix
– incubate for 90 min at 30 ◦C
– incubate for 10 min at 65 ◦C
– put tube/plate on ice and prepare the in vitro cell extract
4 Cell free protein synthesis with the cell ex-
tract
Reagents – RCA-amplified LCR
– CFPS:
∗ cell extract (stored at −80 ◦C)
∗ cell extract buffer (stored at −80 ◦C)
– plate reader, optical sealing foil, top measurement if non-optical
plates/tubes are used
Cell extract
buffer – this buffer is prepared as described in Sun et al. [1]
– the buffer consists of an amino acid solution, energy solution, Mg-
glutamate, K-glutamate, PEG-8000 and DTT
– amino acid solution (4× stock solution in A. dest., stored at −80 ◦C):
∗ 5 mM leucine
∗ 6 mM of all other amino acids




∗ 700 mM HEPES (pH 8)
∗ 21 mM ATP
∗ 21 mM GTP
∗ 12.6 mM CTP
∗ 12.6 mM UTP
∗ 2.8 mg mL−1 tRNA
∗ 3.64 mM CoA
∗ 4.62 mM NAD
∗ 10.5 mM cAMP
∗ 0.95 mM folinic acid
∗ 14 mM spermidine
∗ 420 mM 3-PGA
– to get ca. 2 mL of cell extract buffer:
∗ 532 µL 4× amino acid solution
∗ 459 µL A. dest.
∗ 337 µL 14× energy buffer
∗ 236 µL 40 % − m/v PEG-8000
∗ 251 µL 3000 mM K-glutamate
∗ 94 µL 500 mM Mg-glutamate
∗ 70 µL 100 mM DTT
– the cell extract buffer can be stored at −80 ◦C
CFPS – perform all steps on ice
– prepare a mastermix of cell extract and buffer:
for one reaction:
∗ 0.82 µL cell extract
∗ 0.98 µL cell extract buffer
– add on ice 1.8 µL of the cell extract + cell extract buffer mix to each
RCA-amplified LCR (1.8 µL)
– cover the plate with an optical plate
– the total volume of 3.6 µL has to be mixed
– spin down the volume for ca. 1 min and place the in vitro LCR reac-
tion at 29 to 30 ◦C for 3 h
– an increase of fluorescence can be observed after ca. 30 to 40 min if
a fluorescent reporter gene is utilized
5
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Supplementary Figure 6.19: Plasmid ’p10024’ for the in vitro LCR investigation. For the LCRs of
this plasmid, the plasmid was split in the middle of the sfGFP. ampR: gene for ampicillin resistance, ori:
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Supplementary Figure 6.20: For the preparation of the cell extract the cells were split before the
sonification step. One batch of cell extract was produced by using 700 J, the other one by applying 900 J.
Based on the results, the energy of 700 J for the sonification resulted in a slightly better cell extract.
RCA-amplified plasmid was used in the CFPS for the measurements in the plate reader. The signals
represent the measurements after 3 h. All measurements were performed as sextuplicates (n=6). As
template for the RCA 0.3 nM of the isolated plasmid p10024 was used. Control reactions without plasmid
were negative and are not shown. CFPS: cell free protein synthesis, RCA: rolling circle amplification,
RFU: relative fluorescence unit, sfGFP: super folder green fluorescent protein.
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Supplementary Figure 6.21: The reduction of the RCA volume resulted in lower signal. The volume
of 1.54µL was chosen as the new improved RCA for the volume of sample and reaction buffer. The
volume of the enzyme mix is still 0.3µL in this experimental setup. The effects of lowering the enzyme
mix volume is shown in Supplementary Figure 6.23. The signals represent the measurements after 3 h.
All measurements were performed as sextuplicates (n=6). As template for the RCA 0.3 nM of the isolated
plasmid p10024 was used. Control reactions without plasmid were negative and are not shown. RCA:
rolling circle amplification, RFU: relative fluorescence unit, sfGFP: super folder green fluorescent protein.
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Supplementary Figure 6.22: Influence of the addition of dNTPs in the RCA. The positive effect
of 1mM dNTPs in comparison to no additional dNTPs is shown in Figure 3.24B. For all, 2µL were
used for the measurements in the plate reader. The signals represent the measurements after 3 h. All
measurements were performed as sextuplicates (n=6). As template for the RCA 0.3 nM of the isolated
plasmid p10024 was used. Control reactions without plasmid were negative and are not shown. RCA:
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Supplementary Figure 6.23: Volume of enzyme mix in the RCA. Higher concentrations of the
recommended 5%v/v enzyme mix (manufacturers protocol) per RCA reaction mix (sample buffer +
reaction buffer + enzyme mix) do not clearly improve the signal. As a baseline condition, the volumes
for the sample and reaction buffer were already reduced as shown in Supplementary Figure 6.21. For all,
2µL were used for the measurements in the plate reader. The signals represent the measurements after
3 h. All measurements were performed as sextuplicates (n=6). As template for the RCA 0.3 nM of the
isolated plasmid p10024 was used. Control reactions without plasmid were negative and are not shown.
















Supplementary Figure 6.24: Volume of cell extract in the in vitro LCR. Although the signal of the
baseline condition is ca. 2× higher, the 50% mix will be used for the optimized in vitro protocol. As a
baseline condition, the volumes for the sample, reaction buffer and enzyme mix were already reduced
as shown in Supplementary Figures 6.21 and 6.23. For all, 2µL were used for the measurements in
the plate reader. The presented signals presenting the measurements after 3 h. All measurements were
performed as sextuplicates (n=6). As template for the RCA 0.3 nM of the isolated plasmid p10024
was used. Control reactions without plasmid were negative and are not shown. CFPS: cell free protein
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Supplementary Figure 6.25: A nanoliter dispensing unit decreases the absolute deviation of the in
vitro LCR results. Although the fluorescence signals are lower for the investigation with the nanoliter
dispenser (right plot), a higher reproducibility is observable. For all, 2µL were used for the measurements
in the plate reader. The presented signals presenting the measurements after 3 h. All measurements were
performed as sextuplicates (n=6). As template for the RCA 0.3 nM LCR was used. Control reactions
without DNA were negative and are not shown. CFPS: cell free protein synthesis, RCA: rolling circle




6.3.1 Installation code for the CloneFlow Server
This code was mainly written by Felix Reinhardt (AG Koeppl).
" " " A s s i s t the user with s e t t i n g up the se r ve r .
Ca l l in termina l : python3 i n s t a l l e r . py
" " "
import sys , os , time
import ge tpass
i f " / " in _ _ f i l e _ _ :
s top = input ( " " " I t seems tha t Python i s not run from the termina l .
The setup may f a i l . Proceed : y/n " " " )
i f not s top . lower () in ( " y " , " yes " ) :
p r i n t ( " Abort ing execut ion . " )
sys . e x i t (1)
DIR = os . path . dirname ( os . path . abspath ( _ _ f i l e _ _ ) )+"/ s i t e /env1 "









def p r in t2 ( typ , s ) : p r i n t ( typ+s+END)
def Replace ( path , * p laceho lde r s ) :
" " " Take a p laceho lder f i l e and f i l l out the PLACEHOLDER s t r i n g s to
c rea t e the ac tua l f i l e .
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E . g . Replace ( " f i l e . t x t " , " t e s t " ) w i l l use the f i l e f i l e p l a c e ho l d e r .
t x t and
rep lace a l l "PLACEHOLDER0" with " t e s t " . " " "
name , ext = os . path . s p l i t e x t ( path )
data = open(name+"p laceho lder "+ext , " r " ) . read ()
f o r i , new in enumerate ( p laceho lde r s ) :
data = data . r ep lace ( "PLACEHOLDER"+ s t r ( i ) ,new)
open( path , "w" ) . wr i te ( data )
# I n s t a l l a l l requ i red packages :
rv = os . system ( " sudo apt−get i n s t a l l python3 .5 bui ld−e s s e n t i a l
python3.5−dev python3−tk python3−pip l ibxml2−dev l i b z−dev qt5−
de f au l t po s t g r e sq l pos tg re sq l−con t r i b nginx rabbitmq−s e r ve r " )
i f rv : p r in t2 (BAD , " Something went wrong with i n s t a l l i n g packages .
This might be bad . " )
rv = os . system ( " sudo python3 −m pip i n s t a l l Biopython python−igraph
matp lo t l i b django ce l e r y uwsgi psycopg2 " )
i f rv : p r in t2 (BAD , " Could not i n s t a l l anything with pip . " )
# Set up the database :
p r i n t ( " " )
p r in t2 (YELLOW, " Creat ing DB named clonef low . " )
rv = os . system ( " sudo −u pos tg re s psq l −c ’CREATE DATABASE clonef low
’ " )
i f rv : p r in t2 (BAD, " Could not c r ea t e database . " )
p r i n t ( " " )
p r i n t (YELLOW+"Se t t i ng pos tg re s password . " )
rv = os . system ( " sudo −u pos tg re s psq l −d clonef low −c ’ \ password ’ " )
postgresPassword = getpass . ge tpass ( " Enter password once more : " )
# Create a s e t t i n g s . py with the database password .
p r i n t (END)
Replace ( " env1/ s e t t i n g s . py " , postgresPassword )
pr in t2 (GREEN+BOLD, " Added the password to env1/ s e t t i n g s . py . " )
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# Create env1_nginx . conf from template . Feed in the cur ren t
d i r e c t o r y ( i t does not accept r e l a t i v e paths ) .
a s s e r t os . path . e x i s t s ( " / e t c / nginx / s i t e s−enabled " ) , " nginx
i n s t a l l a t i o n not found . "
Replace ( " env1_nginx . conf " , DIR)
# Make a symbol ic l i n k from env1_nginx . conf to e t c /nginx / s i t e s−
enabled / .
# Create s o f t l i n k only i f i t does not e x i s t .
i f not os . path . e x i s t s ( " / e t c / nginx / s i t e s−enabled /env1_nginx . conf " ) :
a s s e r t not os . system ( " sudo ln −s "+DIR+"/env1_nginx . conf / e t c /nginx
/ s i t e s−enabled /env1_nginx . conf " ) , " Could not c r ea t e s o f t l i n k fo r
nginx . "
# Set the uwsgi paths :
Replace ( " env1_uwsgi . i n i " , DIR)
# Te l l Django about i t :
rv = os . system ( " python3 manage . py makemigrations " )
i f rv : p r in t2 (BAD, " Could not make migra t ions . Did you type the
wrong password in the prev ious s tep ? " )
rv = os . system ( " python3 manage . py migrate " )
i f rv : p r in t2 (BAD, " Could not migrate . " )
# Create django user .
p r i n t ( " " )
p r in t2 (YELLOW, " Create superuser f o r Django ( c t r l+c to sk ip t h i s
s tep ) : " )
rv = os . system ( " python3 manage . py c rea te superuse r " )
i f rv : p r in t2 (BAD, " Superuser not c rea ted . " )
os . system ( " chmod 777 . / r e s t a r t . sh " )
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rv = os . system ( " . / r e s t a r t . sh " )
i f rv : p r in t2 (YELLOW, " Could not r e s t a r t nginx and rabbitmq . " )
os . system ( " chmod 777 . / s t a r t . sh " )
rv = os . system ( " . / s t a r t . sh " )
i f rv : p r in t2 (BAD, " Could not s t a r t the se r ve r . " )
158
